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Abstract 
 
Plasmodium parasites, the causative agents of malaria, are responsible for a significant 
burden of disease worldwide. Understanding populations and parasite biology is critical 
to developing effective control mechanisms and questions relating to these have been 
addressed in this thesis using whole genome and transcriptome sequencing. In Southeast 
Asia, the zoonotic species Plasmodium knowlesi now causes a significant amount of 
malarial disease, particularly in Malaysia. Clinical isolates of P. knowlesi from 
peninsular Malaysia were whole genome sequenced and single nucleotide 
polymorphisms were used to inform population genomic analyses. This work confirmed 
the existence of a third, divergent population of P. knowlesi in peninsular Malaysia and 
uncovered evidence of selection acting on these parasites. In sub-Saharan Africa, P. 
falciparum is responsible for virtually all malarial disease. Clinical isolates sampled 
from West Africa were investigated using whole transcriptome sequencing of ex vivo 
parasites, focusing on a gene known as mspdbl2, which is a possible marker of 
gametocytogenesis. Schizonts from clinical isolates were assessed for MSPDBL2 
expression by immunofluorescence assays and were whole transcriptome sequenced. 
Analysis of gene expression was carried out correlating to expression of MSPDBL2, 
revealing enrichment of genes with known or suspected involvement in 
gametocytogenesis. A limiting factor of this investigation was the very low amount of 
material available from ex vivo culture. An alternative avenue for investigating limiting 
material is through single-cell sequencing. One method for single-cell transcriptomics 
was trialled in this thesis and extensive optimisation resulted in the sequencing of 
transcriptomes from a small number of P. falciparum schizonts, offering a future 
methodology for investigating gene expression using very few parasites. 
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1. Introduction 
 
1.1 Malaria remains a global disease 
Despite extensive control attempts around the world, and elimination strategies 
launched in some selected locations, Plasmodium species continue to cause extensive 
malarial disease and death. In 2017 there were an estimated 219 million new malaria 
cases, reported from 87 countries, with sub-Saharan Africa holding a disproportionate 
burden of disease, accounting for over 90% of all malaria cases and deaths (World 
Health Organisation 2018). Whilst malaria remains a serious, global disease, its effect 
has been lessened over the years, with the number of malaria deaths being reduced from 
over 800,000 in 2000 to 435,000 in 2017 (Figure 1.1), although the rate of decrease of 
malarial disease in at risk populations has slowed in recent years. The use of insecticide-
treated bed nets has been the cause of the greatest decline in malaria cases since 2000, 
although evidence suggests that other control strategies (residual indoor spraying and 
rapid diagnosis and treatment by artemisinin-combination therapy) also have an 
important impact on disease when they are implemented intensively (Bhatt et al. 2015). 
An additional and ongoing problem is the lack of an available and effective vaccine. 
Only one vaccine candidate has been through phase 3 trials, and has been shown to 
provide only moderate and short term protection, estimated to be effective at preventing 
~40% of malaria cases for up to a year (RTS 2015). 
 
Out of 87 malaria endemic countries, 43 reported an increase in the incidence of 
malarial disease between 2010 and 2017, most of which are in Africa (World Health 
Organisation 2018). This increase is mainly thought to be as a result of improved 
surveillance, reporting, and diagnostic techniques, but could also be the result of poor 
vector control and the limited use of effective diagnosis and treatment in many 
populations (World Health Organisation 2018). The development and spread of  
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Figure 1.1. The incidence of malaria measured as the number of new cases of malaria 
per year per 1,000 people at risk between 2000 and 2015. Malaria incidence has 
steadily declined since 2000 but remains a global disease of substantial impact 
(ourworldindata.org/malaria). 
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antimalarial drug resistance in Plasmodium species, along with insecticide resistance in 
mosquitos pose increasing concerns for the re-emergence of disease (World Health 
Organization 2016). Plasmodium falciparum is the main cause of malaria in almost all 
endemic regions, with P. vivax being responsible for the majority of the remaining 
cases. Despite a 40% decrease in the incidence of P. vivax malaria since 2000, it still 
represents an important cause of disease (Battle et al. 2019). In South America, 75% of 
disease in endemic countries is caused by P. vivax. The other three malaria parasite 
species known to cause human disease, P. malariae, P. ovale (which comprises two 
cryptic species), and P. knowlesi, do so at a much lower incidence rate. 
 
1.2 Life cycle of Plasmodium parasites 
Plasmodium parasites have a complex life cycle requiring a vertebrate intermediate host 
and a mosquito definitive host which acts as the parasite vector (illustrated in Figure 
1.2). Parasites undergo many rounds of asexual replication within the circulatory system 
of the vertebrate host, the portion of the life cycle that is responsible for symptomatic 
disease. Infection of the vertebrate host begins when an infected mosquito introduces 
Plasmodium sporozoites into the skin and they circulate through the lymphatic system 
until they reach the liver. Sporozoites enter hepatocytes in the liver and develop 
intracellularly over several days to form hepatocytic schizonts, within which asexual 
replication produces thousands of merozoites. These are polarised cells containing 
specialised organelles and structures at their apical ends to facilitate erythrocyte 
invasion. The merozoites are eventually released into the blood where they are able to 
invade host erythrocytes, initiating the asexual intraerythrocytic development cycle. 
Once invasion has occurred, the parasite exports hundreds of proteins that must traverse 
the parasitophorous vacuole – a membrane-bound compartment created during invasion 
that surrounds the parasite within the erythrocyte – to enter the host cell and many of  
 16 
 
Figure 1.2. The life cycle of Plasmodium species. Plasmodium parasites infect a 
vertebrate intermediate host and mosquito vector definitive host. Injection of 
sporozoites into the vertebrate skin and vascular system begins the infection. 
Sporozoites move through the lymphatic system to the liver, where they enter 
hepatocytes and undergo round of nuclear division to produce thousands of 
merozoites (‘Liver stage’). These are released back into the blood, where they circulate 
and undergo repeated rounds of asexual replication (‘Blood stage’). Within each cycle, 
up to 32 daughter merozoites develop from a single mature schizont. A small 
proportion of parasites undergo gametocytogenesis and develop into male or female 
gametocytes. These are taken up by a mosquito taking a blood meal, where they 
undergo genetic recombination, resulting in the production of sporozoites, ready to 
infect another host. (Source: Cowman, Berry, & Baum, 2012). 
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these proteins are responsible for issuing extensive alterations to the cells (Lingelbach 
and Joiner 1998; Marti et al. 2004). The intraerythrocytic parasite now undergoes 
morphological development, first into a ‘ring’ stage early trophozoite before growing 
rapidly to develop into a haemozoin-sequestering late trophozoite. Trophozoites 
continue to grow, and undergo nuclear division to form multi-nucleate schizonts – the 
mature stage of the parasite’s asexual life cycle. Nuclear division allows the formation 
of up to 32 merozoites within a single schizont, and these are released upon rupture of 
the host erythrocyte. Free merozoites enter the blood stream and will typically reinvade 
erythrocytes in less than five minutes (Gilson and Crabb 2009; Boyle et al. 2010). In 
many cases it is synchronised merozoite egress that is responsible for the periodic and 
cyclical nature of malarial disease symptoms. In addition, P. falciparum trophozoites 
and schizonts adhere to and sequester themselves within organ microvasculature in a 
process mediated by the polymorphic PfEMP1 proteins, encoded by the multi-gene 
family, var, which can lead to severe disease complications, such as cerebral malaria 
(MacKintosh et al. 2004). Cytoadhesion has also been reported for P. vivax and P. 
berghei parasites and proposed for P. knowlesi, although it may not be required for 
these species and the molecular mechanisms involved are still under investigation 
(Carvalho et al. 2010; Fatih et al. 2012; El-Assaad et al. 2013). The length of a single 
erythrocyte invasion cycle varies between species, and lasts for approximately 48 hours 
in P. falciparum, P. vivax, and P. ovale, 72 hours in P. malariae, and only 24 hours in 
P. knowlesi, whose quotidian life cycle can lead to rapid development of complications 
and severe malaria (Cox-Singh et al. 2008). 
 
A small proportion of parasites within the asexual intraerythrocytic cycle will develop 
into male or female gametocytes rather than progressing through further rounds of 
asexual replication and it is these sexual parasites that are transmitted to mosquitos 
 18 
during a blood meal, where they fertilise to form zygotes which undergo genetic 
recombination in the mosquito midgut during the only diploid portion of the parasite’s 
life cycle. 
 
1.3 Plasmodium falciparum is a major global cause of disease 
Plasmodium falciparum is most prevalent malaria parasite species in most endemic 
regions except South America and parts of Asia, and is the most likely species to cause 
severe disease (Figure 1.3A). It disproportionately affects children under 5 years old, 
and in the WHO African region (Figure 1.3B) was responsible for 99.7% of malaria 
cases in 2017 (Figure 1.3A) (World Health Organisation 2018). In other WHO regions 
(Figure 1.3B), it was responsible for up to two thirds of all malarial disease. Since the 
year 2000, control mechanisms and rapid treatment with artemisinin combination 
therapy (ACT) have reduced the incidence of P. falciparum malarial disease by ~40% 
in Africa (Bhatt et al. 2015), where the number of deaths due to P. falciparum malaria 
are estimated to have dropped by 57% since 2000 (Gething et al. 2016). In the two 
decades prior to that, Africa saw a probable increase in mortality rates as resistance to 
the then front line anti-malarial drug (chloroquine) became rampant and widespread, 
and it was only after the introduction of new drugs that mortality decreased substantially 
after 2005 (Murray et al. 2012). Currently there are still regions of Africa which carry a 
high burden of malaria mortality, particularly these that have poor coverage with anti-
malarial treatment and insecticide-treated bed nets (Gething et al. 2016).   
 
Resistance to anti-malarial drugs has been reported in P. falciparum since the 1950s and 
is now widespread throughout P. falciparum endemic regions, presenting a growing 
concern regarding malaria treatment and elimination (Mita and Tanabe 2012). 
Chloroquine was a first line anti-malarial treatment for many years (and is still in some  
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Figure 1.3. Proportion of malaria caused by P. falciparum and P. vivax in WHO 
geographical regions A. Proportion of malaria cases caused by the two most prevalent 
malarial species, P. falciparum (orange) and P. vivax (blue), in World Health 
Organisation geological regions (shown in B). ~200 million cases reported in the 
African region (AFR), 99.7% caused by P. falciparum, ~11 million cases in the Southeast 
Asia region (SEAR), 63% caused by P. falciparum, ~4.4 million cases in the Eastern 
Mediterranean region (EMR), 69% caused by P. falciparum, and ~1.9 million cases in 
the Western Pacific region (WPR), 72% caused by P. falciparum. The region of the 
Americas (AMR) is the only malaria endemic region where P. vivax is the predominant 
cause (74%) of malaria. B. Map of the world divided into the World Health 
Organisation geological regions corresponding to regions in A. 
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regions in which P. falciparum remains chloroquine-susceptible), before the spread of 
resistance resulted in need for other drugs. Resistance to chloroquine was reported 
independently in the 1950s in Southeast Asia (along the Thailand-Cambodia border) 
and South America (along the Panama-Colombia border) (Wellems and Plowe 2001) 
and is mediated by the chloroquine-resistance transporter (pfcrt) gene (Fidock et al. 
2000). Genetic analysis of the pfcrt gene revealed that resistance originating from 
Southeast Asia had spread throughout Africa (Ariey et al. 2006) and into India by the 
1980s (Shah et al. 2011), and resistance originating from the Panama-Colombia border 
had spread to all South American endemic regions by the early 1980s (Mita and Tanabe 
2012). Similar geographic patterns of drug resistance spread can be seen for parasites 
with resistance against other anti-malarials (Mita and Tanabe 2012).  
 
In 2005 Artemisinin-combination therapies (ACT) were recommended by the WHO as 
the first line treatment for P. falciparum malaria. These treatments combine artemisinin 
with another anti-malarial drug, and result in rapid and substantial clearance of 
parasites. Increased usage and availability of ACTs have had a profound impact on 
malaria control (Bhatt et al. 2015). However, as with older anti-malarial drugs, 
resistance to artemisinin has now developed in P. falciparum. Resistance was first 
reported in Cambodia, but is now found throughout Southeast Asia and is associated 
with slow clearance of parasites caused by multiple point mutations in the gene kelch13 
that affect the “propeller” region of the protein (Ashley et al. 2014). Evidence has also 
suggested that patients carrying resistant parasites had higher than expected amounts of 
gametocytes in peripheral blood before and after ACT treatment, suggesting that these 
parasites may also have a transmission advantage over artemisinin-susceptible parasites 
(Ashley et al. 2014). Artemisinin resistance has not yet been clearly reported in Africa, 
with a single isolated case identified in 2013 in Equatorial Guinea, located on the West 
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coast of Central Africa (Lu et al. 2017) and an analysis of kelch13 point mutations in 
isolates from Africa showed them to have no effect on parasite clearance (Ménard et al. 
2016). However, recent evidence from P. falciparum isolates collected from both Kenya 
(East Africa) and Ghana (West Africa) has uncovered single nucleotide polymorphisms 
present within genes that have been linked to delayed parasite clearance upon treatment 
with ACT (Henriques et al. 2014; Adams et al. 2018). Single nucleotide polymorphisms 
and gene expansions have also been found throughout Southeast Asia in genes linked to 
resistance to both drugs in an ACT (Hamilton et al. 2019).  
Aside from drug resistance, an ongoing concern in the context of anti-malarial drugs is 
that the vast majority are ineffective at killing gametocytes, resulting in the risk of 
transmission from treated patients. Development of “transmission-blocking” drugs is 
ongoing, with several that are active against sexual stages in various pre-clinical and 
clinical phases of the development pipeline (Ashley and Phyo 2018). 
 
1.4 Plasmodium knowlesi malaria in Southeast Asia 
In much of Southeast Asia, P. falciparum remains the leading cause of malaria, with P. 
vivax being the second most common causal species (Figure 1.3A) (WHO 2017). 
However, the species P. knowlesi is now recognised as an emerging and underestimated 
cause of disease, and is particularly important in Malaysia. Unlike the common malaria 
parasite species that infect humans, P. knowlesi is a zoonotic parasite which primarily 
infects two species of macaque monkey which occur throughout Southeast Asia 
(Coatney et al. 1972). Although P. knowlesi parasites are potentially capable of human-
mosquito-human transmission, human infections are thought to be acquired sporadically 
from mosquitos that have previously bitten monkeys (Chin et al. 1968). Human 
infections are usually uncomplicated, but do have the capacity to result in severe and 
sometimes fatal disease (Singh et al. 2004; Cox-Singh et al. 2008; Daneshvar et al. 
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2009). In a study of patients from Sarawak in Malaysian Borneo confirmed to be 
infected with P. knowlesi, a small proportion presented with or went on to develop 
severe disease (Daneshvar et al. 2009). In Sabah, Malaysian Borneo, another study 
identified a higher proportion of patients with P. knowlesi malaria that developed severe 
disease (William et al. 2011), and the most common severe complication reported is 
respiratory distress (Cox-Singh et al. 2008; Daneshvar et al. 2009; William et al. 2011; 
Rajahram et al. 2012). Severe disease leading to death has since been identified 
retrospectively in cases of malaria identified incorrectly with P. malariae (Cox-Singh et 
al. 2008; Singh and Daneshvar 2013). Research has indicated that a high fatality rate 
may be caused by a delay in administering appropriate treatment because of P. malariae 
mis-diagnosis (a species that typically causes mild disease), and also due to possible 
misconception that severe disease is limited to P. falciparum infection (Rajahram et al. 
2012). 
 
Human infections with P. knowlesi have been mostly reported from Malaysia (Figure 
1.4). The first report of human P. knowlesi infection came in 1965 from an infected 
traveller returning from peninsular Malaysia where he had spent several nights in the 
forest (Chin et al. 1965; Coatney 1971).  However it was not until the early 2000s that 
the first report of widespread infection appeared, located in Kapit district of Sarawak 
state in Malaysian Borneo (Singh et al. 2004). In this study, blood samples were taken 
from over 200 malaria patients, two thirds of which had been diagnosed with P. 
malariae by microscopy. PCR analysis of these samples reveal that none were infected 
with P. malariae, and in fact over 50% were infected with P. knowlesi, with mis-
diagnosis with P. malariae being a result of the morphological similarities between the 
two species, making microscopic diagnosis challenging (Singh et al. 2004). While the 
traveller in 1965 who contracted P. knowlesi malaria was also briefly mis-diagnosed  
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Figure 1.4. P. knowlesi at-risk regions of Southeast Asia and distribution of reservoir 
host and vector species. A. Regions of Southeast Asia considered to be at risk of 
human P. knowlesi malaria, where “1” (purple) is considered high risk and “0” (green) 
zero risk. Cases have already been reported in all Southeast Asian countries except 
Laos. Adapted from (Shearer et al. 2016). B. Distribution of the mosquito vectors 
(yellow) and macaque reservoir hosts (red and green outlines) of P. knowlesi along 
with regions in which human (blue shading) and macaque (red shading) P. knowlesi 
infection has been reported. Source: (Singh and Daneshvar 2013). 
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with P. falciparum and then P. malariae prior to his correct diagnosis with P. knowlesi, 
the report from Kapit was the first evidence of the chronic and widespread mis-
diagnosis that has unquestionably had an impact on the epidemiological status of P. 
knowlesi in Malaysia and probably elsewhere in Southeast Asia. Retrospective PCR 
analysis of blood films originally classified by microscopy as P. malariae from 1996 
onwards in Malaysia revealed that nearly 100% of samples contained P. knowlesi (Lee 
et al. 2009).  
 
Since this first report of widespread P. knowlesi malaria in Sarawak, further 
investigation has revealed it to be prevalent in other part of Malaysia as well. In the 
Sabah state of Malaysian Borneo, much like in Sarawak, mis-diagnosis of patients with 
P. malariae has led to underreporting of the true extent of P. knowlesi malaria, with 
adults bearing the brunt of this zoonotic disease (Barber et al. 2011). Over 4500 cases of 
P. knowlesi malaria have now been formally identified in Malaysian Borneo (World 
Health Organisation 2017), although actual numbers of cases will be higher due to 
previous mis-reporting. Species-specific PCR analysis has been carried out on human 
blood samples collected throughout peninsular Malaysia as well, and P. knowlesi 
infection was confirmed for between 50% and 70% of malaria cases, across several 
states, showing that the parasite is not limited to Malaysian Borneo (Vythilingam et al. 
2008; Yusof et al. 2014).  Subsequent collection of blood samples from over 100 wild 
long-tailed and pig-tailed macaques (Macaca fascicularis and M. nemestrina, 
respectively) throughout the Kapit region in Sarawak and PCR analysis revealed that 
multi-species and multi-genotype infections were common, and that P. knowlesi was 
present in almost all of the long-tailed macaque samples, and in half of the pig-tailed 
macaque samples (Lee et al. 2011). Similar sampling from wild macaques 
(predominantly long-tailed macaques) in peninsular Malaysia revealed that half were 
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positive for P.  knowlesi, and only a few macaques were positive for non-P. knowlesi 
malaria (Vythilingam et al. 2008). In Kuala Lipis in the state of Pahang in peninsular 
Malaysia, a smaller proportion of macaques were positive for P. knowlesi parasites, but 
in contrast no parasite-positive macaques were found in the state of Selangor, indicating 
that infection is not homogenous throughout all of Malaysia (Vythilingam et al. 2008). 
Sequence analysis of the small subunit ribosomal RNA (SSUrRNA) gene locus, as well 
as the circumsporozoite surface protein (csp) gene locus from a panel of P. knowlesi 
isolates sampled from wild macaques and human infections in Malaysian Borneo 
revealed no clustering based on host species, indicating that transmission is not host-
restricted, and these results implicate the long-tailed and pig-tailed macaques as being 
the primary reservoir hosts for human infection  (Lee et al. 2011). Consequently, 
malaria caused by P. knowlesi is now known to be widespread and is recognised as the 
leading cause of malaria in Malaysia (Singh et al. 2004; Cox-Singh et al. 2008; 
Vythilingam et al. 2008; Lee et al. 2011; Yusof et al. 2014). In Sabah, the incidence of 
P. knowlesi appears to be rising alongside decreasing rates of P. falciparum and P. vivax 
(William et al. 2013; Cooper et al. 2019). This is likely a combination of much 
improved diagnostics and acknowledgment of P. knowlesi malaria but also due to 
human behaviour, with deforestation and changing land use altering the behaviour of 
macaques and resulting in closer proximity between them and humans (William et al. 
2013; Stark et al. 2019). With Malaysia on the World Health Organisation “E-2020” list 
of countries aiming to eliminate human transmitted malaria by 2020, understanding and 
control of P. knowlesi disease is critical. 
 
Outside of Malaysia, P. knowlesi malaria is more rarely reported, although human cases 
have been identified in nine countries in Southeast Asia, with others considered to be at 
risk (Figure 1.4A) (Shearer et al. 2016). With several countries in Southeast Asia on 
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track to achieve malaria elimination, P. knowlesi presents a unique challenge. 
Developing long-term strategies for this infection will be critical as it cannot be 
removed as part of general malaria elimination. Indonesia is one such country that is 
aiming for malaria elimination by 2030 (Sitohang et al. 2018), and which has recently 
reported a significant number of local cases of P. knowlesi malaria (Herdiana et al. 
2016; Lubis et al. 2017; Coutrier et al. 2018; Herdiana et al. 2018). A study carried out 
in North Sumatra (on the island of Sumatra, geographically isolated from mainland 
Southeast Asia and Borneo) has indicated that an unexpectedly high proportion of 
individuals were PCR-positive for P. knowlesi (Lubis et al. 2017). On another isolated 
island of Indonesia, Sabang, which is predominantly forested and home to long-tailed 
macaques, no case of malaria had been reported since 2011 until active case detection 
uncovered two clusters of human P. knowlesi infection. One cluster was associated with 
construction workers known to spend nights in the forest and were therefore in close 
proximity to macaques, while the other occurred within one family at a residential 
location (Herdiana et al. 2018).  
 
In Thailand, the first naturally acquired P. knowlesi infection in a human was reported 
in 2004 from a forested region near the Thailand-Myanmar border (Jongwutiwes et al. 
2004), and more endemic cases have since been identified throughout Thailand 
(Putaporntip et al. 2009; Jongwutiwes et al. 2011). Natural infections have also been 
reported in Singapore (Ng et al. 2008; Jeslyn et al. 2011), Vietnam (Eede et al. 2009), 
Cambodia (Khim et al. 2011), and Myanmar (Ghinai et al. 2017). In the Philippines, 
cases of P. knowlesi infection in travellers have been reported on the island of Palawan 
(De Canale et al., 2017; Ennis et al., 2009), and imported cases have also been reported 
from Indonesian Borneo (Figtree et al. 2010) and Thailand (Müller and Schlagenhauf 
2014). The geographical area reporting human P. knowlesi infection is therefore 
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substantial, and the wide distributions of mosquito vectors and macaque reservoir 
species make control of this parasite challenging (Figure 1.4B). 
 
Understanding the population structure of P. knowlesi may be useful in devising 
effective control strategies against the parasite. In Malaysian Borneo multi-locus 
microsatellite analysis of P. knowlesi has shown that it forms two, genetically distinct 
sympatric populations, associated with different macaque reservoir hosts (Divis et al. 
2015; Divis et al. 2017). These divergent populations have been confirmed by whole-
genome sequencing (Assefa et al. 2015; Pinheiro et al. 2015; Divis et al. 2018). In 
peninsular Malaysia, a third population, genetically distinct from those of Malaysian 
Borneo has been identified, originally comprising a small number of old laboratory 
isolates of P. knowlesi,  but microsatellite analysis of recent clinical samples has since 
confirmed this third population as accounting for all cases analysed in peninsular 
Malaysia (Assefa et al. 2015; Divis et al. 2017).  
Outside of Malaysia however, the genetic structure of P. knowlesi is almost entirely 
unknown. Limited research has been carried out using clinical isolates collected from 
Thailand, based on the amplification and sequencing of a single genetic loci, and it 
seems that these parasites cluster most closely with those from peninsular Malaysia 
indicating some relatedness of parasites on mainland Southeast Asia that have diverged 
from P. knowlesi on Malaysian Borneo (Ahmed et al. 2018), although further sampling 
and deeper sequencing methods will need to be used to verify these results. Increased 
effort for sampling and in-depth genomic analysis will be necessary to understand P. 
knowlesi genomics more broadly in Southeast Asia. Further detail regarding the 
genomic population structure of P. knowlesi populations in Malaysia will be given in 
Chapter 3. 
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1.5 Development of genome sequencing techniques and their use in Plasmodium 
research 
The ability to sequence an organism’s genome has revolutionised genetics. The first 
genome to be fully sequenced was that of bacteriophage F174 in 1977, using “plus and 
minus” DNA sequencing, a predecessor of Frederick Sanger’s hugely successful di-
deoxy chain termination method (“Sanger sequencing”) (Sanger and Coulson 1975; 
Sanger et al. 1977; Sanger et al. 1978). The rapid development, ease of use, and 
reliability of Sanger sequencing eventually over took the plus and minus method and 
other sequencing techniques available at the time, and has been used extensively since. 
The advent and commercialisation of “next-generation” sequencing in the late 1990s  
and early 2000s has since provided an option for very high-throughput DNA sequencing 
(Heather and Chain 2016).  
 
The first “next-generation” sequencing technique was pyrosequencing developed in the 
late 1990s, and this was the first high-throughput, scalable next-generation sequencing 
platform to be commercialised in 2005. Pyrosequencing is a sequencing-by-synthesis 
reaction, where an isolated DNA fragment is used as a template for DNA polymerase in 
the presence of several other compounds, one of which is luciferase. The addition of a 
base by DNA polymerase is controlled by washing the DNA template with one of the 
four nucleotides (dATP, dTTP, dCTP, or dGTP) and incorporation of a nucleotide is 
accompanied by the release of pyrophosphate, which is converted to ATP and acts as a 
substrate for luciferase. This is detected as light, and allows the DNA sequence to be 
elucidated (Nyrén et al. 1993; Ronaghi et al. 1998). Pyrosequencing has fallen out of 
use in recent years in favour of other high-throughput shotgun sequencing techniques, 
such as Illumina’s sequence-by-synthesis chemistry, and so-called “third-generation” 
sequencing which encompasses “single molecule real-time” (SMRT) sequencing from a 
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single intact DNA molecule, with the commercially available PacBio system released in 
2010, followed in 2015 by the first portable SMRT sequencer (the MinION) from 
Oxford Nanopore. One of the advantages of SMRT sequencing over short read 
sequencing, such as what is provided by Illumina, is that as DNA is sequenced as a 
single molecule (“long-read” sequencing), the data can be used to uncover structural 
polymorphisms (for example, copy number variants) that are not easily resolved using 
short-read data.  
 
Illumina sequencing is currently the most widely used technology, and sequencing 
begins with the capture and immobilisation of DNA fragments onto a glass slide (the 
“flow cell”). DNA fragments are then clonally amplified by “bridge amplification”, 
during which the forward DNA fragments bend over to bind an oligo sequence attached 
to the flow cell. DNA polymerase then builds the reverse complementary strand of 
DNA and the two strands release, with the original forward strand being washed away 
and the newly synthesised reverse strand remaining attached to the flow cell. The newly 
synthesised strand of DNA then bends over to bind another oligo, forming a bridge and 
DNA polymerase builds a complementary strand. These two strands are then denatured, 
leaving two single stranded DNA fragments attached to the flow cell, which can go on 
to form further bridges. This process is repeated many times, forming clusters of 
identical DNA strands which will then be sequenced. These clonally amplified clusters 
are an important quality control step and are used to differentiate between mutations in 
the genome and errors introduced during sequencing. After amplification, sequencing-
by-synthesis is carried out. DNA polymerases are primed on the DNA fragments and 
synthesis occurs one base at a time. Each nucleotide fluoresces at a different wavelength 
upon addition to the DNA chain, which is interpreted computationally to build the DNA 
sequence. 
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Plasmodium falciparum was the first malaria parasite to be whole-genome sequenced, 
in a project spanning 7 years from 1995-2002, using Sanger sequencing, carried out on 
individually fragmented and clones chromosomes (Foster et al. 1995; Gardner et al. 
2002). The P. vivax and P. knowlesi genomes were also sequenced using the Sanger 
method with dye-terminator chemistry and published several years later in 2008 
(Carlton et al. 2008; Pain et al. 2008). The publication of these later genomes coincided 
with the first commercial launch of Illumina’s sequencing-by-synthesis next-generation 
sequencing chemistry. The continued decreasing cost of Illumina sequencing, combined 
with robust and reliable sequencing capabilities make it the most used sequencing 
technology (Heather and Chain 2016). Large scale genomic sequencing of Plasmodium 
parasites now allows analysis of population structure (Assefa et al. 2015), 
characterisation and spread of drug resistance loci (Miotto et al. 2013; Ariey et al. 
2014), and insight into parasite biology and evolution (Volkman et al. 2007; Manske et 
al. 2012). Nearly 3000 genomes of P. falciparum have been sequenced in an effort to 
gain a comprehensive understanding of variation within the species around the world as 
part of the MalariaGEN Pf3k project (https://www.malariagen.net/projects/pf3k), just 
one example of how high-throughput sequencing techniques are being implemented for 
large-scale projects. 
 
1.5.1 Plasmodium genomics 
All of the parasite species that cause human malaria now have high quality whole-
genome reference sequences available (Gardner et al. 2002; Carlton et al. 2008; Pain et 
al. 2008; Rutledge et al. 2017). Sequencing of these species has allowed substantial 
analysis of their particular genomics and revealed a surprising number of differences 
between them. The genome of the P. falciparum laboratory line 3D7 was completed 
first in 2002 (Gardner et al. 2002). It is 23Mb in length, comprises 14 chromosomes and 
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contains ~5300 protein-coding genes for a gene density of approximately one gene per 
every ~4300bp. In the initial analysis, only 30% of protein-coding genes had high 
enough similarity to genes in other organisms to assign putative functions. The genome 
has an extremely high content of A + T bases, averaging ~80% genome-wide, rising to 
~90% in introns and intergenic regions. This extreme AT bias is also seen in other 
members of the Plasmodium genus (Figure 1.5), but in particular is shared with other 
species of the Laverania “sub-genus” of Plasmodium, which includes other primate 
malarias, P. reichenowi and P. gaboni alongside P. falciparum. Evidence has suggested 
that there is significant bias towards G:C to A:T transition mutations that could be the 
cause of the extreme A + T content seen in P. falciparum and the other Laverania 
species, leading to possible mutational advantages such as a propensity for gene 
expansions and accumulation of insertion/deletion events affecting gene expression 
(Hamilton et al. 2017). 
 
Within the P. falciparum genome, each chromosome has highly conserved sub-
telomeric regions comprising of large and complex repeat structures, which form five 
sub-telomeric “blocks”. Three antigenic, low complexity and highly polymorphic gene 
families of P. falciparum are located in the sub-telomeric regions, the var, rif, and 
stevor families (Gardner et al. 2002). Members of these three families are formed by 
two exons and their arrangement within the sub-telomeres is highly structured. The var 
gene family encodes highly diverse PfEMP1 proteins that are exposed on the infected 
erythrocyte cell surface and mediate cytoadhesion, which is an integral part of P. 
falciparum’s pathogenicity (Su et al. 1995). The function of rif proteins (rifins) and 
stevor proteins is unknown, but they are also exposed on the erythrocyte cell surface 
and show antigenic variation (Petter et al. 2007). The development of these large gene 
families within the sub-telomeres may be a reflection of the nature of these genomic  
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Figure 1.5. Phylogenetic tree representing relationships between Plasmodium clades 
alongside A+T genome content. Also shown are other non-Plasmodium apicomplexan 
parasites, Babesia microti, Theileria parva, and Toxoplasma gondii. Branches do not 
accurately represent evolutionary distances. Source (Hamilton et al. 2017). 
 
 
 
 
 
 
 
 
 
 
 33 
regions, which are highly polymorphic and interspersed with repeat sequences, 
undergoing frequent recombination and gene duplication events (Fischer et al. 1997).  
 
There has been substantial genomic variation reported in P. falciparum, with the most 
rapidly evolving genes being transmembrane proteins, and those involved in antigenic 
variation, cytoadhesion, and cell invasion, whereas essential genes such as those 
encoding metabolic enzymes show complete conservation  (Jeffares et al. 2007; 
Volkman et al. 2007). Some of these polymorphic, multi-allelic genes are expressed in 
the erythrocytic stage and as such interact with the host environment, representing 
targets of natural immunity. These have evolved under diversifying, balancing selection, 
which produces highly polymorphic loci, for example the merozoite surface proteins 
such as msp3, mspdbl1, and mspdbl2, and antigenic genes such as apical membrane 
antigen-1 (ama1) and erythrocyte-binding antigens, for example eba175  (Tetteh et al. 
2009; Ochola et al. 2010; Amambua-Ngwa et al. 2012). Other polymorphic genes have 
evolved under directional selection and these are often drug resistance loci, such as the 
chloroquine resistance genes pfcrt and mdr1. The selection acting on these genes is 
often causes a selective sweep which increases the frequency of an advantageous allele 
and the flanking chromosomal sequencing which tends to be population specific, and 
causes of selection are driven different treatment programmes in different locations 
(Wootton et al. 2002; Mobegi et al. 2014).  
 
The first reference genome of P. knowlesi to be sequenced was reported as 23.5Mb in 
length distributed across 14 chromosomes (Pain et al. 2008). Unlike P. falciparum, P. 
knowlesi has a less skewed A + T content of 63%. The genome encodes ~5200 protein-
coding genes, 80% of which have orthologues in P. falciparum. In contrast to P. 
falciparum, in which large multi-copy antigenic gene families are mostly in the sub-
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telomeres, genes from the P. knowlesi-specific polymorphic kir and SICAvar families 
are found throughout the chromosomes, often surrounded by intrachromosomal 
telomeric-like sequences. In addition to the SICAvar and kir gene families, five more P. 
knowlesi-unique families were identified (Pk-fam-a to Pk-fam-e) (Pain et al. 2008). The 
genome of P. knowlesi is largely similar to those of other malarias that fall in the simian 
malaria clade, P. vivax (which exclusively infects humans), and P. cynomolgi (which 
while capable of human infection, exclusively infects monkeys naturally), with 
comparable A + T content (Figure 1.5) although it is slightly smaller than the 26 Mb 
genomes of P. vivax and P. cynomolgi. P. cynomolgi also contains the 
intrachromosomal telomeric sequences seen in P. knowlesi, although these are absent in 
P. vivax. Almost all of the genes identified in P. knowlesi have orthologues in P. vivax 
and P. cynomolgi (Tachibana et al. 2012). 
The SICAvar genes are multi-exon and encode antigens exposed on the infected 
erythrocyte cell surface and are associated with virulence. This family is unrelated to 
the P. falciparum var gene family but is also thought to undergo expression switching 
(Al-Khedery et al. 1999). SICAvar genes fall into two types: type I containing 7-14 
exons and type II containing 3-4 (Pain et al. 2008). Both SICAvar and KIR proteins 
have structured domain organisation (Figure 1.6). SICAvar proteins contain a number of 
highly diverse cysteine-rich domains, followed by a transmembrane domain and a 
SICAvar conserved domain (Figure 1.6A). Their intronic regions are low complexity 
and highly repetitive. The kir gene family is part of the pir superfamily and like 
SICAvar genes they are thought to encode antigenic proteins expressed at the 
erythrocyte cell surface (although their precise function remains unknown) and are 
divided into four types based on exon number. KIR proteins consist of 1-3 domains, 
followed by a transmembrane domain (Figure 1.6B) and several were found to contain 
amino-acid sequences with 100% identity to Macaca CD99 protein (an immune protein  
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Figure 1.6. Domain organisation of SICAvar proteins (A) and KIR proteins (B) gene 
families in P. knowlesi. A. SICAvar proteins are formed by highly variable cysteine-rich 
domains (1-2 SICA-α domains and 1-8 SICA-β domains), a transmembrane domain 
(TM), and a cytoplastic domain (SICA_C). B. KIR proteins fall into four types (based on 
the number of exons), but all have the same predicted domain organisation: 1-3 KIR 
domains, and a transmembrane domain (KIR TM). 
 
 
 
 
 
with a critical role in T-cell function) and significant identity to human CD99 (Pain et 
al. 2008). Interestingly, different KIR proteins showed identity to different regions of 
CD99 such that when combined they covered over 50% of CD99’s extracellular domain 
(Pain et al. 2008). 
 
1.5.2 Using next-generation genome sequencing to investigate population structure 
in Plasmodium 
The advent of genetic sequencing drastically changed the way in which biology and 
evolution could be investigated and has allowed the identification and characterisation 
of populations, their structure, and the individuals and selection pressures that affect 
them at the DNA level. Adaptation and selection occur as a result of mutations such as 
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insertion/deletions (INDELs), copy number variants (CNVs), microsatellites, and single 
nucleotide polymorphisms (SNPs). In P. falciparum, INDELs outnumber SNPs and 
occur most frequently in non-coding regions and CNVs covering drug resistance loci 
have been identified (Nair et al. 2007; Miles et al. 2016). Single nucleotide 
polymorphisms are a very common form of genetic variation, and are the most straight 
forward to interpret, and so they have informed vast amounts of research. SNPs can be 
used to infer genomic diversity within and between populations, identify loci under 
specific selection pressures that are driving population structure and differentiation, and 
identify mutations associated with phenotypic changes.  
 
Prior to the advent of high-throughput next-generation sequencing, analysis relied upon 
pre-existing knowledge of SNPs, which required painstaking identification of variants 
which were used to inform the design of DNA microarrays that could then be used for 
calling variants in other samples. Next-generation sequencing has since revolutionised 
the field of SNP discovery and analysis. As more and more high-quality reference 
genomes are sequenced and released, SNP discovery and analysis has become easier, 
but is still a challenge when working with non-model organisms for which high-quality 
reference genomes are not available (Kumar et al. 2012). The nature of short-read 
sequencing means that for every base of the genome, multiple independently sequenced 
DNA fragments will exist, providing consolidatory data and allowing reliable 
identification of novel polymorphisms. In addition, analysis of populations is not just 
limited to pre-identified SNPs, but instead can be based on an entire genome worth of 
data. The accumulation of SNPs is a natural mutational process, however external 
selection pressures that can ultimately lead to adaptation influence SNP patterns, and 
can be used to understand the diversity and evolutions of populations. Whole-genome 
sequencing and SNP discovery has been used to identify loci under selection between 
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different populations of Plasmodium parasites. For example, the whole-genome 
sequencing of parasites taken from two populations in West Africa, one in a high 
transmission region and the other from a low transmission region found detectable 
differences between the populations including divergent directional selection on drug 
resistance loci (correlating to variable drug use in each region), and high differentiation 
surrounding the gdv-1 locus, a gene known to be critical for gametocytogenesis 
(Mobegi et al. 2014). Long-read sequencing from P. falciparum clinical isolates from 
West Africa has since revealed a significant structural dimorphism, consisting of allele-
specific deletions in the 3’-intergenic region of gdv-1 that are under differential local 
selection and found at different frequencies in different populations (Duffy et al. 2018).  
 
The breadth of information available from high-quality SNP discovery from next-
generation data is impressive. Malaysia is considered to be in the pre-elimination stage 
for P. vivax malaria. High-throughput investigations using whole-genome sequencing 
and SNP discovery has allowed comparative analysis of P. vivax parasites from 
Malaysia with populations of parasites elsewhere in Southeast Asia where transmission 
remains high (Auburn et al. 2018). From over 200 isolates, whole genome sequencing 
allowed the identification of over 500,000 high-quality SNPs, which informed analysis 
regarding population structure and evolution of drug resistance loci, and in response to 
the selection pressures induced by near-elimination. Results revealed a high level of 
relatedness among Malaysian P. vivax samples, with one extremely large cluster 
indicating a rapid clonal expansion of a particular strain. SNP analysis also revealed 
differential selection acting on multiple loci in Malaysian samples, many of which are 
known to be involved in drug resistance (Auburn et al. 2018). Analyses such as these 
provide insights into how a changing environment impacts parasites at a molecular 
level, and will be crucial in achieving and maintaining malaria elimination in the future.  
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1.5.3 Next-generation transcriptomic sequencing 
Alongside development of next-generation sequencing for DNA, methods for capturing 
and analysing the RNA from samples were also being developed, allowing high-
throughput analysis of gene expression profiles (transcriptomes). RNA-seq was first 
demonstrated over a decade ago (Bainbridge et al. 2006), and prior to next-generation 
sequencing, cDNA microarrays were most commonly used to assess gene expression. 
However microarrays have several limitations, primarily the need for existing gene 
information (Wang et al. 2009). Next-generation sequencing on the other hand is 
capable of measuring gene expression de novo, and at a much higher scale.  Methods for 
RNA-seq are on the whole the same as those used for DNA-seq, however RNA must 
first go through some additional steps before sequencing libraries can be prepared. Due 
to the instability of RNA it is first reverse transcribed into cDNA, this is typically 
achieved using oligo(dT) primers, designed to enrich for mRNA molecules and remove 
the rRNA molecules that make up ~90% of a cell’s total RNA. Transcriptomic data for 
Plasmodium species is invaluable and (among other applications) RNA-seq has been 
used to interrogate gene expression changes throughout the life cycle of P. falciparum 
and P. vivax (Otto et al. 2010; Zhu et al. 2016), identify genes involved in the parasite 
gametocytogenesis pathway (Bancells et al. 2019), and understand the mechanisms 
underlying anti-malarial drug resistance (Antony et al. 2016; Kim et al. 2019). 
 
1.6 The advent of single-cell RNA sequencing 
Traditional RNA-seq does come with some limitations. These can be technical in 
nature, such as for researchers investigating early stages of development where there are 
simply too few cells available to carry out reliable RNA-seq. There can also be 
biological limitations, as gene expression is plastic and changes may occur in response 
to environmental and cellular cues that we are not always privy to, resulting in 
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individual cells from an identical genetic background having highly variable 
transcriptomic profiles (Tang et al. 2009). As such, when RNA-seq is carried out using 
a surplus of cells/RNA (“bulk” RNA-seq), the acquired data presents an ‘average’ 
transcriptome that is contributed to by the unique transcriptomic profiles of each cell 
(Figure 1.7). 
 
Efforts were first pursued for amplifying and sequencing RNA from single cells in the 
1990s. The first report of RNA successfully amplified from single cells was in 1990, 
analysed by in situ hybridisation (Brady et al. 1990), and the very first transcriptome to 
be sequenced from a single cell was reported in 1992 (Eberwine et al. 1992). With the  
increased availability and affordability of next-generation sequencing, the first 
transcriptome from a single cell to be sequenced using high-throughput methods was a 
mouse blastomere as reported in 2009 (Tang et al. 2009), and significant progress has 
been made since then. The pilot experiment by Tang et al. (2009) detected expression 
from over 5,000 more genes than an equivalent microarray approach that used hundreds  
of cells, and almost all of the genes shown to be expressed by microarray showed 
expression by single-cell RNA-seq (Tang et al. 2009). Applications for single cell 
RNA-seq have been extensive since then. Over the last decade, it has been used to 
investigate early stages of development (Tang et al. 2010; Reinius et al. 2016), profile 
transcriptomic heterogeneity in cancerous tissues (Ramsköld et al. 2012; Patel et al. 
2014; Chung et al. 2017), and recent developments are allowing its’ use with bacterial 
cells, aimed at understanding transcriptional changes in cells in response to 
environmental pressures (Wang et al. 2015). All single-cell RNA-seq methods follow 
the same basic protocol: isolation of single cells, lysis of cell membranes, reverse 
transcription of RNA, amplification of cDNA, followed by library preparation and next-
generation sequencing.  
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Figure 1.7. Individual cells contain unique transcriptomic profiles. RNA-seq from bulk 
material produces an ‘average’ transcriptional profile (A) that is made up from the 
individually varying profiles (B) (Adapted from Macaulay & Voet, 2014).  
 
 
 
 
 
 
Isolation of single cells is generally carried out by fluorescence-activated cell sorting 
(FACS) (Jaitin et al. 2014), microfluidics (Streets et al. 2014; Wu et al. 2014), or 
droplet-based techniques (Klein et al. 2015; Macosko et al. 2015). Lower throughput 
techniques such as cell picking and laser capture microdissection can also be used 
(Islam et al. 2011; Ramsköld et al. 2012; Boone et al. 2013; Picelli et al. 2014). Reverse 
transcription is typically carried out using oligo(dT) primers in order to select for 
mRNA molecules, which make up a small proportion of a cell’s total RNA.  
 
Multiple Displacement Amplification (MDA) is one method that was first adapted for 
use with limiting amounts of human genomic DNA (Dean et al. 2002), before being 
tested on DNA from single cells (Spits et al. 2006a; Lasken 2007) and has since been 
used for amplification of cDNA in RNA-seq experiments (Pan et al. 2013). Multiple 
displacement amplification (MDA) of RNA begins with oligo(dT) primed reverse 
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transcription, followed by ligation of the individual cDNA molecules into long, 
chimeric cDNA strands (Figure 1.8). These long lengths of cDNA facilitate the MDA 
reaction. Amplification is carried out by the bacteriophage F29 DNA polymerase, 
which is used for several reasons. It is a high-fidelity DNA polymerase, with intrinsic 
proof-reading capability, it is highly processive, capable of generating DNA strands 
>70kb in length, and, critically important for MDA, it has DNA strand displacement 
activity (Paez et al. 2004; Pinard et al. 2006). After cDNA molecules have been ligated 
together, random hexamer primers bind throughout the chimeric molecules, and are 
used by F29 DNA polymerase to build the second strand of cDNA. When a F29 DNA 
polymerase reaches the start of the next, newly synthesised DNA strand, its strand 
displacement activity displaces the new strand and F29 DNA polymerase continues 
along the cDNA molecule. The newly displaced cDNA strands are themselves now 
bound by the random hexamer primers and F29 DNA polymerase begins second strand 
synthesis. This results in massively branched chimeric cDNA molecules, which can 
then be prepared for sequencing.  
 
Alternatively, PCR-based amplification can be used, a popular method of which is 
Smart-seq2, a protocol utilising the “SMART™” template-switching chemistry 
developed by Clontech (Zhu et al. 2001). Reverse transcription is initiated with 
specialised oligo(dT) priming and carried out by the Moloney Murine Leukaemia Virus 
(MMLV), which facilitates the addition of 2-5 non-template nucleotides at the 3’ end of 
the newly synthesised cDNA strand (first-strand synthesis). PCR amplification then 
takes place using a limited number of cycles (18 recommended in the protocol), with 
second-strand synthesis occurring by “template-switching” of the MMLV, primed by a 
specialised oligo that binds to the newly added untemplated nucleotides (Figure 1.9). 
Samples can now be prepared directly for next-generation sequencing. Compared to  
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Figure 1.8. Representation of how multiple displacement amplification (MDA) 
amplifies RNA from single cells. After oligo(dT) primed reverse transcription, 
individual cDNA molecules are ligated together into large, chimeric cDNA strands 
which are bound by random hexamer primers. Bacteriophage F29 DNA polymerase 
synthesises the second strand of cDNA using the original chimera as a template. When 
F29 polymerase encounters newly synthesised DNA, it displaces the strand and 
continues to synthesise DNA. Displaced strands can now be bound by random hexamer 
primers and used as templates for F29 polymerase resulting in complex, branched 
cDNA structures formed by mass amplification. Author rendition, inspired by (Spits et 
al. 2006b). 
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Figure 1.9. Representation of the Smart-seq2 protocol for amplifying RNA from single 
cells. Smart-seq2 is a protocol based on the use of a “template-switching” reverse 
transcriptase. RNA is first reverse transcribed using oligo(dT) primers and the Moloney 
Murine Leukaemia Virus (MMLV) reverse transcriptase. The reverse transcriptase adds 
2-5 untemplated nucleotides to the end of the cDNA strand (represented in this figure 
by “C C C”). These untemplated nucleotides are bound by a specialist template-
switching oligo (TSO) which facilitates the “switching” of the MMLV reverse 
transcriptase, which is now able to synthesis the second strand of cDNA after the 
original RNA molecule has been degraded. Author rendition, inspired by (Picelli et al. 
2014). 
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PCR based amplification, MDA is thought to result in less bias, more uniform 
amplification and lower introduction of error due to the high fidelity of F29 DNA 
polymerase (Esteban et al. 1993; Dean et al. 2002; Pan et al. 2013). However, the 
amount of amplification needed to obtain sequenceable amounts of material may 
inevitably lead to some bias.  
 
One method of accounting for technical noise and bias is by using RNA spike-ins, 
molecules of known sequence and added at a known concentration, allowing the 
indirect estimation of and correction for the effect of technical noise. Quantified using 
an RNA dilution series, the amount of starting RNA has been found to be highly 
predictive of the amount of technical noise that can be expected in the dataset, using 
5000pg of starting material resulted in technical noise comparable to that expected from 
bulk RNA-seq analysis (Brennecke et al. 2013). As the amount of starting RNA is 
decreased, the amount of technical noise increases, and genes with a low-read count 
showed highly variable ‘expression’ between replicates, an effect mitigated in genes 
with a high-read count (Brennecke et al. 2013). This was confirmed by spiking single 
Arabidopsis thaliana cells with HeLa total RNA, which found high technical variation 
for HeLa genes with a read count of < 100. Arabidopsis thaliana cells were also spiked 
with ERCC RNA spike-ins to allow correction for technical noise, but these were only 
effective when large cell numbers were used (Brennecke et al. 2013). 
 
An alternative method has been developed which allows for the direct counting of RNA 
molecules. These ‘unique molecular identifiers’ (UMIs) are 5bp barcodes, ligated to 
cDNA molecules during reverse transcription. After sequencing, the number of distinct 
UMIs mapping to each position can be directly counted. Fragments originating from 
PCR artefacts will be represented by the same UMI and can be subsequently removed 
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from the dataset. The use of UMIs is particularly powerful when investigating genes 
with lower read counts, but the nature of UMI ligation during reverse transcription 
means that just the 5’ end of mRNA molecules can be sequenced  (Islam et al. 2014). 
 
In light of the development of numerous single-cell sequencing methods such as Drop-
seq, Smart-seq2, MDA techniques, CEL-seq, MARS-seq, to name a few (Dean et al. 
2002; Jaitin et al. 2014; Picelli et al. 2014; Macosko et al. 2015; Hashimshony et al. 
2016), the commercial sector is rapidly developing its own repertoire of products. 
Qiagen now produces a whole-genome and a whole-transcriptome single-cell 
amplification kit using MDA chemistry. A protocol similar to Smart-seq2, utilising a 
template-switching oligo, is available through Clontech, and is also available integrated 
with the high-throughput microfluidic platform (the C1™) produced by Fluidigm, 
which isolates cells on a microfluidic chip prior to reverse transcription and 
amplification. Another microfluidic platform is available through 10X Genomics which 
allows even higher throughput analysis of thousands of cells in parallel. 
 
1.7 Plasmodium parasites have highly plastic transcriptomes 
The transcriptomic profiles of Plasmodium parasites are not fixed. Like other 
pathogens, continual interaction with a host’s immune system, along with selection 
pressure introduced by anti-malarial drugs and changing transmission dynamics require 
Plasmodium parasites to have flexible and dynamic gene expression. 
Microarray analysis of ~2700 genes and RNA-seq of ~4000 genes carried out 
throughout the P. falciparum intraerythrocytic life cycle have shown global variation in 
gene expression, with transcriptional profiles changing in a cyclical manner, correlating 
to developmental stage (Figure 1.10) (Bozdech et al. 2003a; Otto et al. 2010). Antigenic 
variation in Plasmodium parasites is well-documented and is a critical requirement of  
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Figure 1.10. Heat maps showing the variability of gene expression throughout the P. 
falciparum intraerythrocytic life cycle analysed by microarray and RNA-seq. Each 
horizontal bar represents a gene. A. Expression of 2712 genes detected by microarray 
over the intraerythrocytic life cycle of P. falciparum HB3. Red indicates higher 
expression of that gene, and green indicates lower expression. The cyclical cascade of 
gene expression correlating to different life stages can clearly be seen B. RNA-seq 
analysis of tightly synchronized P. falciparum 3D7 parasites, taken at eight-hour 
increments along the intraerythrocytic life cycle. Each bar represents one of 3975 
genes. Yellow indicates higher expression and blue indicates lower expression. The 
periodic pattern of gene expression is maintained at the greater resolution provided by 
RNA-seq analysis. (Adapted from Bozdech et al. 2003; Otto et al. 2010). 
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the parasite to evade specific immune responses. In P. falciparum, there are 50-100 var 
genes  (encoding the cytoadhesive PfEMP-1 proteins) present in the genome (Su et al. 
1995), with infected erythrocytes expressing only a single, distinct and clonally variant 
PfEMP-1 protein at any one time, but parasites are capable of ‘switching’ their 
expression, a key immune evasion strategy for maintaining infection that is utilised by 
bacteria and other protozoan parasites (Scherf et al. 1998). Expression of var genes is 
controlled at the transcriptional level and there is evidence to suggest this is through 
long non-coding RNA mediated silencing (Amit-Avraham et al. 2015). Other malaria 
parasites also have clonally variant antigenic gene families, including the vir family in 
P. vivax, and the kir and SICAvar families in P. knowlesi. The vir, kir, and rif/stevor 
families together belonging to the “pir” superfamily of genes, also contains orthologues 
in the rodent malarias (Janssen et al. 2002). While less is known about these families 
compared to the var genes, they do show clonally variant expression, and antigenic 
switching has been documented to occur in the SICAvar gene family in P. knowlesi (Al-
Khedery et al. 1999) and throughout the pir superfamily (Cunningham et al. 2010).  
 
Transcriptional variability is not limited to highly polymorphic, antigenic gene families. 
By taking sub-clones of several P. falciparum laboratory lines and carrying to limited 
culture, Rovira-Graells et al. (2009) used a P. falciparum gene expression microarray to 
identify genes showing clonally variant gene expression. It was found that between 
genetically distinct P. falciparum laboratory lines, there was extensive overlap in the 
genes showing transcriptional variability. A large proportion of these belonged to the 
highly polymorphic antigenic gene families, however a considerable amount of 
transcriptional variation was also found in to be members of other gene families. The 
Apicomplexan Apetala-2 (ap2) family of transcription factors (with well-established 
roles in gametocytogenesis), along with three gene families encoding exported proteins 
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were represented by a number of variably expressed genes (Rovira-Graells et al. 2012). 
Experimental testing of the parasite clones’ reaction to heat shock found that 
transcriptionally diverse parasite lines adapted much quicker and more successfully than 
newly sub-cloned parasites (with low transcriptional diversity). The authors theorised 
that an adaptation advantage of the transcriptionally diverse line was due to selection of 
a pre-existing sub-population of parasites which had a more suitable transcriptional 
profile (Rovira-Graells et al. 2012).  
 
Transcriptional variability can also be observed through a process known as invasion 
switching. In P. falciparum, invasion ligands display considerable redundancy, and 
some laboratory lines are capable of switching the ligands used for invasion not only in 
response to an external stimuli but also spontaneously in in vitro culture (Dolan et al. 
1990; Awandare et al. 2018). A key residue used for invasion is sialic acid (SA) which 
is found in glycophorins on the erythrocyte cell surface, and parasite invasion can be 
broadly characterised as being either SA-dependent or SA-independent (Dolan et al. 
1990). Research has shown that P. falciparum parasites are capable of switching 
between invasion phenotypes, either by culturing SA-dependent parasites with 
erythrocytes treated with neuraminidase, a compound which cleaves and removes sialic 
acid residues, or by genetic ablation of the invasion gene erythrocyte-binding antigen-
175 (eba175), the protein for which binds erythrocytes in a SA-dependent manner 
(Duraisingh et al. 2003a). Using microarray analysis of gene expression, the gene 
reticulocyte binding-like protein 4 (Rh4) was identified as being considerably 
upregulated in SA-independent parasites compared to SA-dependent parasites of the 
same genetic background and genetic ablation of this gene resulted in parasites that 
were unable to switch to SA-independent invasion (Stubbs et al. 2005). Laboratory line 
parasites with both functional eba175 and Rh4 show reversible pathway switching and 
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this is thought to occur through silencing of Rh4 (Stubbs et al. 2005) and evidence based 
on gene expression profiling suggests invasion pathway switching of this nature occurs 
naturally in clinical isolates of P. falciparum for as of yet unknown reasons, but 
possibly in association with virulence or as a method of immune evasion (Nery et al. 
2006). 
 
In addition, there is evidence showing that Plasmodium parasites that result in severe 
disease (encompassing complications such as cerebral malaria, respiratory distress, and 
pregnancy-associated malaria) have different transcriptomic profiles to those that cause 
uncomplicated malaria. Genome-wide analysis of cDNA transcripts from P. falciparum 
collected from the placentas of women with pregnancy-associated malaria revealed a 
panel of genes with differential expression when compared to in vitro cultured P. 
falciparum 3D7 parasites, with enrichment of genes located in sub-telomeric regions 
(Ndam et al. 2008). Transcriptional profiling of parasites collected from children with 
cerebral malaria uncovered two distinct and discriminatory transcriptomic profiles of 
parasites significantly associated with high and low parasitemia, with each cluster 
showing differential gene set enrichment (Milner et al. 2012). In addition, comparison 
of profiles between patients with and without retinopathy (damage to the retina resulting 
from cerebral malaria) revealed that parasites from children who developed retinopathy 
had an enrichment of genes involved in the induction of invasion, adhesion, and DNA 
replication (Milner et al. 2012). 
 
1.8 Gametocytogenesis is represented by a rare population of cells in the blood 
The transmission potential of a Plasmodium infection is directly related to the number 
of gametocytes produced in that infection, resulting in a cost-benefit trade-off regarding 
the rate of conversion between increasing transmission or improving within-host 
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survival potential, and it is thought that this is why gametocytogenesis typically occurs 
at a low rate in Plasmodium parasites (Taylor and Read 1997; Carter et al. 2013). 
However, this rate is flexible and varies in response to environmental changes and cues, 
and is known to increase when parasites are under stress (Carter et al. 2013). 
Application of anti-malarial drugs appears to increase the rate of gametocytogenesis, a 
phenomenon that has been demonstrated in vivo in response to several anti-malarial 
drugs in P. falciparum (Buckling et al. 1999b; Peatey et al. 2009) and in the rodent 
malaria P. chabaudi (Buckling et al. 1999a). 
 
The vast majority of anti-malarial drugs are ineffective on gametocytes, leaving the 
window open for further transmission from a treated patient and also leading to relapse 
of disease. Just two anti-malarial drugs (primaquine and tafenoquine, both belonging to 
the 8-aminoquinoline family) have shown effective killing of gametocytes. Both, 
however, can have serious side effects when administered to glucose-6-phosphate 
dehydrogenase deficient patients (Tarlov et al. 1962; Rueangweerayut et al. 2017) and 
also cannot be administered during pregnancy, in breast-feeding mothers, or to babies 
less than 6 months of age, and this has limited their widespread use (Abdul-Ghani et al. 
2015). In addition, further investigations are needed to produce the high quality 
evidence needed for their use as gametocytocidal drugs (Eziefula et al. 2012). 
Understanding the process of gametocytogenesis may help towards developing new 
control tools.  
 
Gametocytogenesis occurs in at least two stages, commitment to sexual development by 
the asexual parasite, and subsequent morphological conversion into a gametocyte. The 
physiological triggers that initiate commitment to gametocytogenesis are not well 
understood, however it is widely thought that it occurs as a stress response due to 
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environmental deterioration, such as when parasitaemia is high or due to drug therapy 
(Bruce et al. 1990). These environmental processes trigger the transcription of ap2-g 
(which is usually marked by H3K9me3 repression), which signals the start of the 
commitment process, and expression of ap2-g is subsequently maintained in a positive 
feedback loop (Kafsack et al. 2014). Transcriptional changes can then be observed 
throughout each stage of gametocyte development (Young et al. 2005). 
 
After commitment, the parasite undergoes five morphological transitions (stage I – V 
gametocytes) to develop into mature male or female gametocytes, a process that takes 9-
12 days in P. falciparum and less than 60 hours in other Plasmodium species (Gautret 
and Motard 1999). Each of these shifts is preceded and accompanied by a drastic and 
widespread change in gene expression, and there is evidence that the gametocyte 
transcriptome is associated with particular epigenetic motifs (Van Biljon et al., 2019). 
Male and female gametocytes are distinguishable by microscopy in stage IV and V 
gametocytes, and it has been reported that two thirds of the gametocyte’s transcriptome 
is differentially transcribed in male and female gametocytes in P. falciparum (Lasonder 
et al. 2016). It is now accepted that post-transcriptional regulation has an essential role 
to play in gene expression changes in Plasmodium parasites, and has a profound impact 
on the rate of transcript degradation at different points in the asexual life cycle (Shock et 
al., 2007). There is good evidence for the transcription of a large number gametocyte-
specific genes early in gametocytogenesis, where they remain untranslated until the 
gamete and ookinete stages where they act as “maternal” mRNAs that initiate 
developmental cascades, and this may be a common regulation method in Plasmodium 
(Kaslow et al., 1988, Liu et al., 2011). However, despite extensive interest and research, 
the genetic and transcriptomic networks controlling gametocytogenesis are still 
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relatively unknown, and as such this represent an important phase of the parasite’s life 
cycle to research and target through drug and vaccine interventions. 
 
Identification of new players in the gametocytogenesis pathway is vital to encouraging 
the development of new therapies specifically targeting the transmission portion of the 
Plasmodium lifestyle. Several interesting genes have been identified in recent years, 
from the more well-known gametocytogenesis activators, such as gametocyte 
development 1 (gdv-1) and ap2-g, to lesser known genes which have more subtle roles 
in the control of gametocyte development. An example of one of these latter genes 
would be ap2-g2, which is involved in the repression of the asexual development gene 
network, and as such assists in gametocytogenesis in a manner unlike the more straight 
forward transcriptional activators (Yuda et al., 2015). Several other genes have been 
implicated in the gametocytogenesis pathway, many of them downstream of gdv-1 or 
ap2-g, but their functions are even more elusive. One gene of interest that falls in this 
category is mspdbl2, a gene encoding a merozoite surface protein. Multiple lines of 
evidence have suggested involvement of mspdbl2 in gametocyte commitment, and the 
protein has a striking “on/off” expression profile in mature schizonts, the basis of which 
remains unknown (Amambua-Ngwa et al., 2012; Tarr et al., 2018; Filarsky et al., 2018). 
The nature of the involvement of mspdbl2 is not yet known, and it may be a marker of 
gametocytogenesis, rather than an active player. Chapter 4 explores this gene in further 
detail and aims to uncover whether or not it could be important in gametocyte 
commitment. 
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1.9 Aims and Objectives 
 
Deep sequencing of genomes and transcriptomes was applied to P. falciparum and P. 
knowlesi parasites in order to gain deeper understanding of population genomics and 
parasite biology. The first aim of this thesis was to profile the population genomics of 
P. knowlesi clinical isolates collected from peninsular Malaysia using whole-genome 
sequencing and investigate divergence and selection based on the analysis of single 
nucleotide polymorphisms. The second aim was to use low input techniques to obtain 
high quality transcriptomic sequence data from clinical malaria isolates for which only a 
limited amount of parasite material is available in order to investigate the expression 
profile of P. falciparum parasites that express the merozoite surface protein MSPDBL2, 
considered as a possible marker of gametocytogenesis. Finally, in an extension of these 
low input techniques, transcriptomics was attempted from single P. falciparum infected 
erythrocytes. 
 
1. Population genomics of P. knowlesi in peninsular Malaysia 
P. knowlesi is a major cause of malaria in Malaysia. Whole genome sequencing has 
revealed dramatic diversity between populations of P. knowlesi parasites throughout 
Malaysia. The proposed population Cluster for peninsular Malaysia (Cluster 3) is not 
understood on a genome-wide level, and profiling these parasites is essential for 
understanding their evolution and adaptation as human infections increase. 
To do this, genomic DNA extracted from P. knowlesi clinical isolates from peninsular 
Malaysia underwent sequencing using Illumina chemistry to obtain genome-wide 
sequence data. High quality genome-wide sequence data were compared to the P. 
knowlesi reference genome to identify single nucleotide polymorphisms, which were 
used to inform population genomics and investigate selection and diversity within these 
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parasites and between P. knowlesi populations in peninsular Malaysia and Malaysian 
Borneo. 
 
2. Transcriptomic profiling of MSPDBL2 in P. falciparum clinical isolates 
Gametocytogenesis is an essential stage of the Plasmodium life cycle, however is poorly 
understood from a genetic and mechanistic perspective. The gene mspbl2 is suspected to 
be involved in, or be a marker for gametocyte commitment, but is not yet characterised. 
In order to further understand where this gene fits into the gametocytogenesis pathway, 
its expression was investigated in P. falciparum clinical isolates. Plasmodium 
falciparum clinical isolates from West Africa were cultured ex vivo, and schizonts were 
harvested after approximately 48 hours prior to re-invasion. Immunofluorescence assays 
were used to profile the expression of MSPDBL2 protein in schizonts. Clinical isolates 
underwent whole transcriptome sequencing using Illumina chemistry and the 
transcriptomic data was analysed to identify genes with expression correlating to 
MSPDBL2 protein expression. 
 
3. Applying single-cell transcriptomics to P. falciparum schizonts 
Plasmodium parasites display striking transcriptional plasticity, and this can be difficult 
to investigate using bulk methods. Some genes (mspdbl2, for example) show strikingly 
different expression between clonal parasites and can be investigated with single cell 
sequencing. In order to apply these methods to Plasmodium parasites, two were tested 
and optimised for use on P. falciparum laboratory lines. 
A commercially available kit was tested and used to sequence transcriptomes from 
flow-sorted single schizont-infected erythrocytes. A microfluidic platform was tested 
with schizont-infected erythrocytes as a potential alternative to the method based on cell 
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sorting. The quality and reliability of the transcriptomes sequenced from the single cells 
was assessed by bioinformatic analysis. 
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2 Materials and Methods 
 
2.1 Plasmodium culturing methods 
2.1.1 Thawing of Plasmodium parasites 
Cryopreserved Plasmodium isolates were removed from liquid nitrogen and allowed to 
thaw at room temperature. Half the sample volume of room temperature 12% NaCl was 
added dropwise while mixing gently by hand and the sample left to incubate at room 
temperature for 5 minutes. Following this, 10x times the sample volume of 1.6% NaCl 
was added slowly in a 50ml falcon tube to facilitate consistent mixing. Samples were 
then pelleted by centrifugation at 500g for 5 minutes. The supernatant was removed, 
and the pellet was washed twice by resuspending in RPMI-1640 (Sigma-Aldrich) media 
supplemented with 0.2% AlbuMAX™ II (Thermo Fisher Scientific, MA, USA), 2mM 
L-glutamine and 20µg/ml of Gentamycin (complete media) and pelleting by 
centrifugation at 500g for 5 minutes, before being resuspended in complete media and 
freshly washed red blood cells at approximately 2.5% haematocrit. 
 
2.1.2 Preparation of red blood cells 
Whole blood of varying blood types was collected from anonymous donors at the 
London School of Hygiene and Tropical Medicine and stored at 4˚C. Working in a 
sterile environment, the buffy coat layer was first removed from the blood, before the 
erythrocytes were washed three times with complete media by centrifugation at 2500g 
for 5 minutes. Washed blood was then diluted to 50% haematocrit with complete media 
and stored at 4˚C. A+ research red cells (NHS Blood and Transplant Service) were 
taken from 4˚C storage and washed once in complete media prior to use, before being 
resuspended at 50% haematocrit in complete media and stored at 4˚C. Washed blood 
was used for no longer than 7 days or until lysis could be seen in Giemsa-stained 
parasite smears. 
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2.1.3 Plasmodium falciparum laboratory line culture conditions 
Parasites from the Plasmodium falciparum 3D7 laboratory line were maintained in 
culture at < 5% haematocrit in complete media. Parasites were grown with either 
washed whole blood or A+ research red cells prepared according to Section 2.1.2. 
Cultures were incubated shaking at 37°C in an atmosphere of 95% N2 and 5% CO2, and 
media was changed no less than every two days. 
 
2.1.4 Plasmodium falciparum clinical isolate culture conditions 
Clinical isolates of P. falciparum were maintained in culture at 2.5% haematocrit in 
complete media. Parasites were cultured with washed whole blood (various blood types) 
incubated with 5% O2, 5% CO2, and 90% N2, at 37˚C while shaking at 60 R.P.M. P. 
falciparum ex vivo cultures were grown to maturity within original host erythrocytes 
and harvested prior to reinvasion. 
 
2.1.5 Synchronisation of Plasmodium falciparum parasites using Percoll® 
Long-term laboratory lines of P. falciparum were synchronised using a Percoll® (GE 
Healthcare, IL, USA) gradient. Firstly, cultures were spun down for 2 minutes at 500g 
and resuspended at approximately 25% haematocrit. In a separate tube, 70% Percoll® 
with 2.9% Sorbitol in 1X PBS was overlaid with 35% Percoll® (1.4% Sorbitol). The 
25% haematocrit culture was then carefully pipetted to lay on top of the 35% Percoll®. 
This was then spun at 2500g for 10 minutes at 24˚C with zero break to prevent 
disturbing the Percoll® gradient. Cellular debris remained suspended on the 35% 
gradient and was discarded. Schizonts suspended on the 70% Percoll® layer were 
transferred into a fresh falcon tube and washed with complete media by centrifugation 
at 500g for 2 minutes. The late-stage enriched pellet was then either put back into 
culture (Section 2.1.3) or parasites were harvested for downstream use. 
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2.1.6 Enrichment of Plasmodium falciparum schizonts from clinical isolates by 
magnetic separation 
As clinical isolates do not reliably allow purification of schizonts using Percoll®, these 
were enriched by magnetic activated cell sorting (MACS®) using a manual separator 
with magnetic LD separation columns (Miltenyi Biotec, Germany). As parasites mature, 
they digest iron obtained from red blood cells, the product of which is deposited within 
the parasite as haemozoin. The haemozoin concentration increases as a parasite matures, 
and young parasites (rings and early trophozoites) do not contain any haemozoin. 
Magnetic-activated separation uses ferromagnetic beads held in a column, magnetised 
by an external magnetic stand. As parasites are passed through the tube, the haemozoin-
containing later parasite stages bind, and the remaining parasites are washed away. 
These late parasites can then be collected by removing the tube from the magnetic field 
and washing the beads (Ribaut et al., 2008). 
For the separation, parasite cultures were first pelleted by centrifugation at 500g for 2 
minutes and resuspended in no less than 1ml of fresh complete media. LD columns 
were placed on the magnetic stand and charged by running through with 12ml of 
complete media. Resuspended parasite cultures were then applied to the column and 
allowed to run through. The column was then washed with 3ml of complete media, or 
until the run-through was clear. The column was then removed from the magnetic stand 
and placed in a fresh 50ml falcon tube. 1ml of media was applied to the column and 
forced through to dislodge bound parasites. Parasites were then pelleted by 
centrifugation at 500g for five minutes. 0.5µl of pelleted cells was used for microscopy 
to assess staging of the parasites using Giemsa staining. Remaining pelleted cells were 
resuspended in <500µl of complete media with 10µM of E64 to prevent schizont egress 
in a round-bottom 96-well plate and incubated for 4.5 hours in an atmosphere of 5% O2, 
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5% CO2,, and 90% N2 at 37˚C. 0.5µl of these parasites was used to make a smear to 
assess staging at the end of the 4.5 hours using Giemsa staining. 
 
2.2 Immunofluorescence Assays 
For immunofluorescence assays, previously produced and published polyclonal mouse 
serum raised against MSPDBL2 was used. This was generated from a construct 
designed against the conserved N-terminal of MSPDBL2. The recombinant protein was 
expressed in E. coli and antibodies were raised by inoculation into laboratory mice, with 
the final serum collection occurring seven days after the final inoculation (Amambua-
Ngwa et al., 2012). 
 
Schizonts from P. falciparum clinical isolates in Chapter 4 were isolated by magnetic 
separation, matured in the presence of E64 and mixed with uninfected erythrocytes to 
give a parasitemia of 2-3% before being washed three times in cold 1% bovine serum 
albumin (BSA) in 1X PBS. On the final wash, the supernatant was removed, and the 
cell pellet resuspended in 1% BSA to give a final haematocrit of 2%. 15µl of this was 
spotted into 12-well slides (Hendley-Essex, U.K.) and left to dry overnight. In the 
morning, slides were carefully wrapped in tissue and stored with silica pouches in 
sealed bags at -40˚C. For long-term storage, slides were moved into purpose-built boxes 
packed with silica gel pouches and, kept at -40˚C. 
 
For antibody staining, slides were removed from -40˚C and thawed in a “desiccation” 
chamber (an air-tight plastic box lined with silica pouches). Slides were then fixed in 
4% paraformaldehyde, 0.0075% glutaraldehyde in 1X PBS for 30 minutes. The fixative 
was exchanged for 0.01% Triton™ X-100 in 1X PBS and left to incubate for 10 
minutes at room temperature. Finally, slides were blocked overnight at room 
temperature in 3% BSA/0.01% sodium azide in 1X PBS. The next day, slides were 
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washed in excess sterile-filtered 1X PBS for five minutes with shaking, and then dried 
on a heat block set at 50˚C. On each slide one well was designated as a “secondary 
antibody-only control” well and 15µl of 3% BSA in PBS was added to this well. The 
remaining wells were incubated with 15µl of a 1:200 dilution of ⍺MSPDBL2 
polyclonal mouse serum (diluted into 3% BSA with 0.01% sodium azide in 1X PBS) 
for 3 hours at room temperature in a sealed box to minimise evaporation. Slides were 
then rinsed three times in excess 1X PBS as done previously and dried on a heat block. 
Next, the slides were incubated in a dark sealed box with a 1:1000 dilution of the 
secondary antibody goat anti-mouse IgG Alexa Fluor™ 555 (diluted into 3% BSA in 
PBS) for one hour (Thermo Fisher Scientific, MA, USA). Slides were then washed 
three times and dried as described previously. Vectashield® mounting fluid with DAPI 
(Sigma Aldrich, MO, USA) was added to each well and the slide sealed with a coverslip 
and nail varnish. Slides were stored in the dark at 4˚C prior to fluorescence microscopy. 
Microscopy was carried out on a manual Leica microscope with Retiga colour camera. 
 
 
2.3 Extraction of RNA from parasites using TRIzol® reagent 
RNA from non-limiting parasites samples was extracted using the phenol-chloroform 
protocol. Parasite cultures were spun down, and the supernatant removed. The packed 
cells were then resuspended in 5X the pellet volume off TRIzol® and immediately 
stored at -80˚C. For phenol-chloroform extraction, first 200µl of chloroform was added 
per 1ml of TRIzol® preserved sample, which were mixed prior to incubating at room 
temperature for 10 minutes. Samples were then centrifuged at 13,000rpm for 15 
minutes. After centrifugation the upper phase containing the RNA was transferred to a 
new tube. To clean up the extracted RNA, the RNeasy® Micro kit (Qiagen, Germany) 
was used following the manufacturer’s instructions, with the inclusion of the additional 
DNase step and using an elution volume of 30µl. Eluted RNA was stored at -80˚C. 
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2.4 RNA extraction from limited starting material 
In Chapter 4 ex vivo clinical isolates of P. falciparum were harvested for mature 
schizonts from limited amounts (~100-1000µl) of infected blood. Parasite material 
destined for RNA extraction was stored in either TRIzol® reagent or RNAlater™ 
(Thermo Fisher Scientific, MA, USA). Material preserved in RNAlater™ was initially 
stored overnight at 4˚C to allow full penetration of the cells before being moved to -
20˚C for long-term storage. Samples in TRIzol® were kept at -80 ˚C. RNA was 
extracted from samples stored in TRIzol® as described in Section 2.3. 
RNA was extracted from the material stored in RNAlater™ by phenol-chloroform 
extraction using TRIzol® LS reagent at 10X the volume of RNAlater™ and RNA was 
cleaned up using the NucleoSpin® RNA XS extraction kit (Macherey-Nagel, 
Germany), following manufacturer’s instructions. RNA quality was assessed on the 
Bioanalyzer using the RNA 6000 Pico kit (Agilent Technologies, CA, USA).  
 
2.5 Reverse transcription and amplification of low input RNA from clinical isolates 
Samples showing successful RNA extraction were reverse transcribed and amplified 
using the SmartSeq® v4 Ultra® Low Input RNA Kit for Sequencing (Takara Bio. Inc., 
Shiga Prefecture, Japan). SmartSeq® v4 reactions were carried out following 
manufacturer’s instructions but using ½ volumes of reagents as this has been shown to 
give equivalent quality results (Dr. Sarah Tarr, personal communications, 2018). 12 
PCR cycles were used during the amplification step. Amplified cDNA was run on the 
Bioanalyzer using the High-Sensitivity DNA analysis chemistry (Agilent Technologies, 
CA, USA) to check for successful amplification and fluorometrically quantified using a 
Qubit® 2.0 with dsDNA high-sensitivity reagents (Thermo Fisher Scientific, MA, 
USA). 
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2.6 Whole transcriptome amplification from single cells using REPLI-g®  
In Chapter 5, the REPLI-g® whole transcriptome amplification kit (Qiagen, Germany) 
was used to obtain single cell transcriptomes. All single-cell work was completed in a 
PCR-free environment and within a Laminar Flow Hood cleaned with RNaseZap® and 
70% ethanol and sterilised under a UV light for 15 minutes prior to use. The 
Manufacturer’s protocol was followed initially before several permutations were tested 
in order to improve output. In the final protocol parasites were isolated (either by 
limiting dilution or FACS) directly into the REPLI-g® lysis buffer, supplemented with 
recombinant RNasin® (rRNasin®) at a final concentration of 1U/µl (Promega, WI, 
USA), and diluted to the appropriate volume using sterile, molecular grade, and 
RNase/DNase free 1X PBS. After cell lysis, further rRNasin® was added to the reaction 
at 1U/µl, before the genomic DNA was disrupted using the ‘gDNA Wipeout buffer’. 
RNA then underwent reverse transcription using an oligo(dT) primer. The cDNA 
fragments are then ligated together into long strands up to 12kb in length. The REPLI-
g® ‘SensiPhi DNA Polymerase’ amplifies the cDNA strands by MDA in an isothermal 
reaction. Alongside each experiment, 50pg of previously purified, DNase-treated P. 
falciparum 3D7 RNA was included as a control.  
 
2.7 Fixation of parasites and whole transcriptome amplification using the Fluidigm 
C1™ platform 
The Fluidigm C1™ system was used to isolate single parasites fixed with dithobis 
(succinimidyl propionate) (DSP) and carry out whole transcriptome amplification in 
Chapter 5. The cell fixation protocol using DSP was modified from Attar et al. (2018), 
as follows. After incubating parasites with E64, the cultures were spun down and the 
schizont pellet washed and then aliquoted out at the appropriate concentration according 
to manufacturer’s instructions in 1X PBS. 200µl of DSP was added to the cells which 
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were then incubated at room temperature for 30 minutes. DSP was subsequently 
quenched using 1M Tris-HCl (pH 7.5), for a final concentration of 2mM. Fixed cells 
were stored at 4˚C. Prior to running on a C1™, cells were supplemented with 2% BSA 
to reduce cell stickiness and approximately 1700 cells were loaded onto the mRNA 
Integrated Fluidic Circuit (IFC) microfluidic chip (Fluidigm, CA, USA). The standard 
C1™ SmartSeq® v4 protocol was followed with the inclusion of 50mM DTT in the 
C1™ lysis mixture in order to reverse the DSP crosslinking. Capture sites into which 
cells are isolated by microfluidics were photographed and number of cells per site was 
recorded along with presence of any debris in each site’s microfluidics. 
 
2.8 Library preparation for Illumina sequencing 
2.8.1 TruSeq Nano LT library preparation for DNA 
Genomic DNA (gDNA) sequencing libraries were prepared using the TruSeq Nano LT 
DNA kit (Illumina, CA, USA), following the manufacturer’s instructions. Genomic 
DNA was first fragmented into 350bp or 550bp fragments using the M220 Focused-
ultrasonicator™ (Covaris, MA, USA) using 300ng of input gDNA. The fragmentation 
process results in DNA fragments with overhanging ends. The next step in library 
preparation converts these into blunt ends. Following this, the DNA fragments of 
desired size (550bp for reads 350bp in length) are selected for, to remove large and 
small fragments. Next, the blunt 3’ ends of the DNA fragments are adenylated with a 
single “A”, firstly to prevent DNA-DNA ligation during the adaptor ligation process, 
and also to facilitate the ligation of the adaptors, which contains a single overhanging 
“T” at their 3’ ends. DNA fragments were then enriched by PCR, using primers that 
anneal to the ends of the adaptor sequences. 
Quantification of completed libraries was carried out by quantitative PCR (qPCR) using 
the KAPA Library Quantification kit for Illumina® (Kapa Biosystems, MA, USA) on a 
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7500 Fast Real-Time PCR System (Thermo Fisher Scientific, MA, USA). Library 
quality and size distribution of fragments was assessed with the Agilent High 
Sensitivity DNA kit on the Agilent Bioanalyzer (Agilent Technologies, CA, USA) 
allowing accurate calculation of gDNA concentration and appropriate dilution factors. 
Samples showing significant primer dimer on the Bioanalyzer or containing less than 
4nM of DNA by qPCR were not carried forward for sequencing. Samples passing 
quality criteria were normalised to 4nM and pooled equimolar in batches of no more 
than twelve. Library pools were denatured using freshly prepared 0.2N NaOH and 
diluted to a final concentration of 15pM and spiked with 1% PhiX. Paired-end 
sequencing was carried out on the Illumina MiSeq using the 600-cycle v3 MiSeq 
reagents using the ‘generate FASTQ’ programme and a read length of 300bp. 
 
2.8.2 Nextera XT library preparation 
For cDNA originating from low input, limiting samples the Nextera XT DNA Library 
Preparation Kit was used following manufacturer’s instructions (Illumina, CA, USA), 
however reactions were carried out in ¼ volumes of those recommended in the 
reference guide. In brief, samples containing sufficient cDNA were first fragmented and 
tagged with DNA adaptor sequences using the ‘tagmentation’ chemistry. Tagged cDNA 
fragments were then amplified by PCR over 12 cycles, which also ligates the Index 1 
and Index 2 adaptor sequences which are required for cluster generation and 
sequencing. Amplified libraries were cleaned by bead purification using Agencourt 
AMPure XP beads (Beckman Coulter, CA, USA). Libraries were run on a Bioanalyzer 
using the High-Sensitivity DNA analysis reagents to assess quality. Libraries were 
normalised by fluorometric quantification on a Qubit® 2.0 device using dsDNA high-
sensitivity reagents and diluted to 4nM in RSB. Normalised libraries were pooled 
equimolar and stored at -20˚C prior to sequencing. Library pools were denatured in 
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0.1M NaOH and diluted to 15pM, and spiked with 1% PhiX. Paired-end sequencing 
was carried out using the 150-cycle MiSeq v3 reagents on an Illumina MiSeq using the 
‘generate FASTQ’ programme. 
 
2.9 Assembly of Illumina short reads 
2.9.1 Genome Assembly 
Prior to assembling the short reads to the reference genomes, the quality of each sample 
was assessed using FastQC (http://www.bioinformatics.babraham.ac.uk/projects 
/fastqc/). In FastQC the GC% of each library was investigated, along with visual 
assessment of the average base quality along the reads. Short reads were then trimmed 
of low quality bases with Trimmomatic v0.3.2 using default parameters, which will 
drop reads if they are less than 36 bases in length, remove leading and trailing bases 
with low quality (less than 3), and move along the read in a 4-base sliding window, 
cutting the read when the average quality of the window drops below 15 (Bolger Lohse 
2014). Trimmed reads were aligned to the P. knowlesi H-strain version 2.0 reference 
genome using Burrows-Wheeler Aligner version 0.7.15 using the bwa-mem algorithm 
and default parameters (Li and Durbin 2010), using paired reads outputted by 
Trimmomatic. Aligned reads were output in “sam” format and these were converted to 
“bam” format, sorted and indexed using samtools version 1.3.1 (Li et al. 2009). Reads 
originating from PCR duplication were removed using Picard version 2.9.1 
“MarkDuplicates” function (https://broadinstitute.github.io/picard/). Average read depth 
for each isolate was estimated using samtools “depth” function, this calculation does not 
include sites that have zero coverage and calculated read depth for each region before 
averaging across the genome. 
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2.9.2 Transcriptome Assembly 
Whole transcriptome short read sequence data were assembled by alignment to the P. 
falciparum 3D7 v3 reference genome using HISAT2 (Kim et al. 2015) with default 
parameters to generate ‘sam’ alignment files, which were converted into ‘bam’ format 
using samtools as was carried out in Section 2.9.1. Reads with MAPQ scores of <60 
were removed using a custom, in-house python script. 
 
2.10 Analysis of differential gene expression  
Raw gene counts for each sample were made using the summarizeOverlaps function of 
the GenomicAlignments package (Lawrence, Huber et al., 2013) in the R statistical 
framework (R Development Core Team 2013). A custom made GFF reference file 
which had been prepared previously in which P. falciparum sub-telomeric, polymorphic 
gene families (var, rifin, stevor) and regions of the genome which showed allelic 
diversity between the P. falciparum 3D7 version 3 reference genome and ten schizont 
stage (40 h.p.i.) clinical isolate transcriptomes was used for generating read counts per 
gene (Tarr et al., 2018). Staging of samples was carried out by comparison of gene 
transcript levels in the clinical isolates with RNA-seq data obtained from a 
developmental time course of P. falciparum 3D7 (Otto et al. 2010). In this time course, 
RNA was sequenced from parasites harvested from seven timepoints (0 – 48 hours post 
invasion in 8 hour increments) (Otto et al. 2010). Normalised transcript levels for the 
clinical isolates and time course samples were calculated using Fragments Per Kilobase 
of transcript per Million mapped reads (FPKM) for all the genes using the DESeq2 
“fpkm” function (Love et al. 2014). FPKM values for genes in each of the clinical 
isolates were correlated against the time course data using Spearman’s Rank correlation. 
Differential expression analysis was carried out in R using the package DESeq2 (Love 
et al. 2014).  
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DESeq2 estimates differential expression using negative binomial generalised linear 
models takes a table of raw read counts per gene with an associated table holding 
phenotype data for each sample. Firstly, the data is normalised internally to correct for 
RNA composition bias and library size. It also estimates dispersion, calculated within a 
group, which describes how much the observed value is expected to be away from the 
mean value (Love et al. 2014). For visualisation of volcano plots, the R package 
EnhancedVolcano was used (Blighe 2019).  
Genes with known or suspected involvement in gametocytogenesis were identified 
firstly by carrying out gene searches on PlasmoDB (https://plasmodb.org), each gene 
was investigated to identify those with known gametocytogenesis involvement for 
which literature was available. To identify genes with a suspected role in 
gametocytogenesis, which is not always immediately obvious from PlasmoDB, a master 
gene list of 121 genes (Appendix 1) was created using data gathered from publications 
relevant to the current research that covers a spectrum of gametocyte-related gene 
expression (Silvestrini et al. 2010; Filarsky et al. 2018; Josling et al. 2019). All genes 
identified in differential expression analysis were cross-referenced with this list to find 
overlap. 
 
2.11 Identification of single nucleotide polymorphisms 
Single nucleotide polymorphisms were identified for the P. knowlesi populations in 
Chapter 3. The first round of SNP calling was carried out on each sample 
independently. SNPs were initially marked using samtools mpileup run with the 
following flags: -B -I -Q 23 -d 2000 -C 50 and marked SNPs were then called using 
bcftools call -m -v and filtered using vcfutils.pl varFilter -d 10 -D 2000. The resulting 
per-sample SNP lists were then filtered and positions with a read depth of less than 30x 
were discarded. A read depth of 30x was used based on recommendation from Illumina, 
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and in line with previous research (Assefa et al., 2015; Divis et al., 2018). The SNPs for 
each sample were then compiled into a single file and filtered to exclude redundant 
SNPs, resulting in a ‘unique SNP list’ representing the P. knowlesi population, 
containing SNP positions and alternate bases.  
 
It is difficult to assemble short reads to some parts of the genome such as low 
complexity, repetitive regions, and these were therefore masked from analysis. This 
includes the sub-telomeres and the multi-copy kir and SICAvar gene families, and low 
complexity intergenic regions between these. Boundaries of sub-telomeric regions were 
defined as in previous analysis (Divis et al. 2018), while kir and SICAvar genes were 
identified using the gene search function of PlasmoDB (www.plasmodb.org) and 
verified by inspecting the P. knowlesi annotation EMBL files in Artemis (Rutherford et 
al. 2000). In genomic regions where several polymorphic genes belonging to kir and 
SICAvar families occurred sequentially, the masked region was extended to include all 
genes and intergenic sequence, and extended on each side until the first SNP called after 
the final masked gene in that region.  SNPs falling into these regions were filtered out of 
the unique SNP list using bedtools intersect v2.27.0 (Quinlan and Hall 2010). A second 
round of SNP calling and filtering was then implemented using custom made Perl 
scripts (Assefa et al. 2015) in order to make the major genotype call at each SNP 
position for each sample. SNP positions that had a 50:50 split in mixed base calls for a 
particular sample were deemed uncalled and replaced with ‘N’. SNPs that were missing 
in more than 10% of the infection samples were not analysed. 
 
2.12 Using single nucleotide polymorphisms to inform population genomic analysis 
The packages adegenet (Jombart 2008) and pegas (Paradis 2010) in the R statistical 
framework were used to carry out principal component analysis and generate a 
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Neighbour-Joining tree of the samples using a genetic distance matrix based on SNP 
data (R Development Core Team 2013). For population structure analysis, SNP data 
was loaded into R and the package PopGenome (Pfeifer et al. 2014) was used to 
calculate nucleotide diversity, the within-population Tajima’s D index, and the 
between-population fixation index (FST). Nucleotide diversity was calculated genome-
wide in non-overlapping sliding windows of 50kb. To scan for genes that may be under 
balancing selection, Tajima’s D was calculated on a gene-by-gene basis, with genes 
only being considered if they contained three or more SNPs. The fixation index (FST) 
was calculated for all individual SNPs across the genome with a minor allele frequency 
of at least 10%, and mean values were calculated in all sliding windows of 500 
consecutive SNPs, overlapping by 250 SNPs, across the genome. 
 
A scan for loci under recent positive selection was performed by identifying SNPs with 
an allele associated with extended haplotype homozygosity, using the R package rehh 
(Gautier et al. 2012). The standardised integrated haplotype score (|iHS|) is a statistic 
that is used to look for evidence that recent positive selection has acted at a particular 
locus. The score is based on the level of Extended Haplotype Homozygosity (EHH) 
surrounding a given (“core”) SNP on the ancestral allele relative to the derived allele, 
where the EHH measures the decay of a haplotype around the core SNP. At each SNP, 
the iHS gives a measure for the strength of evidence for positive selection having acted 
on that SNP (Voight et al., 2006).  
The |iHS| was calculated for biallelic SNPs with no missing calls and with a minor 
allele frequency of at least 10%. SNPs with |iHS| values in the top 0.01% were set as 
“core” SNPs, around which putative windows of selection were identified using the 
extended haplotype homozygosity (EHH) score, plotted until the EHH signal declined 
to less than 0.05 on each side.  Overlapping windows of EHH resulting from more than 
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one core SNP were merged to produce one overall putative selection window for that 
region, and any gaps of over 20kb between SNPs with elevated |iHS| values were 
considered to break a putative window of selection. The Rsb statistic was also 
calculated in rehh and this is also derived from the EHH and comes from contrasting the 
haplotype lengths associated with the same SNP in different populations to identify 
regions under different selection in different populations (Tang et al., 2007).  
 
Within-isolate mixedness was assessed for each P. knowlesi cluster independently using 
the FWS metric, carried out as previously described (Manske et al. 2012) using custom R 
scripts kindly provided by Prof. Antoine Claessens (Montpellier University). For each 
SNP, the within-isolate (HW) and within-population (HS) heterozygosity were calculated 
and plotted in R to show the relationship between HW and HS for each isolate. The FWS 
score is calculated from the gradient of this line and indicates the genome-wide estimate 
of heterozygosity. Isolates with scores ≥0.95 were considered to contain a predominant 
single genotype.  
 
2.13 msp-4 PCR for discriminating genomic DNA and cDNA 
To quickly and reliably differentiate between cDNA and genomic DNA (gDNA) in 
Chapter 5, an intron-spanning PCR was developed within the gene msp-4. PCR was 
carried out with either HiFi (Clontech) or Phusion (Thermo Fisher Scientific, MA, 
USA) reagents and polymerases. Primers were designed within exons 1 and 2 of msp-4 
using the NCBI Primer-BLAST tool to encompass the msp-4 intron (Figure 2.1). 
Forward primer sequence 5’-3’ (within exon 1): CCCCCAATTTATCTGACGCA. 
Reverse primer sequence 5’-3’ (within exon 2): TCATCTCCACAACCCCCATT. 
Cycling conditions were based on manufacturer guidelines with an extension time of  
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Figure 2.1 Primer strategy for the intron-spanning msp-4 PCR. In order to assess 
whether single cell transcriptomic techniques had amplified cDNA originating from 
RNA or genomic DNA, the msp-4 intron-spanning PCR was designed. Amplification of 
msp-4 gDNA results in a 589bp product due to inclusion of the 145bp intron. 
Amplification of msp-4 cDNA results in a 440bp product due to intron splicing. 
 
 
 
 
 
 
 
one minute and an annealing temperature of 60˚C. The expected amplicon sizes are 
589bp for gDNA and 440bp for cDNA. 
 
2.15 Analysis of transcriptomes obtained from single P. falciparum schizonts 
Analysis of single-cell and low cell number transcriptomes was carried out in R 
statistical software using the package Scater (McCarthy et al. 2016) within the 
Bioconductor framework. Gene counts for the transcriptomes obtained from single-cells 
were generated using HTSeq-count (Anders et al. 2015) with the “intersection strict” 
option using the P. falciparum GFF reference file described in Section 2.10. For the low 
input P. falciparum clinical isolates, the summarizeOverlaps function of the R 
GenomicAlignments package was used, so as to integrate with the DESeq2 
recommended procedures (Lawrence, Huber et al., 2013). Contamination of non-
Plasmodium microbial origin was identified using the taxonomic assignment software, 
Kraken, using the MiniKraken database (Wood and Salzberg 2014). 
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3. Genome-wide analysis of population structure and adaptation of Plasmodium 
knowlesi in peninsular Malaysia 
 
3.1 Introduction 
All human malaria parasite species originated as zoonotic cross-infections from non-
human primates (Liu et al. 2010; Rutledge et al. 2017; Sundararaman et al. 2018), and 
the most prevalent species, P. falciparum and P. vivax now exclusively infect humans. 
Plasmodium knowlesi is one of the recognised human malarias that has remained 
primarily a zoonosis. Human infection from zoonotic malaria had been considered to be 
extremely rare, but findings in Malaysia (Singh et al. 2004; Cox-Singh et al. 2008), and 
subsequent surveys elsewhere in Southeast Asia have revealed that many human 
malaria cases are due to Plasmodium knowlesi, a malaria species associated with 
macaque hosts (Shearer et al. 2016). In Malaysia, overlapping distributions of the 
natural macaque hosts, mosquito vector species, and human populations have resulted in 
P. knowlesi being the cause of almost all human malaria cases (Singh and Daneshvar 
2013). Transmission is thought to still be maintained exclusively in macaques, with 
human infection remaining opportunistic in nature. As several countries in Southeast 
Asia are working towards eliminating malaria, P. knowlesi represents a unique public 
health challenge. Due to the presence of wild reservoir hosts, elimination is unlikely, 
and the problem would worsen if the parasite adapts, or environments change to enable 
effective transmission between humans (William et al. 2013). 
 
Investigations into parasite population genomics and dynamics are essential to 
understand whether there has been recent adaptation. In P. knowlesi, this understanding 
has been achieved by microsatellite genotyping (Divis et al. 2015; Divis et al. 2017) and 
whole-genome sequencing (Assefa et al. 2015; Divis et al. 2018). However, gaining a 
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full picture of the P. knowlesi population is complicated by its reservoir hosts. Whole-
genome sequencing from human samples is usually straight-forward, as a human patient 
typically carries just a single Plasmodium infection. However, macaques are commonly 
host to several Plasmodium species, and often these are multi-genotype infections, 
which makes whole-genome sequencing using standard, short-read methods very 
challenging.  
 
In Malaysian Borneo, P. knowlesi forms two genetically divergent sympatric 
populations, (termed Clusters 1 and 2), that are respectively associated with different 
reservoir hosts; long-tailed macaques (Macaca fascicularis) and pig-tailed macaques 
(M. nemestrina) (Divis et al. 2015). In peninsular Malaysia, on the Asian mainland, it is 
clear that there is a different genetic subpopulation of P. knowlesi (termed Cluster 3). 
This was initially identified by genome sequencing of a few old laboratory isolates 
(Assefa et al. 2015), however subsequent microsatellite analysis of many clinical cases 
from peninsular Malaysia has confirmed these to all be Cluster 3 type (Divis et al. 
2017). Whole-genome sequencing of clinical isolates from Clusters 2 found that these 
parasites have a heterogenous pattern of nucleotide diversity throughout their genomes, 
unlike the fairly uniform pattern seen in Cluster 1 genomes, and analysis of inter-cluster 
divergence between Cluster 1 and 2 revealed large genomic regions of high and low 
divergence, indicative of recent introgression between the populations, with the genetic 
isolation between the clusters being maintained within the regions of high divergence 
(Divis et al. 2018). Independent, secondary analysis of whole-genome sequence data 
from Cluster 1 and 2 isolates has also indicated that these parasites have recently 
undergone introgression events (Diez Benavente et al. 2017). 
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With regards to future adaptation and epidemiology of P. knowlesi, any one of the three 
independently occurring Clusters of P. knowlesi might emerge further, particularly as 
human and macaque populations continue to encroach and overlap and it is an 
increasing cause for concern in Southeast Asia, particularly in Malaysia. In this Chapter, 
I aimed to increase our understanding of the population structure of P. knowlesi in 
peninsular Malaysia, following on from research that has shown that a population of 
parasites exists here that is geographically isolated and divergent from the populations 
profiled in Malaysian Borneo. The Tajima’s D statistic will be used to uncover any 
signatures of balancing selection that may indicate whether there are any loci under 
increasing selection pressures from both the human and macaque host. Finally, 
signatures of positive selection will be identified and analysed to understand if there is 
evidence of any selective sweeps acting on the population from peninsular Malaysia and 
to see if these relate to possible adaptation to the human host. The degree of divergence 
between the three population clusters is impressive, and by analysing the Cluster 3 
population structure, I hope to uncover possible genomic locations driving some of this 
divergence.  
 
3.2 Materials and Methods 
3.2.1 Sample collection and DNA extraction 
The study was approved by the Medical Research and Ethics Committee of the 
Malaysian Ministry of Health, and by the Ethics Committee of the London School of 
Hygiene and Tropical Medicine. Heparinised venous blood samples of up to 10 ml were 
collected from 56 patients presenting with P. knowlesi malaria at five hospitals in 
Peninsular Malaysia between February 2016 and January 2018, after written informed 
consent from each patient was obtained Leukocytes were depleted by passing each 
blood sample through a CF11 cellulose column, to thereby increase the proportion of 
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parasite compared to host DNA. Genomic DNA (gDNA) was extracted using QIAamp 
DNA Mini kits (Qiagen, Germany), and all infections were confirmed to contain only P. 
knowlesi by nested PCR assays testing for all locally known malaria parasite species 
(Lee et al. 2011). Sample collection and gDNA extraction was carried out by colleagues 
at the University of Malaysia, Sarawak. Genomic DNA was lyophilised prior to 
transport to the UK, following which it was dissolved in 30µl of nuclease-free water 
and quantified on a spectrophotometer using the Quant-IT™ PicoGreen® ds kit 
(Thermo Fisher Scientific, MA, U.S.A). Samples containing at least 300ng of DNA 
were processed for sequencing. 
 
3.2.2 Whole-genome sequencing of P. knowlesi isolates 
Genomic DNA (gDNA) sequencing libraries were prepared using the TruSeq Nano LT 
DNA kit (Illumina), following the manufacturer’s instructions (Section 2.8.1). 
Concentration and quality of the prepared libraries was assessed by qPCR and on the 
Bioanalyzer (Agilent Technologies, CA, USA) (Section 2.8.1), and those showing 
significant primer dimer or containing less than 4nM of DNA by qPCR were not carried 
forward for sequencing. Library pools were denatured diluted to a final concentration of 
15pM and spiked with 1% PhiX. Paired-end sequencing using a read length of 350bp 
was carried out on the Illumina MiSeq (Section 2.8.1). 
 
Quality of short reads was assessed, and reads were appropriately trimmed before 
assembly to the P. knowlesi H-strain version 2.0 reference genome (Section 2.9.1). 
Samples with an average read depth of less than 20x were excluded from further 
analysis. Samples with a low mapping rate and low coverage were presumed to be 
contaminated; with low mapping rates correlating to a GC content differing from 38%. 
After assembly and quality filtering data from 28 samples were available for 
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downstream analysis, representing samples from five hospitals in peninsular Malaysia 
(Figure 3.1). For comparison with samples from elsewhere, Illumina short reads were 
retrieved from previous studies (Assefa et al. 2015; Pinheiro et al. 2015; Divis et al. 
2018) and assembled using the pipeline described in Section 2.9.1. 
 
3.2.3 Analysis of whole-genome sequence data 
Single nucleotide polymorphisms were called using a full repertoire of P. knowlesi 
genomes, including 28 new sequenced infection samples from peninsular Malaysia 
obtained in this study as well as 74 previous samples from Malaysian Borneo (40 from 
Cluster 1, 34 from Cluster 2), and 5 laboratory isolates (107 in total) (Assefa et al. 2015; 
Pinheiro et al. 2015; Divis et al. 2018). SNPs were called in two rounds, the first to 
obtain per-sample SNP lists, which were then filtered to remove those that fell into 
polymorphic regions before the second round of SNP calling was implemented to make 
the major genotype call at each SNP position (Section 2.11) 
 
Analysis of SNP data was carried out in the R statistical framework using the packages 
adegenet (Jombart 2008) and pegas (Paradis 2010), used to elucidate population 
structure (Section 2.12). The R package PopGenome (Pfeifer et al. 2014) was used to 
calculate nucleotide diversity, the within-population Tajima’s D index, and the 
between-population fixation indices (FST) using parameters and methods outlined in 
Section 2.12. A scan for loci under recent positive selection was performed by 
identifying SNPs with an allele associated with extended haplotype homozygosity using 
the integrated haplotype score (|iHS|) and Rsb metrics, calculated in the R package rehh 
(Gautier et al. 2012) (Section 2.12). Within-isolate mixedness was estimated with the 
FWS score, calculated as described in Section 2.12. 
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3.3 Results 
3.3.1 Population structure of P. knowlesi Cluster 3 in peninsular Malaysia 
After processing and quality filtering, genome sequences were successfully obtained 
from 28 clinical samples of P. knowlesi from cases recruited at five locations in 
peninsular Malaysia (Figure 3.1, Table 3.1), none of the samples from Kuala Krai 
hospital met the criteria for sequencing. From the new infection samples, 994,761 SNPs 
were called initially, of which 40,934 were removed as they were in polymorphic 
regions which show generally unreliable short read mapping (kir and SICAvar genes, 
and sub-telomeres), leaving 953,827 SNPs present in the rest of the genome. SNPs in 
isolates that had mixed base calls were replaced with “N”, and SNPs that had missing 
data in >10% of individual infection samples were removed (affecting less than 1% of 
SNPs), leaving a total of 474,109 SNPs were included in subsequent analysis. 
 
A Neighbour-Joining (NJ) tree was generated using pairwise genetic distances among 
individual samples, which showed that all the newly sequenced samples belonged to a 
population (Cluster 3) genetically divergent from those in Malaysian Borneo (Clusters 1 
and 2) (Figure 3.2A). These clinical samples clustered with the old, previously 
sequenced laboratory isolates, which had initially shown the existence of a third major 
genetic population within this species (Assefa et al. 2015). The overall genome-wide 
nucleotide diversity (π) for Cluster 3 as a whole was 4.13 x 10-3. This is slightly higher 
than the nucleotide diversity for Cluster 1 (π = 3.89 x 10-3) and much higher than for 
Cluster 2 (π = 2.13 x 10-3) (Figure 3.2B).  
 
Analysis of SNP allele frequencies genome-wide confirmed that the Cluster 3 
population in peninsular Malaysia is highly divergent from each of the separate Clusters 
1 and 2 in Malaysian Borneo, showing respective genome-wide mean FST values of 0.32  
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Figure 3.1. Locations of P. knowlesi clinical sampling in peninsular Malaysia. Sampling 
took place in the states of Perak (Taiping and Sungai Sipit), Kelantan (Gua Musang and 
Kuala Krai), and Pahang (Kuala Lipis and Temerloh). Out of 56 infection samples, 32 
yielded P. knowlesi DNA of sufficient quantity and purity for Illumina Sequencing. Of 
these, 28 yielded high coverage genome-wide sequences for population genomic 
analysis (Table 3.1). No samples from Kuala Krai were of sufficient quality to be 
included in genomic analysis, and this location is therefore not represented by the final 
dataset. 
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Table 3.1. Details of the 28 Clinical isolates of Plasmodium knowlesi that were sequenced successfully and included in downstream analysis. 
Sample Actual 
Parasitemia (p/ul) 
Year gDNA concentration 
(ng/ul) 
Library 
concentration (nM) 
total reads 
(x106) 
GC% Mapped reads 
(x106) 
Alignment 
rate (%) 
Average 
coverage 
GMK02 88164 2017 214 48.3 5.8 38% 5.7 98.9 47x 
GMK03 16480 2017 26.8 68.1 5.6 40% 4.9 87.6 40x 
GMK06 98800 2018 68.8 3.50 8.7 38% 8.6 98.5 74x 
GMK07 12900 2018 12.5 5.99 7.9 38% 7.7 97.2 66x 
KLK02 1932 2017 28.5 209 3.2 39% 3.1 97.1 40x 
KLK04 50938 2017 147 298 4.0 38% 3.9 98.6 32x 
KLK05 27251 2017 122 81.9 5.0 38% 4.5 98.2 36x 
KLK06 661875 2017 283 45.2 5.8 38% 5.4 98.8 43x 
KLK08 84400 2017 80.8 314 3.6 38% 3.6 98.7 91x 
KLK12 7236 2017 22.8 89.5 3.6 38% 3.3 96.3 27x 
KLK14 33060 2017 62.9 84.7 5.8 38% 5.7 98.1 46x 
KLK15 136408 2017 304 80.4 5.4 38% 4.7 95.3 37x 
KLK16 13756 2017 33.8 57.3 5.4 39% 5.1 85.4 37x 
KLK17 22554 2017 13.3 15.6 5.8 38% 5.4 95.5 44x 
KLK19 46035 2018 10.0 11.9 4.4 38% 4.2 94.3 37x 
KLK21 60950 2018 59.6 9.87 4.5 38% 4.5 98.4 39x 
KLK23 23288 2018 19.7 6.13 8.3 38% 8.3 98.9 71x 
KLK24 141069 2018 93.9 7.15 5.7 38% 5.6 98.4 47x 
KLK25 54352 2018 26.6 12.5 3.7 38% 3.7 98.1 32x 
KLK27 69160 2018 22.7 4.71 7.8 38% 7.6 97.5 64x 
SSK01 6027 2017 13.1 7.30 8.8 47% 5.1 61.2 40x 
SSK02 2763 2017 13.5 15.9 7.6 38% 7.4 94.6 62x 
SSK04 6750 2017 16.6 74.6 3.6 40% 2.9 83.4 22x 
SSK05 6750 2017 90.2 316 3.8 38% 3.5 98.4 30x 
TK01 3806 2017 12.1 7.60 4.4 47% 2.6 64.3 21x 
TK03 10323 2017 51.0 80.0 6.0 39% 5.8 95.7 49x 
TPK03 4000 2018 6.88 6.06 9.8 46% 6.3 64.3 55x 
TPK06 12494 2018 12.8 7.36 8.8 38% 8.5 96.0 74x 
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Figure 3.2. Population structure of Cluster 3 in the context of Clusters 1 and 2. A. 
Neighbour-Joining tree based on a pairwise genetic distance matrix between individual 
P. knowlesi infection samples, for the 28 new clinical samples from peninsular Malaysia 
(shown in red), five previously sequenced laboratory isolates (orange, most were 
originally isolated from peninsular Malaysia many years ago) (Assefa et al. 2015), and 
74 samples from Malaysian Borneo that grouped into separate clusters (Cluster 1 
shown in blue, Cluster 2 in green) (Assefa et al. 2015; Pinheiro et al. 2015; Divis et al. 
2018). All the clinical isolates from peninsular Malaysia grouped into Cluster 3 together 
with the laboratory isolates. The distance matrix is based on the proportion of all SNPs 
with differences between each infection sample (scale bar shows branch length for 
0.5% of SNPs differing), with the majority of reads within each infection sample 
determining the allele scored for each SNP. B. Genome-wide scan of nucleotide 
diversity (π) for P. knowlesi among the clinical isolates in peninsular Malaysia (Cluster 
3, red), compared with diversity seen in the sub-populations in Malaysian Borneo 
(Clusters 1 and 2). The sliding window plot shows values of nucleotide diversity for 
non-overlapping windows of 50 kb in each of the 14 chromosomes. 
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and 0.42 (Figure 3.3), with 3713 and 6738 SNPs being at complete fixation in the 
respective comparisons (Figure 3.4 and 3.5, respectively). There is little variation across 
the genome in the level of divergence when comparing Cluster 3 with Cluster 1 (Figure 
3.3A), but more variation in the comparison with Cluster 2 (Figure 3.3B). This is due to 
a previously described mosaic pattern of diversity across the genome of Cluster 2 (Divis 
et al. 2018), which contributes to greater genome-wide heterogeneity in divergence 
between Clusters 1 and 2 in Malaysian Borneo (Figure 3.3C) than between either of 
these and Cluster 3. 
 
The Neighbour-Joining tree also indicated branching among the Cluster 3 clinical 
samples from peninsular Malaysia into three different sub-clusters; containing fifteen, 
ten, and three of the infection samples (Figure 3.2A). To examine this further, Principal 
Component Analysis (PCA) based on the SNP data was carried out, and the individual 
samples separated into three groups as predicted (Figure 3.6A). Three samples clustered  
tightly, away from the rest along Principal Component 1 (which accounted for 10.5% of 
the overall variation), while the others clustered into two less tightly separated groups 
along Principal Component 2 (which accounted for 6.5% of the overall variation). 
These three groups existing within Cluster 3 in peninsular Malaysia are considered to be 
sub-populations, and have been labelled here as sub-cluster A (15 infections), B (10 
infections), and C (three infections). They are not separated geographically within 
peninsular Malaysia, as samples from each group have been detected at multiple sites 
(Figure 3.6B), and one hospital (in Kuala Lipis) had infections of all three sub-clusters. 
 
The most divergent sub-cluster (C) consisted of infections that were highly related to 
each other, being virtually identical in large parts of the genome (Figure 3.6C); despite 
the fact that each of these infections came from different hospitals, located in three 
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Figure 3.3. Genome-wide FST scan of divergence between P. knowlesi Clusters 1, 2, 
and 3. All SNPs with overall allele frequencies of at least 10% were included, and 
analyses show values for windows containing 500 consecutive SNPs, centred by the 
midpoint of each sequential window and overlapping by 250 SNPs. Red dotted lines 
show the genome-wide average FST. A. The level of divergence between Cluster 3 in 
peninsular Malaysia and Cluster 1 in Malaysian Borneo does not differ greatly 
throughout the genome (mean FST = 0.32). B. Divergence between Cluster 3 in 
peninsular Malaysia and Cluster 2 in Malaysian Borneo is slightly higher (mean FST = 
0.42), and shows more heterogeneity between genomic regions due to mosaic 
structure of diversity in Cluster 2 (as explained by the bottom panel). C. Divergence 
between Clusters 1 and 2 in Malaysian Borneo, showing marked heterogeneity across 
the genome, correlating with the more modest variation in the panel above due to 
mosaic structure of diversity in Cluster 2 as previously reported (Divis et al. 2018). 
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Figure 3.4. FST values shown for all individual SNPs comparing between P. knowlesi 
Cluster 3 in peninsular Malaysia and Cluster 1 in Malaysian Borneo. SNPs with a 
minor allele frequency of < 10% were excluded. In red are shown the means for 
overlapping windows of 500 SNPs (step size of 250 SNPs along each chromosome). 
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Figure 3.5. FST values shown for all individual SNPs comparing between P. knowlesi 
Cluster 3 in peninsular Malaysia and Cluster 2 in Malaysian Borneo. SNPs with a 
minor allele frequency of < 10% were excluded. In red are shown the means for 
overlapping windows of 500 SNPs (step size of 250 SNPs along each chromosome). 
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Figure 3.6. Population substructure of P. knowlesi Cluster 3 in peninsular Malaysia. A. 
Principal Component Analysis (PCA) of the 28 Cluster 3 P. knowlesi clinical isolates 
from peninsular Malaysia shows that these cluster into three groups, termed sub-
clusters A (15 isolates), B (10 isolates) and C (three isolates). The assignment of all 
samples to these three sub-clusters is completely consistent with their placement in 
the within-Cluster 3 branching of the Neighbour-Joining tree based on the pairwise 
distance matrix (Figure 3.2A). A. The first Principal Component accounts for 10.5% of 
overall variation and separated sub-cluster 3 from the others, while the second 
Principal Component accounts for 6.5% of overall variation and separated sub-clusters 
A and B. B. Each of the Cluster 3 P. knowlesi sub-clusters was detected at multiple sites 
within peninsular Malaysia (points shown at each of the five sampling sites show 
individual infections with colours for the different sub-clusters as in the previous 
panel). The site with most samples had all three sub-clusters co-occurring locally. C. 
Genome-wide scan of diversity shows that the sub-cluster C samples are virtually 
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identical in large parts of the genome, whereas sub-clusters A and B are both highly 
diverse throughout the genome, with only a few genomic regions showing lower 
diversity in sub-cluster B compared to A (in chromosomes 2, 7, 12 and 13). D. Genome-
wide scan of differentiation between sub-clusters A and B by sliding window FST 
analysis shows peaks of differentiation corresponding to regions with differences in 
diversity. Most notable is a large region of chromosome 12 having many windows with 
FST values exceeding 0.2, and containing some individual SNPs with fixed differences 
(Figure 3.8). 
 
 
 
 
 
 
 
 
 
 
 
different states in peninsular Malaysia (Figure 3.6B). The validity of the low nucleotide 
diversity seen in sub-cluster C was assessed by calculating nucleotide diversity of three 
random samples from sub-cluster A and sub-cluster B (Figure 3.7). It was found that the 
nucleotide diversities from the three sub-cluster A samples and three sub-cluster B 
samples were broadly comparable to the estimates for the entire sub-clusters. This 
indicates that the regions of extremely low nucleotide diversity seen in sub-cluster C are 
biologically meaningful, and represent isolates that are highly related, perhaps where a 
more clonal population may have developed due to selection pressures unique from sub-
clusters A and B. 
 
Although sub-clusters A and B had similar levels of nucleotide diversity to each other 
genome wide (overall π = 4.02 x 10-3 and 3.78 x 10-3 respectively), sliding window 
analysis indicated a few genomic regions in which sub-cluster B shows lower diversity 
than sub-cluster A, the most prominent of these regions covering half of chromosome 
12 (Figure 3.6C). 
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Figure 3.7. Comparison of nucleotide diversity between sub-cluster C and three 
samples from each sub-cluster A and sub-cluster B. In order to validate the low 
diversity seen in sub-cluster C and to explore whether this was due to the limited 
number of samples, or is biological meaningful, three samples were randomly selected 
from sub-clusters A and B and genome-wide nucleotide diversity was calculated for 
these. As can be seen, the sub-cluster A and B diversities from limited samples were 
comparable to each other and to Figure 3.6C. This indicates that the low diversity seen 
in sub-cluster C is biological in nature, and not an artefact of limited sample numbers. 
 
 
 
 
 
 
 
A comparison of differentiation by FST sliding window analysis within Cluster 3 
between sub-clusters A and B revealed a background of low differentiation, interspersed 
with peaks of high differentiation. The genome-wide average FST was 0.073. The 
regions that showed differences in levels of nucleotide diversity are also the most 
differentiated between the sub-clusters, most notably a large region of chromosome 12, 
in which many windows had FST values exceeding 0.2 (Figure 3.6D), and also 
containing some individual SNPs with fixed differences (Figure 3.8). The other regions 
of differing nucleotide diversity between sub-clusters A and B on chromosomes 7 and 
13 also show elevated FST values. 
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Figure 3.8.  FST values shown for all individual SNPs comparing between P. knowlesi 
Cluster 3 sub-cluster A and sub-cluster B. SNPs with a minor allele frequency of < 10% 
were excluded. In red are shown the means for overlapping windows of 500 SNPs (step 
size of 250 SNPs along each chromosome). 
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3.3.2 Potential signatures of balancing selection in Cluster 3 
In order to scan for genomic loci that may be under different selection pressures in P. 
knowlesi in peninsular Malaysia, nucleotide site allele frequencies were first 
summarised by calculating the Tajima's D index for all 4742 genes containing three or 
more SNPs. Overall, values were negatively skewed, with a mean of -0.86 (Figure 
3.9A), and only 215 genes had values above zero, or which just eight had values above 
1 (Figure 3.9B). The genome-wide pattern is consistent with expectations if there had 
been long-term population size expansion. Individual genes with the highest Tajima’s D 
values may be under balancing selection, and should be considered separately 
(Appendix 2). The gene with the highest Tajima’s D (D) value of 1.81 (locus 
PKNH_0309800) encodes a protein of unknown function. Some genes with high values 
have orthologues in other malaria parasite species that are likely targets of immunity, 
including a tryptophan-rich protein (PKNH_1472400, D = 0.98), a 6-cysteine protein 
(PKNH_1254400, D = 0.61), an exported protein PHIST (PKNH_0808500, D = 0.57), 
and an MSP7-like protein (PKNH_1265900, D = 1.15). However, some genes with 
orthologues considered to be targets of immunity in other malaria parasite populations 
have negative Tajima’s D values here, including the circumsporozoite protein (csp) 
gene which had the highest Tajima’s D value genome-wide in Cluster 1 P. knowlesi in 
Malaysian Borneo (Assefa et al. 2015), as well as the apical membrane antigen 1 gene 
(ama1, D = -1.35), the duffy binding protein alpha (DBPα, D = -0.89) and normocyte-
binding protein gene (NBPXa, D = -0.42). 
 
Tajima’s D was also estimated for the larger two Cluster 3 sub-clusters (A and B). It is 
important to note that these results exist against a background of limited sample 
numbers (15 and 10), which will artificially inflate Tajima’s D values. As such, precise 
Tajima’s D values are less useful than investigating trends between the different sub- 
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Figure 3.9. Variation in nucleotide site allele frequency spectra (summarised by 
Tajima’s D index) across 4742 P. knowlesi genes. Only genes with three or more SNPs 
were included in the analysis. A. Overall values were negatively skewed with a mean 
Tajima’s D of -0.86, consistent with a pattern that would be caused by long-term 
population size expansion. B. The minority of genes with high values are distributed 
throughout the genome, some of which may be under balancing selection (individual 
values for all genes are shown in Appendix 2). 
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clusters. Both sub-clusters had negative genome-wide Tajima’s D, and despite the 
limitations imposed by small sample numbers, the region of divergent nucleotide 
diversity, and high FST differentiation between sub-clusters A and B on chromosome 12 
is also shown to have divergent Tajima’s D values. 
 
3.3.3 Selection acting upon chromosome 12 in Cluster 3 
Chromosome 12 was consistently presented as a region of divergence between Cluster 3 
sub-clusters A and B, showing divergent nucleotide diversity, high fixation, and 
elevated Tajima’s D values between the sub-clusters. To more accurately identify the 
region of divergence, the moving average of Tajima’s D values for both sub-clusters 
was calculated and plotted in windows of 50 genes (with a step size of 1 gene per 
window) (Figure 3.10).  This method identified a region of nearly one million base pairs 
(1,833,887bp-2,823,486bp), which corresponded to 193 genes, that were contributing to 
the divergent Tajima’s D values in chromosome 12, with elevated values seen in sub-
cluster B. A second, smaller region with a positive moving average occurred 
subsequently, and was just under 200,000 base pairs in length (2,855,684bp-
3,051,598bp), and corresponded to 63 genes. The gene with the highest Tajima’s D 
(1.96) in the larger or the two divergent regions was locus PKNH_1252400, encoding a 
TBC domain protein. The overall mean Tajima’s D for the genes in this region for sub-
cluster B was 0.07, which is much higher than for the same region for sub-cluster A (-
0.74) and higher than the average Tajima’s D across the whole of chromosome 12 for 
sub-cluster B (-0.29). Other genes in these regions, with Tajima’s D values of greater 
than one include kelch13 (PKNH_1257700, TD = 1.38), an early transcribed membrane 
protein gene orthologous to etramp14.2 in P. falciparum (PKNH_1246400, TD = 1.31), 
and the gene encoding an MSP7-like protein (PKNH_1265900, TD = 1.15), along with 
several uncharacterised genes of unknown function. 
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Figure 3.10. Variation in nucleotide site allele frequency spectra (summarised by 
Tajima’s D index), plotted as a moving gene average across chromosome 12. Moving 
average has been plotted for Cluster 3 sub-cluster A (blue) and B (red). Sub-cluster A 
shows a negative Tajima’s D distribution across chromosome 12, whereas sub-cluster B 
has two regions of positive Tajima’s D distribution. The positive regions correlate with 
the region in chromosome 12 showing lower diversity in sub-cluster B. 
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3.3.4 Signals of positive selection in Cluster 3 
The standardised integrated haplotype score (|iHS|) index was used to scan for evidence 
of genomic regions affected by recent positive directional selection. When analysing the 
full population complement of clinical isolates from peninsular Malaysia, SNPs with 
standardised |iHS| values in the top 0.01% had the extent of their influence evaluated by 
examination of the ranges of their extended haplotype homozygosity. This identified 
four distinct genomic windows of extended haplotypes (Figure 3.11 and Appendix 3). 
Two of these windows (in chromosomes 1 and 9) spanned across regions which 
included SICAvar and kir gene clusters that had been masked from SNP calling and 
analysis. This was an interesting observation, indicating unlikely positive selection of 
the regions around these polymorphic genes. However, these genes are not well mapped 
and do not have well characterised gene boundaries, and it is also likely that the extreme 
selection upon these regions is affecting the surrounding genomic regions. As it is not 
known if this phenomenon is biological or technical in nature and is likely due to poor 
mapping in these regions, these EHH windows were not further analysed. The other two 
windows that did not span SICAvar and kir genes covered ~28 kb (11 genes) on 
chromosome 9 and ~315 kb (81 genes) on chromosome 12. The large region on 
chromosome 12 coincides with the region that has high genomic divergence and 
differentiation between Cluster 3 population sub-cluster A and B (Figure 3.4D). 
Although analysis of |iHS| in sub-clusters A and B separately is statistically weak due to 
low sample sizes, examination of the data shows that the chromosome 12 region has 
differing |iHS| values sub-cluster A and sub-cluster B (Figure 3.12). Overall, evidence 
suggests that recent selection has operated strongly on a locus on chromosome 12, and 
that this has particularly affected part of the P. knowlesi population in peninsular 
Malaysia.  
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Figure 3.11. Scan for evidence of genomic regions affected by recent positive 
directional selection in P. knowlesi Cluster 3 using the standardised integrated 
haplotype score |iHS| index. Examination of the ranges of extended haplotype 
homozygosity for individual SNPs with high |iHS| values identified four distinct 
genomic windows of extended haplotypes (specified in detail in Table S3). Two of 
these (in chromosomes 1 and 9) spanned across SICAvar and kir genes which were 
masked from SNP calling, while the other two did not include SICAvar or kir genes but 
covered ~28 kb on chromosome 7 and ~ 315 kb on chromosome 12. The large region 
on chromosome 12 is a merged window, comprised of five high |iHS| core SNPs having 
overlapping windows of extended haplotype homozygosity, and coincides with the 
region of chromosome 12 that has the highest genomic divergence between Cluster 3 
population sub-clusters A and B (Figure 3.4D). 
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Figure 3.12. Scan for evidence of genomic regions affected by recent positive 
directional selection in P. knowlesi Cluster 3 sub-clusters using the standardised 
integrated haplotype score |iHS| index. A. |iHS| index for SNPs in sub-cluster A. B. 
|iHS| index for SNPs in sub-cluster B, which has lower values genome-wide, with 
particularly low values for SNPs in the region of divergence on chromosome 12.  
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To scan for differences in recent selection between populations of P. knowlesi, the Rsb 
metric was calculated for pairwise populations of P. knowlesi. When comparing Cluster 
3 to the Malaysian Borneo Cluster 1 and 2 (Figure 3.13A and 3.13B), two regions were 
identified in which identical SNPs showed elevated Rsb values (Appendix 4A and 3B). 
Peaks in these regions were not seen in the Cluster 3 sub-cluster A and sub-cluster B 
pairwise comparison (Figure 3.12C), and possibly represent a geographic difference in 
selection. SNPs in these shared regions occur clustered together over small genomic 
areas, and occur both within genes and in intergenic DNA. The first of these regions is 
on chromosome 10. SNPs here did not fall in protein-coding DNA, and instead are 
restricted to the region between a gene encoding a V-type proton ATPase 16 kDA 
proteolipid subunit (PKNH_1013800) and one encoding protoheme IX 
farnesyltransferase (PKNH_1013900). The second region is on chromosome 14, with 
SNPs occurring within and in the region downstream of DNA gyrase subunit B 
(PKNH_1459600). Other SNPs with high Rsb values occurred mostly in isolation or 
alongside a single other SNP. The cross-population Rsb was also calculated for the 
Cluster 3 sub-clusters A and B (Appendix 4C). Four regions were identified with more 
than one SNP with elevated Rsb in close proximity, on chromosomes 6, 8, 11, and 14. 
None of these regions overlap with those identified in the between Cluster 3 and 
Clusters 1 and 2. The region with the most number of SNPs with elevated Rsb values 
was on Chromosome 11, occurring both within and upstream to the gene encoding RAP 
protein PKNH_1120900. 
 
3.3.5 Estimation of  P. knowlesi mixed infections 
The within-infection FWS fixation index was used to calculate the genetic diversity 
within infections (Auburn et al. 2012; Manske et al. 2012). The FWS was calculated 
independently for each of the P. knowlesi population clusters (Appendix 5). In the  
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Figure 3.13. Scan for evidence of positive directional selection acting on a population 
level using the Rsb metric, across all SNPs identified for P. knowlesi. A. Pairwise 
population comparison using Rsb between Cluster 3 and Cluster 1. This identified five 
regions containing more than one elevated SNP. B. Pairwise population comparison 
between Cluster 3 and Cluster 2, identifying seven regions containing more than one 
elevated SNP. Two regions (on chromosome 10 and chromosome 14) had high Rsb 
values for identical SNPs between Clusters 3 and 1 and Clusters 2 and 1, indicating a 
possible geographical separation in these regions. C. Rsb metric for Cluster 3 sub-
cluster A and sub-cluster B. No SNP in this comparison reaches the Rsb values seen for 
inter-Cluster tests. Four regions contained more than one SNP with elevated Rsb 
values. 
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process, allele frequencies for each SNP were calculated within each individual 
infection (HW) and for the local population as a whole (HS), and the gradient of HW/HS 
was used to calculate the FWS score for each infection. An FWS score of ≥0.95 (close to 
the complete fixation value of 1.0) is considered to represent a predominantly single 
genotype infection, whereas samples with an FWS of <0.95 are very clearly composed of 
more than one genotype (Manske et al. 2012). Cluster 1, comprised of 41 clinical 
isolates had an FWS values ranging from 0.82 to 0.99 (mean = 0.98), and four of these 
samples (9.8%) had scores of <0.95 (Figure 3.14 A, D). Cluster 2, comprised of 33 
samples had an FWS values ranging from 0.90 to 0.99 (mean = 0.99), and five of these 
samples (15.2%) had scores of <0.95 (Figure 3.13 B, D). Cluster 3, comprised of 28 
clinical isolates, had an FWS values ranging from 0.76 – 0.99 (mean = 0.98), with four 
out of the 28 isolates (14.3%) having FWS scores of <0.95 (Figure 3.14 C, D). There was 
no significant difference found between the Fws estimates for each Cluster (Cluster 1 vs. 
Cluster 2 t=-0.52, P=0.60; Cluster 1 vs. Cluster 3 t=0.04, P=0.96; Cluster 2 vs. Cluster 3 
t=-0.41, P=0.69). The high FWS scores for the P. knowlesi isolates indicate that the 
genotyping and SNP calling methods used in this chapter were appropriate for the data. 
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Figure 3.14 Within-host and within-population diversity measured using the FWS 
metric for P. knowlesi population clusters. A-C. Within-host heterozygosity (HW) and 
within-population heterozygosity (HS) based on SNP allele frequencies show a linear 
relationship. Each line represents this relationship for individual isolates of Cluster 1 
(A), Cluster 2 (B), and Cluster 3 (C). D. The FWS metric, calculated from the gradient of 
the HW/HS relationship, for each isolate of Cluster 1 (blue dots), Cluster 2 (green dots), 
and Cluster 3 (red dots). The horizontal line at FWS 0.95 shows the cut-off above which 
isolates are considered to be predominantly single genotype infections. 
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3.4 Discussion 
Genomic analysis has revealed unexpected parasite population structure and evidence of 
recent selection in P. knowlesi in peninsular Malaysia. Following previous multi-locus 
microsatellite analysis, it was expected that whole genome sequencing of samples from 
peninsular Malaysia would reveal a population distinct from those in Malaysian Borneo 
but grouping together with several old laboratory isolates. This was clearly shown, all 
samples from peninsular Malaysia belonged to a genetic population termed Cluster 3 
that is highly divergent from both of the Clusters 1 and 2 in Malaysian Borneo 
(genome-wide mean FST values of 0.32 and 0.42). In addition, and as has been indicated 
by previous whole genome sequencing (Assefa et al., 2015), Cluster 3 has a high 
genome-wide nucleotide diversity, being comparable to the diversity seen in Cluster 1. 
Cluster 2 has a much lower nucleotide diversity due to the mosaic structure of parasites 
in this population, as has been described previously (Divis et al., 2018).  
As mentioned, Cluster 3 is highly diverse, and the clinical samples from peninsular 
Malaysia diverged into three distinct sub-clusters. The cause of the genetic population 
structure within peninsular Malaysia needs to be determined. However, as the old 
laboratory isolates that had been previously sequenced are dispersed throughout the sub-
structure of the peninsular Malaysia clinical isolates, it is likely that this separation is 
well-established. There does not appear to be any geographic separation, as each of the 
three sub-clusters was found in overlapping locations, and all were detected from the 
hospital with most samples analysed. The population structure may reflect more than 
one zoonotic transmission cycle, or could be a sign of recent selection and potentially 
emergence of a sub-population of P. knowlesi transmitted more effectively between 
humans.  
 
 101 
In Malaysian Borneo, long-tailed and pig-tailed macaques are respective reservoir hosts 
for the Cluster 1 and 2 populations of P. knowlesi transmitted to humans (Divis et al. 
2015; Divis et al. 2017), but it is unknown whether different reservoir hosts contribute 
to the parasite population structure within peninsular Malaysia. Microsatellite analysis 
of P. knowlesi in long-tailed macaques from peninsular Malaysia has indicated that 
most of them belong to Cluster 3, although some samples from long-tailed macaques 
from two locations had indeterminate cluster assignments (Divis et al. 2017). It will be 
important to sample and genotype parasites from pig-tailed macaques in peninsular 
Malaysia, as well as to analyse more samples from long-tailed macaques, to investigate 
whether the parasite sub-clusters have different reservoir host species locally.  
 
Genetic sub-clusters of P. knowlesi in peninsular Malaysia may also be transmitted by 
different mosquito species. Plasmodium knowlesi parasites are transmitted by the 
Anopheles leucosphyrus group of mosquitoes, containing a diverse array of species 
found throughout Southeast Asia (Sallum et al. 2005), including An. latens, An. cracens, 
An. Introlatus, and An. hackeri in which P. knowlesi has been detected in peninsular 
Malaysia, and other species that have been shown to be infected elsewhere 
(Vythilingam et al. 2018). Anopheles leucosphyrus group mosquitoes predominantly 
inhabit forested areas (Sinka et al. 2011; Moyes et al. 2016), so changes to forest areas 
and ongoing deforestation will affect human exposure. The potential vector species vary 
in relative abundance among different sampling sites in peninsular Malaysia 
(Vythilingam et al. 2008; Jiram et al. 2012; Vythilingam et al. 2014), but more surveys 
are required to determine the relative extent to which they transmit P. knowlesi, and 
whether they transmit different populations of the parasite corresponding to those 
described here.  
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Genome-wide scans revealed a few chromosomal regions of divergence between 
Cluster 3 sub-clusters A and B, the most prominent of which is a large region on 
Chromosome 12. This region showed lower nucleotide diversity in sub-cluster B 
compared to A, and was also the genomic region with the strongest evidence of recent 
direction selection, shown by the extended haplotype homozygosity analysis. It would 
seem that selection is operating on a locus in this chromosomal region of sub-cluster B, 
and might be driving this signature of local population structure. Local population 
genetic sub-structure has been seen in the endemic malaria parasite P. falciparum in 
Cambodia under strong antimalarial drug selection (Miotto et al. 2015), although 
antimalarial treatment is unlikely to be a major cause of selection on P. knowlesi as long 
as it remains primarily a zoonotic infection. It is notable that the Chromosome 12 region 
did not show a signature indicating recent selection in Malaysian Borneo (Assefa et al. 
2015), indicating that this signature of selection is specific to sub-cluster B of Cluster 3. 
 
More unexpected is the observation of another subpopulation of parasites, here termed 
sub-cluster C, which are highly related and virtually identical to each other throughout 
most of the genome. Although less common than infections belonging to sub-cluster A 
and B, clinical cases with this parasite type presented in different hospitals in three 
different states in peninsular Malaysia. Local population genetic sub-structure has been 
previously seen in the human malaria parasites P. falciparum (Anthony et al. 2005) and 
P. vivax (Auburn et al. 2018) in Malaysia, although that has been interpreted as 
indicating fragmented populations that are close to being eliminated. It is likely that 
zoonotic P. knowlesi populations are sub-structured for other reasons, as seen in 
Malaysian Borneo where the two divergent parasite genetic populations seen in human 
cases are associated with different reservoir hosts (Divis et al. 2015; Divis et al. 2017). 
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Cluster 3 had a skewed allele frequency spectrum with an overall negative Tajima’s D, 
reflecting an excess of low frequency alleles and suggesting long term population 
expansion, as seen in most malaria parasite populations including the separate P. 
knowlesi Clusters 1 and 2 in Malaysian Borneo (Assefa et al. 2015; Divis et al. 2018). 
This is notable, as the overall trend remains apparent in Cluster 3 despite population 
sub-structure that can push Tajima’s D values in the other direction. Scanning for genes 
that have unusually positive values and that might be under balancing selection showed 
different results from those seen in other parasite populations. For example, in the 
Cluster 1 population in Malaysian Borneo, the highest Tajima’s D value was seen for 
the circumsporozoite surface protein (csp) gene, which was also within a window of 
extended haplotype homozygosity indicating recent selection, whereas in peninsular 
Malaysia csp did not have an elevated Tajima’s D value, nor did it fall into an extended 
haplotype homozygosity window. As previously noted, these indices are less suited for 
analysis of Cluster 2 which shows more profound genome-wide mosaicism in diversity, 
likely affected by occasional introgression with sympatric Cluster 1 in Borneo (Diez 
Benavente et al. 2017; Divis et al. 2018). 
 
Multi-genotype P. knowlesi infections have been shown using microsatellite analysis to 
be common in macaques but rarer in humans, perhaps due to the differences in 
transmission intensity in the two host species (Divis et al. 2015). Previous 
microsatellite-based analysis did not find any significant difference in the frequency of 
multi-genotype infections based on location of Cluster 1 and 2 infections in Malaysian 
Borneo and this was reflected by FWS calculation of Clusters 1 and 2 carried out in a 
subsequent study (Assefa et al. 2015; Divis et al. 2015). Likewise, the FWS re-
calculations for Clusters 1 and 2 carried out here, which included all the previously 
analysed samples along with additional Cluster 2 isolates which had been sequenced 
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subsequent to the previous calculation, showed similar levels of within-host diversity, 
with no significant difference found between the Cluster estimates. The FWS calculation 
for Cluster 3 also did not show any significant difference in mixedness compared to 
Clusters 1 and 2. While multi-genotype infections can be an indicator for the potential 
of recombination events occurring after parasites are taken up by mosquitoes, in the 
case of P. knowlesi the high proportion of predominantly single genotype infections in a 
population is most likely due to the low transmission intensity affecting this species, 
particularly among human hosts, and it could also be influenced by geographic isolation 
between human infections (Manske et al. 2012). FWS scores for P. falciparum in West 
Africa have been shown to reflect differing transmission intensities, with higher 
transmission regions showing lower mean FWS scores, but in general these parasites 
have much lower FWS scores than any of the P. knowlesi clusters (Auburn et al. 2012; 
Mobegi et al. 2014; Duffy et al. 2015).  In the case of P. knowlesi, which as far as we 
know remains exclusively a zoonotic disease, the low rate of infection mixedness is 
likely a function of intermittent, opportunistic transmission. 
 
Experimental studies on P. knowlesi have been conducted only on a few strains, of the 
Cluster 3 type (Assefa et al. 2015; Divis et al. 2017), isolated many years ago and used 
to infect laboratory monkeys (Coatney et al. 1972). Diverse observations have 
suggested that parasite virulence increased as a result of serial passage of blood stage 
parasites from one monkey to another, or from one human to another as part of induced 
malaria fever therapy for neurosyphilis. One of these laboratory strains has been 
adapted twice to in vitro culture in human erythrocytes, as a result of independent 
experimental approaches involving culture with mixtures of macaque and human 
erythrocytes prior to growth in human erythrocytes alone (Lim et al. 2013; Moon et al. 
2013). The short-term adaptability of this single parasite strain is further shown by 
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selection for culture in long-tailed macaque erythrocytes, enhanced growth being 
associated with the loss of an invasion pathway needed for invading human erythrocytes 
(Moon et al. 2016). These limited examples illustrate it is very likely that the highly 
diverse natural parasite populations are adapting to changing conditions in Malaysia. 
 
Population genomic analysis of P. knowlesi so far has focused on parasites from 
Malaysia, where most reported cases of P. knowlesi malaria have been described. 
However, cases of P. knowlesi malaria in humans have now been reported from all 
Southeast Asian countries, and the actual numbers may be much higher in many areas, 
as there has been very limited molecular identification of parasite species in most parts 
of the region. It is not yet known if there are other local zoonotic sub-populations 
throughout the region, or whether all parasites belong to the major sub-populations seen 
in Malaysia. It will be particularly interesting to conduct population genetic analysis to 
determine the situation at sites where P. knowlesi has only very recently been realized to 
occur in humans (Herdiana et al. 2018; Imwong et al. 2019).  
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4. Transcriptomic profiles of P. falciparum clinical isolates expressing variable 
levels of MSPDBL2 – a possible marker of gametocytogenesis 
 
4.1 Introduction 
Transmission of malaria parasites from humans to mosquitoes is vital for continuation 
of the parasites’ life cycle, and requires the development of male and female 
gametocytes from asexual precursors. This process of gametocytogenesis has been the 
focus of much research and represents an attractive target for drug development. 
However, although we now have some understanding of the processes involved, we still 
do not know the precise mechanisms. Gametocytogenesis occurs in two main stages, the 
first is commitment, whereby an asexual parasite commits irreversibly to developing 
into a gametocyte, a process which is indicated and initiated by a transcriptional 
‘switch’ from an asexual programme of gene expression to a sexual programme of gene 
expression (Kafsack et al. 2014). The second stage is conversion, where the committed 
parasite physically develops from a trophozoite into a gametocyte by undergoing 
massive morphological and transcriptional changes. The gene identified to be at the 
centre of the switch to sexual commitment is a particular member of the apicomplexan 
Apetala-2 (ap2) gene family, termed ap2-g (Kafsack et al. 2014). This gene is a 
transcription factor that has been recognised as a ‘master regulator’ of sexual 
commitment, which controls many of the downstream gene expression cascades needed 
for commitment to be established. Evidence for this comes from whole genome 
sequencing of gametocyte non-producing lines of P. berghei which revealed that ap2-g 
was the only gene to carry independently derived mutations, and likewise whole 
genome sequencing of gametocyte non-producing P. falciparum laboratory lines 
revealed again that the only gene containing loss of function mutations was ap2-g 
(Kafsack et al. 2014; Sinha et al. 2014). 
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The commitment stage of gametocytogenesis was originally described as occurring in 
the intraerythrocytic cycle previous to the one in which parasites underwent the 
morphological conversion (Bruce et al. 1990a). It was originally found that the progeny 
from a single schizont tended to all either be gametocytes or asexual parasites, 
suggesting that the fate of a parasite’s progeny is fixed prior to the subsequent invasion 
cycle in which gametocyte conversion occurs (Bruce et al. 1990b). However, recent 
evidence has now suggested that (provided certain parameters are met) commitment and 
conversion can occur within the same invasion cycle (Bancells et al. 2019). Under this 
newly suggested model, if ap2-g transcription begins early enough in the ring stage 
parasite for sufficient AP2-G protein to be achieved prior to schizogony then parasites 
are able to convert within the same invasion cycle (Bancells et al. 2019). If the threshold 
level of AP2-G is not reached during the same invasion cycle, the parasite will continue 
along the asexual pathway, re-invade, and will then convert into a gametocyte in the 
subsequent invasion cycle (Bancells et al. 2019). In this way, AP2-G expression strictly 
controls the rate at which gametocytogenesis occurs in asexual parasites.  
 
The upstream region of ap2-g contains H3K9me3 methylation marks associated with 
Heterochromatin protein-1 (HP1), which binds the H3K9me3 and recruits 
methyltransferases to facilitate heterochromatin formation and heritable silencing of the 
targeted locus (Flueck et al. 2009; Lopez-Rubio et al. 2009). Experimental conditional 
knock-out of the HP1 locus in P. falciparum resulted in a 25-fold increase in the 
number of parasites expressing the early gametocyte marker Pfs16, and a high 
proportion of gametocytes were seen in the cultures. Restoring HP1 expression in HP1-
knockout parasites prior to schizogony halted the inflated conversion to gametocytes 
(Brancucci et al. 2014). These experimental data strongly indicate that expression of 
ap2-g is controlled by HP1-dependent gene silencing. A method proposed for the 
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control of AP2-G expression is through gametocyte development protein-1 (GDV-1), 
which was one of the first genes identified as being critical to gametocytogenesis (Eksi 
et al. 2012). The mechanism of GDV-1 mediated activation of genes is suggested to be 
through destabilisation of heterochromatin through interaction of GDV-1 with HP1. Co-
immunoprecipitation assays have shown that GDV-1 and HP1 co-purify and it is 
thought that the two proteins form a complex, co-localising at the nuclear periphery 
(Filarsky et al. 2018). In a parasite line containing a conditional knock-out of gdv-1, 
induction of the gene significantly induced transcription of ap2-g along with eight other 
genes compared to gdv-1 knockout parasites, all of which contain the upstream 
H3K9me3 marks of HP1-mediated silencing. One of these genes encode the merozoite 
surface protein MSPDBL2 (Filarsky et al. 2018).  
 
MSPDBL2 is a merozoite surface protein and is one of two MSP3-like proteins that 
contains a duffy-binding like (DBL) domain (Singh et al. 2009). MSPDBL2 has been 
found to co-localise with MSP-1, in a classic pattern of expression consistent with that 
of a protein expressed on the merozoite cell surface (Singh et al. 2009; Hodder et al. 
2012). Genome-wide analysis of single nucleotide polymorphism frequencies in P. 
falciparum populations has revealed the mspdbl2 gene to be under strong balancing 
selection (Ochola et al. 2010; Amambua-Ngwa et al. 2012). Further analysis of mspdbl2 
transcription in ex vivo clinical isolates and long-term adapted P. falciparum laboratory 
lines revealed generally very low transcript levels. Consistent with this, MSPDBL2 
protein expression is restricted to a small proportion of schizonts representing each 
isolate (Amambua-Ngwa et al. 2012). The number of schizonts expressing MSPDBL2 
varied between isolates, but was expressed by less than 1% of schizonts in all culture-
adapted lines except HB3, which expressed the protein in ~10% of schizonts  
(Amambua-Ngwa et al. 2012). A limited amount of data have suggested that MSPDBL2 
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could be involved in drug resistance (Van Tyne et al. 2011; Van Tyne et al. 2013), or in 
the development of protective immunity against repeated P. falciparum infection 
(Tetteh et al. 2013; Chiu et al. 2015). More recently, it has been suggested that 
MSPDBL2 could have a role in gametocytogenesis. Induction of gdv-1 has been shown 
to result in upregulation of mspdbl2 alongside other genes known to be involved in 
gametocytogenesis. An independent experiment in which gdv-1 antisense RNA was 
disrupted in the F12 P. falciparum laboratory line, which is unable to produce 
gametocytes due to a nonsense mutation within ap2-g (Kafsack et al. 2014), also 
identified mspdbl2 as being upregulated compared to wild-type F12 parasites in which 
gdv-1 antisense RNA is active  (Filarsky et al. 2018). Strand-specific RNA-seq has 
shown that gdv-1 is likely regulated by its own antisense RNA and disruption of the 
antisense RNA results in a marked induction of GDV-1 expression (Broadbent et al. 
2015; Filarsky et al. 2018). Variation in mspdbl2 transcription has also been noted to be 
differential between P. falciparum laboratory lines and clinical isolates (Tarr et al. 
2018). Utilising multiple biological replicates of four laboratory lines and six clinical 
isolates from Ghana, it was found that among ten highly expressed genes showing 
significant differences in gene expression between the groups of samples only two had 
increased expression in the clinical isolates, one of these was gamete antigen 27/25 
(PF3D7_1371600) and the other was mspdbl2 (PF3D7_1036300) (Tarr et al. 2018). 
While these lines of evidence suggest some association between the expression of 
mspdbl2 and the onset of gametocytogenesis, it is not known whether the gene is 
marker of the process or whether it plays a more active role.  
 
Gametocytogenesis is a key part of the Plasmodium life cycle, and recent efforts have 
increased our understanding of the genetics behind this process, and what 
environmental cues may trigger it. In this chapter, I am aiming to determine whether the 
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gene mspdbl2, proposed as either being involved in, or a marker for, gametocytogenesis 
is associated with the transcription of other genes in the gametocytogenesis pathway. I 
will undertake analysis of MSPDBL2 protein in order to profile its expression in a panel 
of clinical isolates collected from West Africa to determine the frequency of isolates 
with high mspdbl2 expression. These isolates will undergo RNA-Seq and genes that are 
differentially expressed between MSPDBL2-high and MSPDBL2-low expressors will 
be identified to determine if they are involved in gametocytogenesis. The association of 
mspdbl2 expression with gametocytogenesis genes will provide strong grounds for 
continuing investigations into this gene in this context. 
 
4.2 Materials and Methods 
Blood samples from clinical malaria cases collected from patients attending local health 
facilities in Ghana (Kintampo), Mali (Nioro), and Senegal (Pikine) between 2012 and 
2013 were used in these studies. Patients aged between 2 and 14 years were eligible if 
they had uncomplicated clinical malaria, had not taken antimalarial drugs in the 72 
hours preceding sample collection and tested positive for P. falciparum malaria by 
lateral flow rapid diagnostic test and slide microscopy. Up to 5ml of venous blood was 
collected in heparinised, anti-coagulation BD Vacutainer® tubes (BD Biosciences). 
Blood samples were leukocyte depleted by centrifugation, separation of plasma, and 
removal of leukocyte buffy coat layer. Erythrocytes were cryopreserved in glycerolyte 
and stored at -80˚C or in liquid nitrogen before shipment on dry ice to the London 
School of Hygiene and Tropical Medicine. Ethical approval for the collection and 
analysis of clinical samples was granted by the Ethics Committee of the Ministry of 
Health in Senegal, the Ethics Committee of the Ministry of Health in Mali, the Ethics 
Committee of the Ghana Health Service, the Noguchi Memorial Institute for Medical 
Research, University of Ghana, the Kintampo Health Research Centre, and the London 
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School of Hygiene and Tropical Medicine. Written informed consent was obtained from 
parents or legal guardians of participating children and additional assent was received 
from participating children. 
At the London School of Hygiene and Tropical Medicine, the clinical isolates were 
thawed in batches of eight (Section 2.1.1) and maintained in culture ex vivo (Section 
2.1.4). Microscope slides were made for each isolate upon thawing, and then again 
periodically to assess their progression into schizogony. Isolates containing schizonts on 
the second day after thawing were purified by magnetic separation and parasites were 
allowed to mature in the presence of E64 to prevent schizont rupture, matured parasites 
were centrifuged to leave the erythrocyte pellet (Section 2.1.6). Clinical isolates with 
sufficiently large erythrocyte pellets were used for both immunofluorescence assays as 
well as RNA-seq and are referred to as “matched” isolates. 
 
Erythrocyte pellets containing matured schizonts were prepared for 
immunofluorescence assays by washing and resuspending parasites in 1% BSA and 
spotting into individual wells of 12-well slides (Hendley-Essex), dried slides were 
stored at -40˚C before use (Section 2.2). Antibody staining was carried out on thawed 
slides by incubation with ⍺MSPDBL2 polyclonal mouse serum and subsequently with 
goat anti-mouse IgG Alexa Fluor® 555 secondary antibody. Vectashield® mounting 
fluid containing DAPI was used to visualise nuclei (Section 2.2). Mature schizonts 
(containing >8 nuclei) were counted using DAPI and scored for MSPDBL2 expression 
on a manual Leica microscope with a 100x objective, a sample size of approximately 
1000 mature schizonts were counted per isolate.  
 
Parasite material for RNA extraction was stored in either TRIzol® or RNAlater™ 
(Thermo Fisher Scientific, MA, USA) and RNA was extracted from these samples by 
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phenol-chloroform extraction and cleaned up using the NucleoSpin® RNA XS 
extraction kit (Macherey-Nagel, Germany), following manufacturer’s instruction 
(Section 2.4). Samples showing successful RNA extraction on the Bioanalyzer were 
reverse transcribed and amplified using the SmartSeq® v4 Ultra® Low Input RNA Kit 
for Sequencing (Takara Bio. Inc., Shiga Prefecture, Japan) (Section 2.5). Successfully 
amplified isolates were then prepared for sequencing on the Illumina MiSeq using the 
Nextera XT Library Prep kit using 75bp paired-end reads (Illumina, California, USA) 
(Section 2.8.2). Samples were pooled equimolar at 4nM with no more than 12 samples 
per pool and were run on an Illumina MiSeq using the 150-cycle MiSeq reagent kit v3. 
Due to the amplification process used for the isolates, it was not possible to use strand-
specific RNA sequencing. 
 
Whole transcriptome short read sequence data were assembled by alignment to the P. 
falciparum 3D7 reference genome using HISAT2 (Kim et al. 2015) (Section 2.9.2), and 
read counts per gene were calculated. Differential gene expression analysis was carried 
out in DESeq2, where MSPDBL2 protein expression in schizonts in each isolate (based 
on IFA counting) was used to categorise or rank the isolates for differential gene 
expression analysis (Section 2.10). For the differential gene expression analysis using 
discrete groups with a 1% cut-off, 12 samples fell into the “low expressor” group, and 5 
samples fell into the “high expressor” group. For the analysis using discrete groups with 
a 3% cut-off, 14 samples fell into the “low expressor” group and 3 samples fell into the 
“high expressor” group. For the analysis using discrete groups comparing >3% 
expression with <1% expression, 3 samples had expression >3% and 12 had expression 
<1%. For the continuous analysis, samples were binned at 0% expression and then in 
increments of 0.5%. As there were few samples with high expression of MSPDBL2, 
there were five bins that only contained a single replicate. 
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4.3 Results 
92 clinical isolates from three West African countries were thawed for ex vivo culture. 
Six from Senegal, 36 from Ghana, and 50 from Mali. Out of these, 48 contained 
sufficient schizont material to yield both IFA slides and RNA (“matched” samples). 43 
of the 48 samples that contained parasite material were harvested for schizonts at the 
first round before re-invasion (approximately 48 hours after thawing); three of the 48 
samples were cultured for 10 days prior to collection and two of the 48 samples had 
been grown in culture for 73 days. 24 isolates did not contain enough material for IFA 
slides and instead 100% of the material was stored in RNAlater™ for potential separate 
RNA-seq. 
 
4.3.1 MSPDBL2 protein expression varies among clinical isolates from West Africa 
Multiwell slides containing schizonts prepared from the 48 “matched” isolates (those 
from which IFA slides were made as well as RNA-seq transcriptome data), along with 
an additional four isolates whose slides had been previously prepared, were stained with 
polyclonal sera against MSPDBL2 and sealed with mounting medium containing DAPI; 
a nuclear stain used to identify and count merozoites. A schizont was considered to be 
positive for MSPDBL2 if it contained eight or more merozoites and was clearly 
fluorescent above the background. As MSPDBL2 is usually expressed in only a small 
proportion of schizonts, in order to get accurate counts, approximately 1000 schizonts 
with 8 or more nuclei were counted per parasite isolate. Of the 48 matched samples, ten 
did not contain sufficient schizonts to count 1000, this was due to either high levels of 
contamination with younger parasites (mid-trophozoite to early schizont stages), or a 
parasite density either too low or too high to allow for accurate merozoite counting and 
scoring of MSPDBL2. Of the 38 samples with sufficient schizonts for counting, 24 had 
an MSPDBL2 expression of less than 1% (four of these had no MSPDBL2-positive 
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schizonts scored). Fourteen of the 38 isolates expressed MSPDBL2 in more than 1% of 
their schizonts and five isolates had MSPDBL2 expression in over 3% of schizonts. The 
range of expression was 0% to 6.6% in these samples (Table 4.1). MSPDBL2 protein 
was localised to the merozoites, as expected for a surface protein. In addition to 
MSPDBL2-positive 8+ nuclei schizonts, any “ambiguous” positives were also scored 
separately. These included early schizonts and late trophozoites showing fluorescence, 
the presence of MSPDBL2 in these younger parasites was not unexpected, as it is 
expressed from approximately 32 hours post invasion (h.p.i) (Otto et al. 2010). 
 
These new data from the 38 isolates were combined with MSPDBL2-expression count 
data from previously studied clinical isolates for which IFA expression data are 
available (prepared and analysed by Dr. Sarah Tarr, and Ms. Lindsay Stewart at 
LSHTM), taking the total number of isolates assessed for MSPDBL2 protein expression 
by IFA up to 77, collected from five West African countries (Ghana n=43, Senegal 
n=10, The Gambia n=4, Guinea n=1, Mali n=19). Including these previous results, 
MSPDBL2 expression ranged from 0% to 73% (Figure 4.1). An exceptional isolate with 
most schizonts expressing MSPDBL2 (73%) was INV236 from Senegal. INV236 was 
cultured ex vivo and RNA was extracted by Ms. Lindsay Stewart (LSHTM). RNA was 
cleaned and amplified using the SmartSeq® v4 Ultra® Low Input RNA Kit for 
Sequencing and sequenced by Dr. Sarah Tarr (LSHTM) using the methods outlined in 
Section 4.2. 
 
4.3.2 Obtaining samples with matched IFA and RNA-seq data 
RNA was extracted from the schizont preparations of 38 samples which were analysed 
by IFA. RNA was run on the Bioanalyzer to obtain the RNA Integrity Number (RIN) 
for that isolate and to qualitatively assess the presence or absence of the 18s and 28s  
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Table 4.1. MSPDBL2 protein expression and RNA-seq details of clinical isolates 
Sample 
ID 
MSPDBL2 IFA 
expression 
Harvested 
RNA? RIN 
Library 
concentration (nM) 
Total reads 
(x106) 
Alignment 
rate (%) 
INV236* 73.0% Yes N/A N/A 0.8 82.0 
INV374* 0.4% Yes 9.8 13.1 1.1 84.9 
INV375 0.3% No - - - - 
INV378 0.2% No - - - - 
INV382 0.4% No - - - - 
INV384 0.2% No - - - - 
INV394 0.2% No - - - - 
INV395* 6.5% Yes 7.6 7.80 3.0 84.9 
INV396* 2.0% Yes 8.2 8.60 3.8 88.2 
INV273/2 0.6% No - - - - 
INV284/2 0.9% No - - - - 
INV401* 1.1% Yes 7.9 8.10 2.0 84.6 
INV406* 0.6% Yes 8.8 12.8 1.6 87.5 
INV408 0.7% No - - - - 
INV409 1.4% No - - - - 
INV410* 1.0% Yes 8.1 10.8 2.6 83.9 
INV419* 0.0% Yes 7.2 15.3 2.4 80.3 
INV420 4.5% No - - - - 
INV425* 3.7% Yes 8.2 20.1 1.4 84.8 
INV427 4.4% No - - - - 
INV428 1.5% No - - - - 
INV429 1.5% No - - - - 
INV430 1.0% No - - - - 
INV431 0.3% No - - - - 
INV432 1.1% No - - - - 
INV438 3.3% No - - - - 
INV440* 0.7% Yes 7.4 11.7 2.1 84.6 
INV441 1.1% No - - - - 
INV443 0.0% No - - - - 
INV444 0.5% No - - - - 
INV445* 0.2% Yes 6.4 14.0 1.8 83.3 
INV446* 0.3% Yes 6.5 11.6 2.0 85.4 
INV447 0.6% No - - - - 
INV448* 0.0% Yes 9.0 15.5 2.9 77.6 
INV449* 0.8% Yes 8.7 12.5 3.2 83.6 
INV450* 0.1% Yes 6.7 18.2 1.7 82.8 
INV455* 0.2% Yes 6.0 13.7 1.4 86.9 
INV458 0.4% No - - - - 
INV459* 0.0% Yes 8.2 10.1 2.3 82.5 
39 ex vivo clinical isolates were counted for their number of MSPDBL2-positive 
schizonts. Of these, 17 were of sufficient quality to undergo RNA-seq from low input 
RNA material. Only samples with a RIN of six or higher were considered high enough 
quality for downstream analysis and these have matched MSPDBL2 expression data 
analysed by IFA. RNA-seq yielded between 7.7x105 to 3.8x106 reads per sample. 
MSPDBL2 expression was assessed by IFA in approximately 1000 schizonts with eight 
or more nuclei per isolate. 17 samples gave high-quality RNA-seq data which informed 
differential gene expression analysis and are indicated with *. 
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Figure 4.1. Expression of MSPDBL2 in P. falciparum schizonts in 77 clinical isolates, 
collected from five countries in West Africa (Ghana n=43, Senegal n=10, The Gambia 
n=4, Guinea n=1, Mali n=19). Approximately 1000 mature schizonts containing eight or 
more nuclei were scored in immunofluorescence assays, using anti-MSPDBL2 
polyclonal mouse serum. Ten of the samples had 0% expression, and 21 had 
expression over 1%. Included are 39 clinical samples previously analysed by IFA for 
MSPDBL2 expression (prepared and analysed by Dr. Sarah Tarr, and Ms. Lindsay 
Stewart, LSHTM), and the new samples with matched IFA and RNA-seq data. 
 
 
 
 
 
 
 
 
 117 
ribosomal RNA (rRNA) peaks (Figure 4.2A). 30 of the 38 samples showed distinct 18s 
and 28s rRNA and it was decided that these would all be carried forward for reverse 
transcription and amplification, and subsequently sequencing, despite the fact that 
several had low RIN values (9 isolates had RIN values of < 6).  After reverse 
transcription and amplification five samples did not show the characteristic ‘hump’ of 
cDNA that was expected by Bioanalyzer analysis, which results from many amplified 
cDNA fragments of varying lengths, indicating that either the reverse transcription or 
the amplification step had failed (Figure 4.2B). Library preparation for sequencing 
using the Nextera XT kit (Illumina) was carried out for the remaining 25 samples and 
was successful for all but one sample. Successfully prepared libraries showed an 
expected distribution of read lengths (Figure 4.2C). The 24 isolate libraries were pooled 
equimolar into two batches of 12 and successfully sequenced. Eight of these 
transcriptomes were generated from RNA with a RIN of less than 6 and it was decided 
at this point to remove these samples from the dataset in order to minimise the 
introduction of errors or bias. INV236 (73% MSPDBL2-positive schizonts), which was 
prepared previously, was added to the transcriptome dataset. This left a final sample 
size of 17 isolates with matched IFA and RNA-seq data of sufficiently high quality. Of 
these, 5 had MSPDBL2 expression by IFA of greater than 1%. 
 
4.3.3 Quality of Transcriptomic data from low input samples 
Due to the amplification carried out on the isolates prior to sequencing, it was not 
possible to carry out strand-specific RNAseq. It is therefore not possible to assess the 
presence and abundance of non-coding antisense RNA molecules, which could affect 
the measurement of gene expression. However, during the reverse transcription stage of 
the amplification process, mRNA molecules are enriched for by the use of oligod(T) 
primers. Polyadenylation of antisense RNA is not commonplace, and in Plasmodium it  
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Figure 4.2. Illustrative representation of Bioanalyzer traces at each successful step of 
the RNA extraction, reverse transcription, amplification and library preparation 
process. A. Quality of RNA was assessed using the RNA 6000 Pico kit (Agilent 
Technologies, CA, USA). The two peaks between 40s and 50s represent the 18s and 28s 
ribosomal RNA peaks and presence of these peaks, alongside the RNA Integrity 
Number (RIN) indicate the quality of the RNA. B. After reverse transcription and 
amplification of RNA using the SmartSeq® v4 chemistry, the expected “hump” of cDNA 
can be seen, resulting from a range of cDNA fragment lengths. This indicates successful 
generation of amplified cDNA material. The very small peaks around the 35bp lower 
marker likely originate from degraded RNA. C. Libraries were prepared using the 
Nextera XT library preparation kit (Illumina, CA, USA). The distribution of fragment 
sizes allows for accurate calculation of library concentration and normalisation. 
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is thought to affect a very small number of transcripts (<160) (Siegel et al., 2014). For 
these reasons, it is not expected that the presence of antisense RNA will have a 
significant impact on the expression levels for genes in this chapter. 
 
Whole transcriptomes were obtained for 17 novel clinical isolates (16 prepared in the 
current study plus INV236). Short reads from the 17 samples were assembled against 
the P. falciparum v3 3D7 reference genome. Trimming the paired-end 75bp raw short 
reads was not necessary as the quality of the reads did not diminish significantly 
towards the ends. A visual assessment of multi-exon genes was undertaken in Artemis 
to ensure that reads did not extend into introns; this indicated by proxy that cDNA 
rather than genomic DNA had been captured (Figure 4.3). Percentages of reads aligning 
to the P. falciparum 3D7 reference genome ranged from 74% to 88%, indicating that 
there were not high levels of contamination within the preparations, with total number 
of reads per sample ranging from 862,000 – 3.7 million (Table 4.1). Transcript levels of 
mspdbl2 were assessed using the “Fragments Per Kilobase of transcript per Million 
mapped reads” (FPKM) metric, which measures the number of short DNA fragments 
mapping to a particular gene, normalised for the size of the sequencing library and for 
the length of the gene. Isolate INV236 (with 73% MSPDBL2-positive schizonts by 
IFA) had an extremely high FPKM value for mspdbl2 of 22,000 relative to that of the 
other isolates whose FPKM values ranged from 0 – 340. 
 
In order to test for bias and any batch effects that might be acting on the dataset, 
transcriptome data from the 17 samples were loaded into the R package DESeq2, using 
a masked GFF annotation file that had the var, rifin, and stevor gene families removed  
(Tarr et al. 2018). In addition to removal of these subtelomeric genes, portions of other 
protein-coding genes that show high allelic diversity were masked to ensure mapping  
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Figure 4.3. Representation of the expected distribution of Illumina short reads 
throughout multi-exon genes for RNA-seq data. A. When short reads (blue bars) are 
created from mRNA molecules, they are distributed throughout the spliced gene, with 
some reads covering exon-exon boundaries. B. When these short reads are mapped 
back to the genome which contains the exon and intron sequences, the short reads are 
‘split’ across exon-exon boundaries, resulting in an absence of sequence data covering 
the introns (shown by the grey bars). C. Representation of short read distribution 
(blue, green, and black bars) viewed in Artemis from INV374 for two multi-exon genes 
mapped to the P. falciparum 3D7 reference genome, clearly showing the absence of 
read data in introns, indicating that the sequencing library represented cDNA and not 
genomic DNA. 
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occurred only in conserved regions of those genes to give a more accurate calculation of 
expression and minimise allelic bias among samples (Tarr et al. 2018).  
 
Principal Component Analysis (PCA) was carried out in DESeq2 to identify clustering 
of samples, which would identify potential technical bias. Principal components (PC) 1-
4 were examined (Figure 4.4). The data was normalised using the DESeq2 rlog 
normalisation prior to PCA. When based on genes which contained a minimum of 10 
reads in any one sample, the majority of the samples broadly clustered together along 
principal component 1 (PC1), which covered 94% of the variance. Two samples 
(INV236 and INV374) were separated along PC2, which accounted for 2% of the total 
variation. The only technical difference shared between these two samples and unique 
from the other samples was that schizont material from them had been stored in 
TRIzol® prior to extraction, rather than RNAlater™. When an alternative approach is 
taken whereby PCA is carried out on the top 500 genes with the highest variance across 
isolates, INV236 and INV374 are separated from the main cluster along PC1, 
accounting for 45% of the total variation, indicating that the RNA preservation method 
may be influencing read counts, but that there was little bias introduced by the library 
preparation and sequencing processes. There was not any obvious clustering along PC1-
PC4 related to MSPDBL2 protein expression (Figure 4.4). 
 
In addition to PCA, other methods can be used to investigate the quality and bias of a 
dataset. A distance matrix between samples was constructed from regularised log (rlog) 
normalised data. This allowed us to look at sample similarity and the heatmap shows 
that the samples disperse into three groups (Figure 4.5). As seen in the PCA, the 
TRIzol®-preserved samples grouped separately from the others, while the remaining  
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Figure 4.4. Principal component analysis of gene expression from 17 clinical isolates 
RNA-seq data for the 17 clinical isolates with matched IFA MSPDBL2 expression data 
were assessed by Principal Component Analysis to investigate any clustering that may 
be the result of technical bias, or from biological differences between isolates. 
Principal Components 1-4 have been calculated based on all genes which have ten of 
more mapped reads (to reduce background noise). The isolates are coloured red were 
represented by less than 1% of schizonts expressing MSPDBL2 by IFA, and the blue by 
greater than 1% of schizonts expressing MSPDBL2 by IFA. PC1 accounts for almost all 
(98%) of the variance, and does not appear to be driven by significant clustering. 
INV236 is the only sample placed slightly away from the majority. Along PC2 (2% of the 
variance), two samples are placed slightly away from the remainder. These are INV236 
and INV374; two samples whose RNA was preserved in TRIzol® rather than RNAlater™. 
Along PC3 and PC4 no obvious clustering of samples can be seen, and none of the 
principal components are associated with the proportions of schizonts showing 
MSPDBL2 protein expression. This indicated that a comparison of transcriptomes to 
test for associations with MSPDBL2 will not contain any systematic bias. 
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Figure 4.5. Heat map showing sample similarity of transcriptomes between the 
clinical isolates. Sample similarity was assessed by constructing a distance matrix of 
rlog normalised read counts of each sample. The samples are shown as pairwise 
comparisons. The lighter blue indicates increasing sample difference. The samples 
cluster into three groups; one of these is formed by INV236 and INV374, which also 
cluster together in principal component analysis (Figure 4.4). The remaining samples 
fall broadly into two groups. 
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samples separate broadly into two groups. To investigate the technical variability 
further, the number of genes per sample with zero mapped reads was plotted (Figure 
4.6A) alongside the average number of reads per gene, per sample (Figure 4.6B). The 
distribution of untransformed read data shown in Figure 4.6C shows sample variation, 
however this was normalised by the rlog transformation, as expected (Figure 4.6D). 
These methods of interrogating samples for technical bias show that, despite INV236 
and INV374 clustering separately by PCA, there was no evidence of poorer 
amplification or sequencing of these samples. 
 
4.3.4 Obtaining first-round schizonts from ex vivo culture 
Significant effort was put in at the ex vivo culturing stage of this project to ensure that 
the maximum possible number of parasites had reached schizogony prior to harvesting. 
However, clinical isolates have lifecycle lengths varying from each other and from 
those of laboratory lines, and as these were mostly ex vivo samples they were not tightly 
synchronised. MACS® purification filtered out the majority of younger parasites, and 
the four-hour incubation with E64 allowed parasites to mature without the most mature 
schizonts rupturing. To assess the success of methods used to promote maturity in this 
project, the FPKM values for each isolate were compared to an RNA-seq time course 
generated from transcriptome data derived from tightly synchronised P. falciparum 3D7 
parasites, which were harvested at seven timepoints in eight hour increments of hours 
post invasion, h.p.i. (0 h.p.i, 8 h.p.i, 16 h.p.i, 24 h.p.i, 32 h.p.i, 40 h.p.i, and 48 h.p.i) and 
whole transcriptome sequenced (Otto et al. 2010). Spearman’s rank correlation was 
calculated for each isolate against each timepoint in the time course. This approach has 
been used previously to assess the overall correlations of life stages of clinical isolates 
and laboratory lines (Tarr et al. 2018). Results are shown in Figure 4.7 and the 
Spearman’s rank correlations shown in Table 4.2. Of the 17 isolates, 13 were found to  
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Figure 4.6. Graphs assessing technical differences between clinical isolate sequencing 
libraries A. The number of genes with zero mapped reads per isolate. B. The average 
number of reads per gene. C. Distribution of the numbers of reads per gene based on 
raw read data. D. Variation in number of reads representing genes is normalised by 
rlog transformation. 
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Figure 4.7. Estimated development of the 17 clinical isolates. FPKM values for the 17 
clinical isolates, correlated with previous data collected across seven timepoints in the 
P. falciparum life cycle (Otto et al. 2010). Ex vivo preparation of these samples involved 
MACS® purification to obtain later stage parasites, followed by 4.5 hours with the 
addition of E64 to block schizont egress with the aim of capturing late stage schizonts. 
The majority of samples were captured at 32 h.p.i. or 40 h.p.i. 
 
 127 
Table 4.2. Spearman’s rank correlation between clinical isolates and RNA-seq 
timecourse data 
 Spearman’s rank correlation with reference data at: 
Isolate 0 h.p.i. 8 h.p.i. 16 h.p.i. 24 h.p.i. 32 h.p.i. 40 h.p.i. 48 h.p.i. 
INV236 0.57 0.41 0.48 0.64 0.75 0.68 0.47 
INV374 0.67 0.55 0.59 0.68 0.75 0.75 0.60 
INV395 0.52 0.42 0.57 0.66 0.70 0.75 0.46 
INV396 0.56 0.44 0.58 0.69 0.73 0.78 0.49 
INV401 0.55 0.41 0.55 0.70 0.79 0.79 0.46 
INV406 0.46 0.33 0.48 0.67 0.75 0.74 0.38 
INV410 0.48 0.34 0.49 0.66 0.74 0.75 0.39 
INV419 0.49 0.37 0.51 0.69 0.75 0.71 0.40 
INV425 0.48 0.34 0.48 0.64 0.74 0.76 0.40 
INV440 0.59 0.43 0.53 0.68 0.80 0.82 0.50 
INV445 0.57 0.41 0.51 0.66 0.78 0.76 0.48 
INV446 0.57 0.40 0.51 0.63 0.76 0.78 0.49 
INV448 0.57 0.40 0.50 0.64 0.79 0.79 0.48 
INV449 0.53 0.40 0.56 0.71 0.75 0.77 0.45 
INV450 0.53 0.39 0.52 0.66 0.75 0.78 0.45 
INV455 0.51 0.37 0.51 0.67 0.76 0.74 0.42 
INV459 0.41 0.29 0.44 0.58 0.66 0.69 0.34 
FPKM values for genes in the 17 isolates were correlated using Spearman’s Rank with 
previous RNA-seq data harvested from tightly synchronised P. falciparum 3D7 
parasites at seven timepoints in eight hour increments across the parasite life cycle (0 
h.p.i. – 48 h.p.i.) (Otto et al. 2010). 
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correlate most strongly with 40 h.p.i 3D7 parasites and four isolates had the strongest 
correlation with 32 h.p.i. This analysis indicates that the majority of parasites in most 
samples were either approaching or in schizogony. Based on time course data available 
at PlasmoDB.org from P. falciparum 3D7, mspdbl2 gene expression is lowest during 
the trophozoite stage (at around 16 h.p.i) and can be seen to increase during early 
schizogony (around 32 h.p.i) before peak expression is reached at 40 h.p.i. Expression 
remains at 48 h.p.i and lower expression can still be seen in merozoites and re-invaded 
rings at around 8 h.p.i. (Otto et al. 2010). As such, no samples were excluded based on 
their staging, as expression of MSPDBL2 can be seen throughout schizogony. 
 
4.3.5 Analysing differential gene expression between discrete MSPDBL2 
phenotype groups 
Differential gene expression analysis was carried out in DESeq2 in R. In each 
comparison, genes for which expression differed between groups at a significance level 
of P < 0.01 were considered. Samples were split into discrete groups based on 
MSPDBL2 protein expression. Firstly, a 1% threshold for MSPDBL2 expression was 
used: with “low-expressers” having <1% MSPDBL2-positive schizonts and “high-
expressers” having >1% MSPDBL2-positive schizonts. This identified 42 genes with 
increased expression and 18 with decreased expression in the MSPDBL2 “high-
expressers” (Figure 4.8A, Appendix 6A). Of the 42 genes with increased expression, 
four are known or suspected to have a role in gametocytogenesis: exported protein 
factor 1 (epf1, PF3D7_0114000) (Silvestrini et al. 2010), nucleoporin nup116/nsp116 
(PF3D7_1473700) (Brancucci et al. 2014; Josling et al. 2019), a zinc finger protein 
(PF3D7_0315600) (Josling et al. 2019), and an unknown conserved Plasmodium 
protein PF3D7_1467600 (Josling et al. 2019). Secondly, the threshold for low-
expressers and high-expressers was set to 3%. Three isolates had MSPDBL2 expression 
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over 3%. This analysis identified 38 genes with increased expression and 4 with 
decreased expression (Figure 4.8B, Appendix 6B). Five of the genes with increased 
expression are known or suspected to have a role in gametocytogenesis: nup116/nsp116 
(PF3D7_1473700), lysine-specific histone demethylase lsd2 (PF3D7_0801900) (Josling 
et al. 2019), a zinc finger protein (PF3D7_1134600) (Josling et al. 2019), early 
gametocyte enriched phosphoprotein egxp (PF3D7_1466200) (Nixon et al. 2018), and a 
gene encoding a conserved Plasmodium protein of unknown function 
(PF3D7_1467600) (Filarsky et al. 2018; Josling et al. 2019). 
A third comparison based on discrete grouping was made using a “buffer” zone within 
which intermediate level expression isolates were excluded. The low-expressers were 
those with <1% MSPDBL2 expression and the high-expressers were the isolates in the 
>3% category. This comparison was carried out in order to reduce noise between 
phenotype groups. This approach identified 35 genes with increased expression and 9 
with decreased expression (Figure 4.8C, Appendix 6C).  Four of the genes with 
increased expression are known or suspected to have a role in gametocytogenesis: 
nup116/nsp116 (PF3D7_1473700), lsd2 (PF3D7_0801900), a zinc finger protein 
(PF3D7_1134600) and egxp (PF3D7_1466200).  
 
The gene lists from the three discrete group comparisons were cross-referenced to 
identify genes that were consistently higher in the high MSPDBL2 groups. 
Approximately half of the genes identified in one comparison were also present in one 
or both of the others (35 genes out of 71), and 26 genes were present in two out of the 
three comparisons, with nine present in all three comparisons (Table 4.3). Of the 26 
genes present in more than one analysis, three genes (nup116/nsp116, lsd2, the 
zincfinger protein PF3D7_1134600, the protein of unknown function PF3D7_1467600, 
and egxp) have known or suspected involvement in gametocytogenesis (Appendix 1). 
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Figure 4.8. Volcano plots showing the log2 fold difference in gene expression 
between samples placed in discrete groups of MSPDBL2 expression. Samples were 
placed into high or low MSPDBL2 expressing groups based on IFA expression. The Y-
axis shows the P-values, with the threshold of 0.01 indicated by the dotted line; dots 
shaded blue had significant P-values below 0.01. MSPDBL2 is labelled on each plot. A. 
Samples were split into groups of those with <1% of schizonts expressing MSPDBL2 
and >1% expressing MSPDBL2. This identified 42 genes with higher expression in the 
>1% group. B. Samples were split into groups with <3% of schizonts expressing 
MSPDBL2 and >3% expression MSPDBL2. This identified 38 genes with higher 
expression in the high group. C. Samples were grouped into those with <1% expression 
of MSPDBL2 in schizonts (n=12) and >3% expression (n=3), this left a “buffer” zone (1-
3%) in which no samples were included, designed to reduce noise and identified only 
the most significant hits. This approach identified 35 genes with higher expression in 
the >3% group. Of all the genes identified in the three analyses (72), 35 of these were 
present in two comparisons, and nine were present in all three. 
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Table 4.3. Analysis of gene expression correlated with expression of MSPDBL2 was 
assessed in three comparisons of discrete groupings 
Gene ID 1% 
cut-off 
3% cut-
off 
<1% and 
>3% 
Description 
PF3D7_0110800 1.03 NS 1.25 transcription initiation factor TFIIB  
PF3D7_0112100 2.11 2.35 2.58 conserved Plasmodium protein, UF 
PF3D7_0202000* NS 2.02 2.12 knob-associated histidine-rich 
protein 
PF3D7_0214300* NS 3.03 2.91 conserved Plasmodium protein, UF 
PF3D7_0309200 NS 2.14 2.07 asparagine synthetase, putative 
PF3D7_0416100 1.35 1.8 1.82 glutamyl-tRNA(Gln) 
aminotransferase subunit A 
PF3D7_0416300 NS 1.53 1.53 DNA helicase MCM9, putative 
PF3D7_0416900 NS 2.04 1.97 conserved Plasmodium protein, UF 
PF3D7_0516500 NS 1.85 1.92 major facilitator superfamily 
domain-containing protein, putative 
PF3D7_0516900 1.11 NS 1.22 60S ribosomal protein L2 
PF3D7_0722400 1 NS 1.2 Obg-like ATPase 1, putative 
PF3D7_0723400 NS 2.22 2.2 conserved Plasmodium protein, UF 
PF3D7_0801900 NS 2.45 2.41 lysine-specific histone demethylase 
PF3D7_0803400 NS 1.56 1.42 DNA repair/recombination RAD54 
PF3D7_0829400* NS 2.13 2 prolyl 4-hydroxylase subunit alpha 
PF3D7_0831800 2.15 NS 2.34 histidine-rich protein II 
PF3D7_1023100 NS 1.79 1.64 dynein heavy chain, putative 
PF3D7_1027300* 2.75 2.93 2.76 Peroxiredoxin 
PF3D7_1028900 NS 1.43 1.51 inner membrane complex protein  
PF3D7_1036300* 6.34 7.05 7.07 MSPDBL2 
PF3D7_1134600 NS 3.08 2.92 zinc finger protein 
PF3D7_1232900 1.31 NS 1.6 nucleotidyltransferase 
PF3D7_1319600* NS 2.91 2.91 ACDC domain-containing protein 
PF3D7_1327200 NS 1.62 1.63 ribonuclease P protein subunit RPR2 
PF3D7_1361200* NS 2.09 2.03 conserved Plasmodium protein, UF 
PF3D7_1362700* 2.49 3.35 3.2 conserved Plasmodium protein, UF 
PF3D7_1408000 1.55 2.12 2.1 plasmepsin II 
PF3D7_1408600 0.98 NS 1.1 40S ribosomal protein S8e, putative 
PF3D7_1413800 1.19 NS 1.35 diphthamide biosynthesis protein 1, 
putative 
PF3D7_1431400* NS 2.05 1.89 surface-related antigen SRA 
PF3D7_1461800* 2.53 3.15 3.17 conserved Plasmodium protein, UF 
PF3D7_1466200* NS 2.26 2.23 early gametocyte enriched 
phosphoprotein EGXP 
PF3D7_1467600* 2.74 3.47 NS conserved Plasmodium protein, UF 
PF3D7_1473700* 3.21 3.88 3.89 nucleoporin NUP116/NSP116 
PF3D7_1474000* 2.36 2.88 2.95 conserved Plasmodium protein, UF 
Differential gene expression analysis carried out using a 1% MSPDBL2 expression cut-
off, a 3% MSPDBL2 expression cut-off, and a third using a “buffer” zone, comparing 
samples with <1% MSPDBL2 expression to samples with >3% MSPDBL2 expression. 
Genes listed are those that were identified in two or three of the comparisons. Values 
shown in the table indicate the log2 fold difference between the groups. NS indicates 
the gene was not considered to have differential expression in that comparison 
(P>0.01). Genes highlighted in bold have known or suspected roles in 
gametocytogenesis. Genes with * were also present in the gene expression analysis 
associated with isolates continuously ranked by their MSPDBL2 protein expression 
with a significance of <0.001. UF: protein has unknown function. 
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A small number of genes in each discrete phenotype group analysis were identified as 
having lower expression in the group with higher MSPDBL2 protein expression 
(Appendix 7A-C). None of these genes from any of the three analyses are known to be 
involved in gametocytogenesis, based on investigation using PlasmoDB and cross-
referencing with gene lists suspected to be involved in gametocytogenesis (Silvestrini et 
al. 2010; Filarsky et al. 2018; Josling et al. 2019) (Appendix 1) 
 
4.3.6 Analysing differential gene expression through a continuum of MSPDBL2 
protein expression 
An additional approach was taken whereby instead of splitting isolates into discrete 
groups of “low expressers” and “high expressers”, MSPDBL2 protein expression was 
treated as a continuous variable, and differential gene expression was carried out on 
samples based on their MSPDBL2 IFA expression. Samples were divided into multiple 
bins based on their expression of MSPDBL2 (Section 4.2), using an interval of 0.5% 
between bins. However, due to the very few samples expression MSPDBL2 at a high 
level, these bins only contain one replicate, which is a limitation of this analysis. 
Differential gene expression is then calculated between each of the bins. Due to the 
stochastic nature of gene expression, no gene will have “zero” change when samples are 
placed into multiple bins and as such every gene will have an “increased” or 
“decreased” skew of expression, therefore a higher P-value stringency helps to reduce 
background noise. At a P-value of < 0.01, 194 genes with increased expression and 304 
genes with decreased expression were identified (Appendix 8 and 9). Of the 194 genes 
that increased alongside MSPDBL2, 17 are known to be, or to potentially be involved in 
early gametocytogenesis, based on previous studies. For example, exported protein 
family-1 (epf1, PF3D7_0114000) (Silvestrini et al. 2010), Pfs16 (PF3D7_0406200) 
(Bruce et al. 1994), gexp-13, -15, -02, and -04 (PF3D7_0831300, PF3D7_1031600, 
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PF3D7_1036300, PF3D7_1102500, and PF3D7_1372100, respectively) (Silvestrini et 
al. 2010), Two members of the AP2 family of transcription factors, ap2 
(PF3D7_1342900) and ap2-g2 (PF3D7_1408200) (Sinha et al. 2014; Yuda et al. 2015), 
and a 6-cysteine protein (P47, PF3D7_1346800) (van Schaijk et al. 2006), among 
others. 
 
The continuous variable analysis identified many more genes that were differentially 
expressed than the discrete analysis. In order to identify the most significant hits and 
reduce the effect of ‘noise’, the P-value cut-off was tightened to 0.005, which left 142 
genes with higher expression correlated with MSPDBL2 expression (Appendix 8); the 
stringency was then tightened even further to 0.001, which reduced the list to a subset of 
52 genes (Table 4.4). This list contained 13 significant hits (including mspdbl2) with 
known or suspected roles in gametocytogenesis (25% of the gene list), including a 6-
cysteine protein, encoding the female-specific marker P47 (PF3D7_1346800), the gene 
encoding the early gametocyte marker Pfs16 (Pf3D7_0406200), and the gene encoding 
epf1 (Pf3D7_0114000). The 52 genes with increased expression with P-values <0.001 
had their rlog normalised expression plotted as a heatmap (Figure 4.9) to look at how 
the genes clustered based on their expression. The genes formed two main clusters 
(shown by the distance tree along the y-axis of Figure 4.9). Nine of the 12 genes with 
gametocytogenesis involvement were found in one cluster, with MSPDBL2 and the 
remaining two genes in the second cluster. mspdbl2 was the most highly significant 
gene, showing the greatest change in expression when correlated to its own protein 
expression.  
 
For comparison, the 130 genes with lower expression (P < 0.001) compared to 
increasing MSPDBL2 protein expression were investigated (Appendix 9). Using  
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Table 4.4. List of genes with increased expression across isolates ranked by their 
MSPDBL2 protein expression 
Gene ID 
Increase 
between ranked 
samples* P-value Gene description 
PF3D7_1036300 8.24 5.35E-25 duffy binding-like merozoite surface protein 2 
PF3D7_1476600 5.95 6.67E-08 Plasmodium exported protein UF 
PF3D7_1474000 5.29 7.59E-08 conserved Plasmodium protein UF 
PF3D7_1102500 5.38 1.32E-07 Plasmodium exported protein (PHISTb) UF 
PF3D7_1461800 5.94 2.96E-06 conserved Plasmodium protein UF 
PF3D7_1445700 3.99 1.38E-05 conserved Plasmodium protein UF 
PF3D7_0814200 3.82 1.74E-05 DNA/RNA-binding protein Alba 1 
PF3D7_1466200 4.02 2.04E-05 early gametocyte enriched phosphoprotein EGXP 
PF3D7_0114000 4.23 2.07E-05 exported protein family 1 
PF3D7_1372100 4.86 2.07E-05 Plasmodium exported protein (PHISTb) UF 
PF3D7_0215000 3.61 2.20E-05 acyl-CoA synthetase 
PF3D7_1362700 4.97 2.56E-05 conserved Plasmodium protein UF 
PF3D7_1473700 6.46 2.83E-05 nucleoporin NUP116/NSP116, put 
PF3D7_0829400 3.67 2.84E-05 prolyl 4-hydroxylase subunit alpha, put 
PF3D7_1027300 4.27 5.18E-05 peroxiredoxin 
PF3D7_0515000 3.87 6.17E-05 pre-mRNA-splicing factor CWC2, put 
PF3D7_1346800 5.19 6.23E-05 6-cysteine protein 
PF3D7_1132600 3.58 6.36E-05 pre-mRNA-splicing factor 38A, put 
PF3D7_1477700 4.51 9.14E-05 Plasmodium exported protein (PHISTa) UF 
PF3D7_1431400 3.13 9.94E-05 surface-related antigen SRA 
PF3D7_1140200 3.67 1.06E-04 conserved Plasmodium protein UF 
PF3D7_1467600 4.81 1.16E-04 conserved Plasmodium protein UF 
PF3D7_1130200 2.83 1.23E-04 60S ribosomal protein P0 
PF3D7_0202000 3.64 1.26E-04 knob-associated histidine-rich protein 
PF3D7_1429100 4.15 1.43E-04 apicoplast ribosomal protein L15 precursor, put 
PF3D7_0315600 4.54 1.66E-04 zinc finger protein, put 
PF3D7_0611600 3.54 1.81E-04 basal complex transmembrane protein 1 
PF3D7_0927300 3.23 1.9E-04 fumarate hydratase 
PF3D7_0815500 3.15 1.92E-04 conserved Plasmodium protein UF 
PF3D7_1236200 3.48 2.31E-04 conserved Plasmodium protein UF 
PF3D7_0403600 3.04 2.32E-04 conserved Plasmodium protein UF 
PF3D7_1317000 3.67 2.65E-04 U4/U6.U5 tri-snRNP-associated protein 2 put 
PF3D7_1233200 3.84 2.91E-04 conserved Plasmodium protein UF 
PF3D7_1437900 3.06 3.0E-04 HSP40, subfamily A 
PF3D7_0419600 2.89 3.53E-04 ran-specific GTPase-activating protein 1, put 
PF3D7_0912900 2.68 4.88E-04 26S proteasome regulatory subunit RPN8, put 
PF3D7_1432800 2.92 4.94E-04 HP12 protein homolog, put 
PF3D7_0208000 2.99 5.1E-04 serine repeat antigen 1 
PF3D7_1361200 3.69 5.27E-04 conserved Plasmodium protein UF 
PF3D7_1136300 3.02 5.41E-04 tudor staphylococcal nuclease 
PF3D7_1312100 3.51 5.72E-04 GYF domain-containing protein, put 
PF3D7_0318900 3.25 5.93E-04 conserved protein UF 
PF3D7_0527500 2.68 6.15E-04 Hsc70-interacting protein 
PF3D7_1428300 2.88 6.25E-04 proliferation-associated protein 2g4, put 
PF3D7_1002400 2.95 6.41E-04 transformer-2 protein homolog beta, put 
PF3D7_0420100 3.32 7.59E-04 serine/threonine protein kinase RIO2 
PF3D7_0406200 2.98 8.6E-04 sexual stage-specific protein precursor pfs16 
PF3D7_1134000 3.27 8.89E-04 heat shock protein 70 
PF3D7_0106900 3.68 8.98E-04 cytidylyltransferase, put 
PF3D7_0408500 3.27 9.15E-04 NYN domain-containing protein, put 
PF3D7_1145400 2.61 9.31E-04 dynamin-like protein 
PF3D7_0214300 4.66 9.94E-04 conserved Plasmodium protein UF 
Genes identified with expression that increased in samples alongside MSPDBL2, 
treated as a continuous variable. Using the high stringent p-value cut-off of <0.001, 52 
genes were identified to be highly significant and unlikely to be a result of stochastic 
noise. Of these, 12 alongside mspdbl2 (25%) are known or are suspected to be 
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involved in gametocytogenesis (gene ID highlighted in bold), compared to only 10 (7%) 
of genes among the 130 showing lower expression with increasing MSPDBL2 protein 
expression. mspdbl2 is the most highly significant, and most variable gene identified, 
as expected. 13 of these highly significant genes (Table 4.5) are also present in two or 
more of the differential expression analyses utilising discrete groups of MSPDBL2 
expression (Table 4.3). UF: protein has unknown function. Put: putative. * The log2 of 
the difference in transcription of the gene between the ranked sampled. 
 
 
 
 
 
PlasmoDB, along with cross-referencing of gene lists with suspected involvement in 
gametocytogenesis (Silvestrini et al. 2010; Filarsky et al. 2018; Josling et al. 2019), out 
these 130 genes, only 10 genes (7%) have known or suspected involvement in 
gametocytogenesis. When cross-referencing the continuous analysis with the three 
analyses using discrete sample groups of MSPDBL2 expression, 13 of the highly 
significant (P <0.001) genes with increased expression in the MSPDBL2 continuous 
analysis were also present in two or all of the discrete group comparisons (Table 4.5), 
this included mspdbl2, early gametocyte enriched phosphoprotein egxp, and nucleoporin 
nup116/nsp116. At the lower stringency P-value threshold of <0.01, 18 of the 35 genes 
identified in more than one discrete analysis were also present in the continuous gene 
list (Table 4.3, genes indicated with asterixis). 
 
In all four comparisons (the three discrete comparisons with different cut-off of 
MSPDBL2 expression alongside the continuous one), mspdbl2 (PF3D7_1036300) was 
identified as the gene showing the highest difference in gene expression. This was an 
informative “positive control” showing that MSPDBL2 gene expression was indeed 
associated with the protein expression seen by IFA.  
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Figure 4.9. Clustering of genes showing higher expression in isolates with higher 
MSPDBL2 expression by IFA. Isolates were ranked based on their MSPDBL2 protein 
expression and highly significant (P-value < 0.001) genes with increased expression 
correlating with increasing MSPDBL2 protein expression were identified. The 
normalised read counts for these genes were extracted and plotted as a heatmap to 
investigate clustering of genes based on expression. The genes fall into two broad 
clusters. Twelve of the 52 genes (alongside mspdbl2) have known or suspected 
involvement in gametocytogenesis and these are indicated by red asterixis. Nine of the 
12 genes fall into one cluster of genes. MSPDBL2 and the three remaining genes fall 
into the second cluster.  
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Table 4.5. Genes with increased expression across isolates ranked by MSPDBL2 
protein expression that also had increased expression in one or more of the discrete 
phenotype group analyses 
Gene ID Increase in 
Expression 
P-value Description 
PF3D7_1036300 8.24 5.35E-25 duffy binding-like merozoite surface protein 2 
PF3D7_1474000 5.29 7.59E-08 conserved Plasmodium protein, UF 
PF3D7_1461800 5.94 2.96E-06 conserved Plasmodium protein, UF 
PF3D7_1466200 4.02 2.04E-05 early gametocyte enriched phosphoprotein EGXP 
PF3D7_1362700 4.97 2.56E-05 conserved Plasmodium protein, UF 
PF3D7_1473700 6.46 2.83E-05 nucleoporin NUP116/NSP116, putative 
PF3D7_0829400 3.67 2.84E-05 prolyl 4-hydroxylase subunit alpha, putative 
PF3D7_1027300 4.27 5.18E-05 peroxiredoxin 
PF3D7_1431400 3.13 9.94E-05 surface-related antigen SRA 
PF3D7_1467600 4.81 0.000116 conserved Plasmodium protein, UF 
PF3D7_0202000 3.64 0.000126 knob-associated histidine-rich protein 
PF3D7_1361200 3.69 0.000527 conserved Plasmodium protein, UF 
PF3D7_0214300 4.66 0.000994 conserved Plasmodium protein, UF 
13 genes identified as having increased expression associated with increase in 
MSPDBL2 protein expression in ranked samples were also identified in the previously 
described analyses using discrete phenotype groups. Gene IDs highlighted in bold are 
known or suspected to have a role in gametocytogenesis. UF: protein has unknown 
function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 138 
To understand the extent to which the DGE analysis was being driven by isolate 
INV236 with extreme MSPDBL2 expression, the analysis was repeated after removal of 
INV236 from the dataset. The results from this analysis revealed that three genes from 
the original analysis that included INV236 were also identified when INV236 is 
removed at a p-value of < 0.001. One of these was the sexual stage precursor Pfs16 
(PF3D7_0406200), a ribosomal gene (PF3D7_1130200), and an unknown protein 
PF3D7_1130200, which was the second most highly differentially expressed gene in the 
original analysis that included INV236. At a relaxed p-value of < 0.01, nine genes were 
shared between the two analyses. Interestingly, although MSPDBL2 was shown to be 
differentially expressed in the analysis excluding INV236 (log2FoldChange of 2.2), this 
was at a less significant p-value of 0.013. 
 
4.3.7 Genes differentially expressed in correlation to mspdbl2 FPKM values 
To extend the analysis of samples ranked by MSPDBL2 protein expression and to 
consolidate the results from this analysis, the FPKM values for mspdbl2 were extracted 
for each sample using DESeq2. The IFA MSPDBL2 positivity and FPKM values 
showed a weak, non-significant correlation (Spearman’s rho = 0.21, P-value = 0.43). 
The correlation between IFA and FPKM expression is more clear at higher levels, 
particularly at expression levels of >1% by IFA (Figure 4.10), but is noticeably weak at 
very low IFA and FPKM values (Figure 4.10B), probably due to random noise. 
Therefore, it was decided to use the FPKM values for mspdbl2 to identify genes with 
higher expression in samples with higher transcript levels. At a P-value of <0.001, this 
approach identified 42 genes with higher expression and of these, 17 (40%) were also 
identified when using ranked MSPDBL2 protein level (Table 4.6) and 16 of the 42 
genes (38%) were also present in two or more of the gene lists produced using the 
discrete MSPDBL2 expression phenotype groups (Table 4.3). Of these 42 genes, 12  
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Figure 4.10. Plot showing the correlation between MSPDBL2 protein expression 
measured by IFA and mspdbl2 transcript expression measured by FPKM. A. Isolate 
INV236, which had unprecedentedly high expression of MSPDBL2 by IFA, also had high 
expression by FPKM. B. A correlation can also be seen at IFA expression levels > 1%, 
however at lower expression there is no obvious correlation, possibly due to the effect 
of stochastic noise. 
 
 
 
 
(28%) have known or suspected involvement in gametocytogenesis (Table 4.6), which 
were identified as described previously (Section 2.10). Seven of the 12 genes were also 
identified in the MSPDBL2 ranked protein expression analysis (Section 4.3.6) and six 
were identified in the analyses using discrete MSPDBL2 phenotype groups (Section 
4.3.5). There were three genes with known or suspected involvement in 
gametocytogenesis which did not appear on any of the gene lists produced by previous 
methods, PF3D7_1148700, encoding the exported protein GEXP12 (Silvestrini et al. 
2010), PF3D7_1408200, encoding an AP2 transcription factor, AP2-G2 (Yuda et al. 
2015), and PF3D7_1472200, encoding histone deacetylase-1 (Filarsky et al. 2018). 
Finally, the list of genes with increased expression in isolates with higher mspdbl2 
FPKM values was intersected with the list of genes showing increased expression in  
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Table 4.6. Genes with increased expression correlating to mspdbl2 transcript levels 
measured by FPKM 
Gene ID Increase between 
ranked samples+ 
P-value Product Description 
PF3D7_0114000* 4.53 2.63E-09 exported protein family 1 
PF3D7_0207800 2.92 5.33E-05 serine repeat antigen 3 
PF3D7_0214300*,** 5.45 1.11E-06 conserved Plasmodium protein UF 
PF3D7_0309200** 3.81 3.31E-04 serine/threonine protein kinase, put 
PF3D7_0315600* 3.74 1.81E-04 zinc finger protein, put 
PF3D7_0402200 4.36 9.99E-04 surface-associated interspersed protein 4.1 
pseudo 
PF3D7_0501400 3.69 1.49E-05 interspersed repeat antigen 
PF3D7_0519500 3.18 7.43E-05 CCR4 domain-containing protein 1, put 
PF3D7_0723400** 3.85 4.46E-04 conserved Plasmodium protein, UF 
PF3D7_0724100 3.50 3.94E-04 conserved Plasmodium protein, UF 
PF3D7_0801900** 4.29 2.01E-05 lysine-specific histone demethylase, put 
PF3D7_0829400*,** 3.54 5.28E-04 prolyl 4-hydroxylase subunit alpha, put 
PF3D7_0930300 3.82 9.74E-04 merozoite surface protein 1 
PF3D7_1014300 3.09 7.43E-04 SPRY domain-containing protein, put 
PF3D7_1027300*,** 5.57 2.30E-06 peroxiredoxin 
PF3D7_1036300*,** 9.37 2.59E-45 duffy binding-like merozoite surface protein 2 
PF3D7_1102500* 4.56 2.40E-04 Plasmodium exported protein (PHISTb), UF 
PF3D7_1132400 2.08 5.86E-04 conserved Plasmodium membrane protein, UF 
PF3D7_1133700 3.24 1.27E-04 FHA domain-containing protein, put 
PF3D7_1133800 2.11 9.79E-04 RNA (uracil-5-)methyltransferase, put 
PF3D7_1134600** 4.73 8.65E-05 zinc finger protein, putative 
PF3D7_1138800 2.34 6.24E-04 WD repeat-containing protein, put 
PF3D7_1142100 3.87 7.22E-04 conserved Plasmodium protein, UF 
PF3D7_1148700 2.98 9.80E-04 Plasmodium exported protein (PHISTc), UF 
PF3D7_1212700 3.41 1.49E-04 eukaryotic translation initiation factor 3.A put 
PF3D7_1228300 2.72 7.52E-05 NIMA related kinase 1 
PF3D7_1233200* 3.45 1.57E-04 conserved Plasmodium protein, UF 
PF3D7_1235300 3.28 7.10E-05 CCR4-NOT transcription complex s4, put 
PF3D7_1236200* 3.65 1.33E-04 conserved Plasmodium protein, UF 
PF3D7_1327300 4.04 2.35E-04 conserved Plasmodium protein, UF 
PF3D7_1361200*,** 3.61 8.35E-06 conserved Plasmodium protein, UF 
PF3D7_1362700*,** 5.96 2.60E-08 conserved Plasmodium protein, UF 
PF3D7_1408200 4.00 4.85E-05 AP2 domain transcription factor AP2-G2 
PF3D7_1431400*,** 3.50 3.94E-04 surface-related antigen SRA 
PF3D7_1437200 1.89 8.05E-04 ribonucleoside-diphosphate reductase subunit,  
PF3D7_1461800*,** 5.41 2.52E-06 conserved Plasmodium protein, UF 
PF3D7_1466200*,** 4.38 2.17E-07 early gametocyte enriched phosphoprotein 
EGXP 
PF3D7_1467600*,** 5.71 6.00E-07 conserved Plasmodium protein, UF 
PF3D7_1469600 3.29 2.51E-04 acetyl-CoA carboxylase 
PF3D7_1472200 3.29 3.09E-07 histone deacetylase, put 
PF3D7_1473700*,** 5.88 2.89E-06 nucleoporin NUP116/NSP116, put 
PF3D7_1474000*,** 4.77 1.01E-05 conserved Plasmodium protein, UF 
Genes identified as having higher expression in samples with higher mspdbl2 FPKM 
transcript levels with P-values < 0.001. Genes highlighted bold have known or 
suspected roles in gametocytogenesis. * indicate that these genes were also identified 
as having higher expression correlating to MSPDBL2 IFA expression (Table 4.4). ** 
indicates that these genes were also present in two or more of the discrete phenotype 
group analyses (Table 4.3). UF: protein has unknown function. Put: putative. + The log2 
of the difference in transcription of the gene between the ranked sampled. 
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isolates with higher MSPDBL2 IFA expression with p-values < 0.01, and this identified 
31 genes out of the 42 that also had higher expression in the MSPDBL2 IFA gene list. 
 
31 genes were identified as having lower expression in samples with higher mspdbl2 
FPKM transcript levels (Appendix 10), and only 3 of these have known or suspected 
roles in gametocytogenesis (9%), showing that there is enrichment for gametocyte 
genes in samples with high mspdbl2 FPKM values. 
 
4.4 Discussion 
Through various methods, combining protein and gene-level analysis, and using the 
DESeq2 framework in R, this project has identified a series of genes whose expression 
is associated with MSPDBL2 protein expression in schizonts. Several methods of 
identifying genes whose transcript levels covary with that of MSPDBL2 were tested in 
the DESeq2 framework. In each of these, mspdbl2 was identified as the most 
differentially expressed gene, indicating that MSPDBL2 protein expression, as 
measured by IFA, can be recapitulated on the RNA level using low input RNA 
methods.  
Attention was drawn to mspdbl2 when it was identified as being under strong balancing 
selection in a panel of P. falciparum clinical isolates, and subsequent profiling of 
MSPDBL2 protein expression by IFA showed it to be expressed in an “on/off” fashion 
in schizonts (Ochola et al. 2010; Amambua-Ngwa et al. 2012). Investigation using RT-
qPCR revealed variation in the rate at which mspdbl2 was transcribed among both 
clinical isolates and laboratory lines, and IFA with specific antibodies showed the 
MSPDBL2 protein in less than 1% of schizonts (Amambua-Ngwa et al. 2012). These 
results have been recapitulated by the IFA data from the new clinical isolates from West 
Africa presented here. While most of the newly investigated isolates had MSPDBL2 
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expression in less than 1% of schizonts, expression ranged from 0%-6.6%, except for a 
single isolate (INV236) showing an exceptionally high number of MSPDBL2-positive 
schizonts (73%). This was matched by a very high transcript level, with an FPKM of 
over 21,000 for INV236, indicating that protein expression of MSPDBL2 could be 
reflected by the level of mspdbl2 transcription. It should be noted that INV236 was 
observed in culture to yield mostly gametocytes at the subsequent intraerythrocytic 
cycle and there proved to be insufficient asexual parasites present to allow continuous in 
vitro culture (unpublished data from Ms. Lindsay Stewart, LSHTM).  
 
Multiple approaches were used in this study to identify genes with altered transcription 
correlating to expression of MSPDBL2. The approach in which MSPDLB2 expression 
by IFA was treated as a continuous variable identified 52 highly significant (P-value < 
0.001) genes that had higher transcription associated with higher MSPDBL2 protein 
expression. Of these, 12 (alongside mspdbl2) were previously known or suspected to be 
involved in gametocytogenesis. The equivalent list of genes which showed decreased 
expression in this analysis (130) contained only 10 known or suspected 
gametocytogenesis genes, indicating that the genes with increased transcript levels 
correlated with MSPDBL2 expression are enriched for gametocyte genes (25% of all 
genes with increased expression vs. 7% of all genes with decreased expression at a 
significance of P < 0.001). In every differential expression analysis carried out, genes 
with increased expression correlating to higher MSPDBL2 expression were enriched for 
gametocyte genes compared to genes with decreased expression. 
 
In the analysis was carried out using mspdbl2 transcript level, measured by FPKM, 40% 
of the genes identified were also shown to have higher transcription correlated with 
MSPDBL2 protein expression. The discrepancy between gene lists could be the result 
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of a temporal difference between transcription and expression of a protein, or due to the 
correlation of MSPDBL2 protein expression and transcript levels being poor at low 
expression and transcript levels. 
 
When differential gene expression analysis based on IFA expression was carried out 
excluding INV236, there was some overlap in the genes identified, however this was 
not extensive, and MSPDBL2 was shown to be differentially expressed at a less 
significant p-value than in the other analyses. This indicates that the extremely high 
expression of MSPDBL2 in INV236 is driving some of the signal seen in these samples, 
the correlation seen between the protein (by IFA) and transcript (by FPKM) also 
showed significant noise at lower expression levels. In the future this will have to be 
addressed, and alternative, experimental methodologies should be investigated for 
obtaining isolates with higher mspdbl2 expression. 
 
One key regulator of gametocytogenesis commitment is ap2-g, a target of gdv-1 and 
considered to be a critical element required for switching onto the sexual development 
pathway (Kafsack et al. 2014; Filarsky et al. 2018). Using an ap2-g conditional knock-
out line recently led to the identification of 42 genes that had higher transcription in 
parasites with stabilised and transcribed ap2-g compared to ap2-g knock-out parasites 
(Josling et al. 2019). Five of these genes were found to have increased expression 
associated with increasing MSPDBL2 expression (5/52); PF3D7_0315600, egxp 
(PF3D7_1466200), PF3D7_1467600, nup116/nsp116 (PF3D7_1473700), and 
PF3D7_1476600. The gene nup116 has also been identified being de-repressed in HP1 
knockout parasites, presumably as a result of gdv-1 mediated ap2-g de-repression 
(Brancucci et al. 2014), as HP1 is a known repressor of ap2-g transcription (Filarsky et 
al. 2018).  In the set of genes showing decreased expression associated with increasing 
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MSPDBL2 expression here, just one gene (1/130) (PF3D7_2467700) was identified as a 
target of ap2-g (Josling et al. 2019). 
Additionally, genes with differential transcription were identified using isolates placed 
into discrete phenotype groups based on MSPDBL2 expression (using a 1%, 3% and 
<1% >3% cut-off). Cross-referencing the gene lists from these three analyses identified 
35 genes that had higher transcription in the high MSPDBL2 expression groups in more 
than one analysis (Table 4.3). Five of these genes have been identified as targets of ap2-
g using the conditional knock out line (Josling et al. 2019). It is interesting that a 
number of potential ap2-g target genes are showing increasing expression associated 
with MSPDBL2, as ap2-g itself was not identified in any of the analyses carried out. 
Likewise, mspdbl2 was not identified as a target of AP2-G (Josling et al. 2019). 
 
Targets of GDV-1, which is the upstream activator of ap2-g, have been identified using 
a parasite line in which ectopic gdv-1 is tagged to a destabilisation domain, in a similar 
manner to the line created to investigate ap2-g targets (Filarsky et al. 2018). Targets of 
GDV-1 included ap2-g, mspdbl2, a PHISTa gene pfg14_748 (PF3D7_1477700), and 
PF3D7_1477400. In the analysis of gene transcription using MSPDBL2 protein 
expression as a continuous variable, pfg14_748 was shown to have correlated increased 
expression (Table 4.4), and although this gene was identified as a target of GDV-1, it 
does not seem to be downstream of AP2-G (Josling et al. 2019). Additional research has 
suggested that pfs14_748 is expressed in parasites prior to their morphological 
conversion into gametocytes, with levels of the protein increasing as parasites develop 
along the gametocytogenesis pathway, and GFP-tagged Pfg14_748 was detectable 
alongside the known early gametocytogenesis marker Pfs16 (PF3D7_0406200) (Bruce 
et al. 1994) in asexual parasite cultures before gametocytes were observed to develop 
(Eksi et al. 2005). A number of AP2-G targets have been identified using chromatin 
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immunoprecipitation combined with whole transcriptome sequencing to identify ap2-g 
binding motifs throughout the genome. While several genes (including nup116, gexp02, 
and pfs16) containing the ap2-g binding motif were identified as also being upregulated 
in sexually-committed schizonts, sexually-committed rings, and stage I gametocytes, 
mspdbl2 was not one of them which suggests that it is not activated by ap2-g (Josling et 
al. 2019).  
 
The early gametocyte marker pfs16 also had increased expression associated with 
MSPDBL2 protein expression, and was also found to be differentially expressed 
between the destabilisation domain-tagged GDV-1ON and GDV-1OFF parasites (Filarsky 
et al. 2018). Temporally, the increase in MSPDBL2 expression in parasites with 
stabilised gdv-1 occurred within the same invasion cycle, after gdv-1 induction and 
parallel to that of ap2-g, whereas genes thought to be targets of AP2-G did not show 
sharp increases in expression until the subsequent invasion cycle (Filarsky et al. 2018).  
It might be expected that ap2-g and gdv-1 would be identified as differentially 
expressed in isolates with higher mspdbl2 expression, if mspdbl2 is involved in 
gametocytogenesis, particularly when many of the targets of gdv-1 and ap2-g have been 
identified. As the isolates used in this chapter were synchronised and allowed to 
develop into mature schizonts to obtain peak mspdbl2 expression, it is likely that the 
expression profiles of gdv-1 and ap2-g have already peaked and decreased by the time 
mspdbl2 expression has increased, as indicated in Filarsky et al. (2018). 
 
Two of the gamete-exported protein (GEXP) family genes had increased expression 
associated with increasing MSPDBL2 protein expression (gexp02 PF3D7_1102500 and 
gexp04 PF3D7_1372100), and gexp02 was also shown to have increase transcription at 
higher mspdbl2 FPKM levels. Members of the GEXP family are involved in protein 
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export occurring during gametocytogenesis (Silvestrini et al. 2010). Although the 
GEXP proteins were identified by mass spectrometry and gene enrichment analysis 
from the early gametocyte proteasome, gexp02 has also been independently identified 
as part of the downstream cascade resulting from induced gdv-1 expression, alongside 
mspdbl2 and other early gametocyte markers (Filarsky et al. 2018). It has also been 
shown that gexp02 is de-repressed in HP1 conditional knock out parasites when HP1 is 
disrupted, presumably due to the activation of gdv-1 (Brancucci et al. 2014).  
Together, this information suggests mspdbl2 could be expressed very early during the 
commitment process, possibly downstream of gdv-1 and together with other early 
gametocytogenesis genes, but perhaps not in the ap2-g downstream cascade. This is 
supported by the absence of AP2-G binding sites upstream of MSPDBL2, but the 
presence of HP1 binding motifs, implicating it as either a target of GDV-1 or activated 
alongside gdv-1 (Filarsky et al. 2018; Josling et al. 2019). 
 
This exploratory work aimed at understanding mspdbl2 was carried out on a panel of 
clinical isolates from West Africa, however more extensive research is required to 
confirm if and how mspdl2 is directly involved in gametocytogenesis, whether that be 
directly or indirectly. If the gene is involved, then the timeline of events within 
individual cells needs to be explored and validated, along with identification of the 
upstream regulators and downstream targets of mspdbl2, as it does not appear to be a 
target of ap2-g. Due to the level of noise seen between isolates with low MSPDBL2 
expression, experimental approaches should be investigated as a priority. 
One experimental approach could be to create a P. falciparum laboratory line in which 
mspdbl2 is tagged with GFP. This would allow cells expressing MSPDBL2 to be 
isolated by fluorescence activated cell sorting. These viable, sorted parasites would then 
be maintained in culture to determine whether they proceed along a sexual or asexual 
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pathway. In parallel, I would suggest carrying out RNA-seq on MSPDBL2-positive 
sorted parasites; the equivalent MSDPBL2-negative parasites from the same culture, 
and a collection taken from the mixed population before sorting. This could be done 
with long-term adapted laboratory lines (for example HB3, which has an MSPDBL2 
expression rate in schizonts of ~10%), and also selected clinical isolates with relatively 
high proportions of MSPDBL2-positive parasites. This approach would allow more 
direct and experimentally comparable analysis to be undertaken between MSPDBL2-
positive sorted cells and MSPDBL2-negative sorted cells. As these populations would 
originate from the same bulk culture, differentially expressed genes would be identified 
from an otherwise comparable background, increasing the reliability of the comparison. 
 
This study has utilised RNA-seq generated from limited sample material, and another 
avenue that could be used to investigate mspdbl2 is by utilising single-cell 
transcriptomics. Transcriptomes have been obtained from single malaria parasites 
(Poran et al. 2017; Ngara et al. 2018; Reid et al. 2018), although the nature of 
sequencing from RNA in a single cell results in significant challenges. Low input RNA-
seq from a population of “pure” MSPDBL2-positive sorted cells provides an alternative 
to single-cell approaches and will be vital for validation when single-cell 
transcriptomics is undertaken.  
A complementary approach to pure transcriptomic sequencing would involve inducing 
gametocytogenesis in laboratory lines and/or clinical isolates and periodically taking 
samples for IFA and RNA-seq across a time-course during gametocytogenesis 
induction. Immunofluorescence assays would reveal whether MSPDBL2 is induced 
during gametocyte induction, and RNA-seq would identify associated genes. This 
would complement previous studies in which RNA has been harvested along the 
timeline of gametocyte induction (Filarsky et al. 2018; Josling et al. 2019). 
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5. Application of single-cell transcriptomics to P. falciparum parasites 
 
5.1 Introduction 
Single-cell RNA-seq provides an avenue to investigate aspects of cell biology 
unattainable using traditional techniques. Originally implemented for interrogating cell 
populations in multi-cellular organisms with a particular focus on mammalian early 
development (Tang et al. 2009; Tang et al. 2010) and tumour biology (Ramsköld et al. 
2012), it is increasingly being applied to unicellular organisms, both eukaryotic and 
prokaryotic in origin (Wang et al. 2015; Liu et al. 2017). Transcriptomics has been used 
broadly in malaria research (Otto et al. 2010; Rovira-Graells et al. 2012; Tarr et al. 
2018), however RNA-seq from bulk preparations overlooks transcriptomic differences 
between parasites and presents an “average” transcriptome contributed to by millions of 
cells. Plasmodium infections are frequently clonal within a host, but within these 
parasites exist a rich variety of transcriptomic profiles designed to provide malaria 
parasites with redundancies and strategies for a number of processes, such as evasion 
from a host’s immune system, erythrocyte invasion, and production of gametocytes 
(Duraisingh et al. 2003b; Rovira-Graells et al. 2012; Painter et al. 2017). Differing 
transcriptomic profiles can also be found between parasites causing uncomplicated 
malaria and parasites causing severe disease (Milner et al. 2012; Tonkin-Hill et al. 
2018). Some, but not all, of the transcriptomic clonal variability is contributed to by 
genes that are part of highly polymorphic, antigenic families, such as the var gene 
family in P. falciparum which encode the cytoadhesive PfEMP1 proteins, implicated in 
virulence, pathogenicity, and development of severe malaria (MacKintosh et al. 2004). 
 
Research utilising single cell transcriptomes has greatly expanded in recent years. 
Techniques originally developed for use with larger, mammalian cells (Tang et al. 2009; 
Picelli et al. 2014) have now been tested on unicellular organisms which are typically 
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much smaller than mammalian cells and contain far less RNA. (Kolisko et al. 2014; Liu 
et al. 2017). Transcript recovery rate has been observed to decrease and technical noise 
to increase with decreasing cell size and RNA amount, representing a major limitation 
for obtaining reliable transcriptomic profiles for unicellular organisms (Brennecke et al. 
2013; Kolisko et al. 2014; Liu et al. 2017; Ngara et al. 2018). Despite these limitations, 
investigations into using single-cell transcriptomics on Plasmodium parasites have 
proceeded, and in recent years a number of studies have been published which use these 
techniques to interrogate single parasites. These studies have required a degree of 
adaptation and testing of standard protocols to increase suitability for Plasmodium 
parasites and maximise mRNA capture, but have none-the-less generated robust single-
cell data, correlating to tens of thousands of cells (Poran et al. 2017; Ngara et al. 2018; 
Reid et al. 2018). For a gene such as mspdbl2, which displays a striking “on/off” 
expression pattern, single-cell analysis would give a superior view of the transcriptomic 
differences between MSPDBL2-expressing and non-expressing parasites, particularly 
from parasites isolated from the same genetic background. 
 
A notable and extremely important example of within-clone variability is the production 
of gametocytes. Gametocytes and sexually committed asexual parasites represent a rare 
cell population within a background of non-committed asexual parasites. Conversion 
rate from asexual to sexual development occurs in only a fraction of parasites, typically 
at a rate of less than 10% (Smalley et al. 1981), although this varies between parasite 
isolates and is also influenced by the parasites’ environment (Carter et al. 2013; 
Schneider et al. 2018). As only small proportions of parasites within a clonal population 
will be committed to the sexual development pathway at any one time, single-cell RNA-
seq is a valuable tool for investigating the network of gene expression that results in 
gametocytogenesis. A key regulator of commitment to gametocytogenesis is the 
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transcriptional regulator ap2-g, without which parasites are unable to produce 
gametocytes (Kafsack et al. 2014). In a pioneering study, single-cell RNA-seq was used 
to profile Plasmodium parasites entering the gametocyte pathway and identify 
downstream targets of AP2-G with minimal interference from the transcriptomic 
profiles of non-committed parasites (Poran et al. 2017). The study used a P. falciparum 
parasite line in which ap2-g was tagged to a ‘destabilisation domain’ and used for single 
cell RNA-seq. Parasites of this line are only able to express AP2-G when cultured in the 
presence of the ligand, Shld-1, which allowed direct comparison of the transcriptomic 
profiles of AP2-GON and AP2-GOFF parasites from an otherwise identical genetic 
background. Over 18,000 single Plasmodium infected erythrocytes were isolated 
throughout the invasion cycle and sequenced, and the resulting transcriptomic profiles 
were sufficiently robust to differentiate parasites based on their position in the life cycle 
(Poran et al. 2017). Analysis of differential expression identified a panel of genes 
expressed exclusively in the AP2-GON parasites that were are not known to be involved 
in gametocytogenesis, but are likely activated by AP2-G, indicating the effectiveness of 
single-cell RNA-seq techniques (Poran et al. 2017).  
 
Gametocytogenesis has also been a focus of other Plasmodium single-cell 
transcriptomic studies, perhaps owing to the drastic differences seen between asexual 
and sexually committed parasites. Using the Smart-seq2 protocol (described in Section 
1.6), single Plasmodium infected erythrocytes were collected at six timepoints during 
the intraerythrocytic life cycle to investigate temporal changes to transcriptomic profiles 
(Ngara et al. 2018). While the sequenced parasites broadly grouped with their respective 
timepoints, they showed substantial heterogeneity in their gene expression which 
prevented tight clustering of parasites from the same isolation time. However, a small 
number of sexually-committed parasites were identified by detection of an early 
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gametocytogenesis genetic marker, etramp3.0, and subsequently a small panel of genes 
induced in these cells was identified, members of which may have involvement in 
gametocytogenesis (Ngara et al. 2018).  
An ongoing challenge is being able to measure the reliability of transcriptomes 
sequenced from single cells. To test the specificity of the techniques with Plasmodium, 
erythrocytes infected with P. falciparum (tagged with GFP) or P. berghei (tagged with 
mCherry) were mixed and isolated by FACS. Single cell transcriptomic profiles of these 
parasites were found to be >98% specific to the correct species (Reid et al. 2018). By 
comparing single cell transcriptomes to bulk RNA-seq time course dataset collected 
throughout the intraerythrocytic life cycle (Otto et al. 2010), Reid et al. (2018) were 
able to differentiate single cells as asexual parasites, male gametocytes or female 
gametocytes and predicted abrupt transcriptomic changes associated with progression 
through the life cycle, in contrast to the smooth, overlapping transitions previously 
described (described in Section 1.7 and Figure 1.10).  
 
Another popular technique for both genomic and transcriptomic amplification is 
multiple displacement amplification (MDA) (described in detail in Section 1.6). First 
developed from a loop-based amplification technique for use with bacteria and 
bacteriophages, it was first adapted for use with genomic DNA from limited material 
(tested from 300ng – 0.3ng) (Dean et al. 2002). Compared to PCR based methods, 
MDA was shown to produce much more uniform amplification of genomic DNA which 
resulted in 3-fold amplification bias, compared to between 102 and 106-fold for the PCR 
techniques tested (Dean et al. 2002), making it ideal for transcriptomics where sampling 
error affecting amplification of gene transcripts can drastically affect the interpretation 
of the data. 
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Plasmodium parasites exhibit remarkably plastic gene expression, all the way down to 
the single-parasite level. Some aspects of Plasmodium biology, such as 
gametocytogenesis, are difficult to investigate due to the background ‘noise’ introduced 
by the vast numbers of parasites of different stages. Single-cell RNA-seq is a relatively 
novel technique that has only been optimised and carried out on Plasmodium parasites 
over the last few years. The ability to sort parasites based on a fluorescently-tagged 
gene of interest followed by single-cell RNA-seq is a method of obtaining 
transcriptomes from parasites without the interference of other parasites. In this chapter, 
my aim was to trial single-cell RNA-seq techniques with P. falciparum parasites in 
order to optimise a protocol for these unique cells and obtain reliable and 
representational single cell transcriptomes. These techniques could then be applied to 
investigate rare cell populations, such as those parasites expressing mspdbl2. 
 
5.2 Materials and Methods 
5.2.1 Parasite culturing conditions and schizont isolation 
The P. falciparum laboratory line 3D7 was cultured according to conditions specified in 
Section 2.1.3 using washed research red blood cells (Section 2.1.2). Parasites were 
synchronised on a Percoll® gradient (Section 2.1.5) approximately 48 hours prior to 
purification and Percoll® was then used to isolate schizonts from synchronised 
parasites. Low number and single parasites were obtained by either serial dilution or by 
Fluorescence-Activated Cell Sorting (FACS). The concentration of schizonts obtained 
by serial dilution was assessed using a Neubauer improved C-Chip™ disposable 
haemocytometer (DHC-N01, NanoEnTek Inc., South Korea). Schizonts which were 
isolated by FACS were first stained with Vybrant® DyeCycle™ Green DNA stain (Life 
Technologies) and were sorted by Dr. Sarah Tarr (LSHTM) in a sterile environment on 
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a BD FACSAria™ Fusion cell sorter using an 85µm nozzle and purity mask, which 
prevents a cell from being sorted if it is in close proximity to another cell. 
 
5.2.2 Whole transcriptome amplification from limiting cell numbers 
Schizonts were aliquoted into either single-cells or low-number multiple cells (1 cell, 3 
cells, 10 cells, 20 cells, 100 cells or 1000 cells). Reverse transcription and amplification 
of cDNA was carried out using the REPLI-g® whole transcriptome amplification 
(WTA) kit (Section 2.6). The manufacturer’s protocol was followed initially before 
several permutations were tested in order to improve output. The final protocol is 
outlined in Section 2.6 and incorporated the use of the RNase inhibitor recombinant 
RNasin® (Promega, WI, USA). Alongside each experiment, 50pg of previously 
purified, DNase-treated P. falciparum 3D7 RNA was included as a control (extracted 
using methods outlined in Section 2.3).  
 
5.2.3 Whole transcriptome amplification using the Fluidigm C1™ system 
The Fluidigm C1™ system which integrates with the SmartSeq® v4 chemistry 
(Clontech), based on the template-switching PCR-based amplification methods (Section 
1.6) was used to isolate single parasites fixed with dithobis (succinimidyl propionate) 
(DSP) and carry out whole transcriptome amplification (Section 2.7). Schizonts were 
isolated by Percoll® purification (Section 2.1.5) and fixed with DSP (Section 2.7). Cells 
were supplemented with BSA to reduce stickiness and loaded onto the mRNA 
Integrated Fluidic Circuit (IFC) microfluidic chip. Reagents needed for the C1™ 
SmartSeq® v4 reaction were also loaded onto the IFC along with DTT to reverse the 
DSP cross linking (Section 2.7). 
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5.2.4 Whole transcriptome amplification quality control 
Amplified low input material was quantified fluorometrically either on a Qubit® 2.0 
using the High-Sensitivity dsDNA reagents (Thermo Fisher Scientific, MA, USA), or 
on a Spectramax M3 using the Quant-IT™ PicoGreen® dsDNA reagents (Thermo 
Fisher Scientific, MA, USA). Quality of amplified material was checked on a 
Bioanalyzer using high-sensitivity dsDNA reagents (Agilent Technologies, CA, USA). 
To ensure the cDNA amplified originated from RNA, an intron-spanning PCR was 
developed to amplify part of the sequence within the gene msp-4 (Section 2.13) and 
used to discriminate between cDNA and gDNA produced in the single cell experiments.   
 
5.2.5 Sequencing and transcriptomic analysis of cDNA from low cell number and 
single cell material 
Samples were prepared for sequencing using the TruSeq Nano LT DNA Library 
preparation kit (Illumina) using a 350bp fragment size and were sequenced paired end 
over 150 cycles according to Section 2.8.1. Short reads were assessed for quality and 
assembled to the P. falciparum 3D7 (Pf3D7) reference genome, (Section 2.9.2). 
Analysis of single-cell and low cell number transcriptomes was carried out in R 
statistical software using gene counts generated using HTSeq-count (Anders et al. 2015) 
(Section 2.14), using the custom made P. falciparum GFF reference file with 
polymorphic regions masked described in Section 2.14. Non-Plasmodium microbial 
contamination was assessed using Kraken (Section 2.14). 
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5.3 Results 
Initially, the REPLI-g® protocol was carried out according to Qiagen manufacturer 
instructions, with no additions or changes. Matured and purified P. falciparum 3D7 
schizonts were isolated into single cell aliquots or 100 cell aliquots. Two types of 
negative control were included, following the REPLI-g® protocol without the addition 
of any biological material; the first were wells which remained open during FACS, and 
the second were sealed during FACS. All samples were treated identically throughout 
the REPLI-g® protocol (FACS and REPLI-g® protocol carried out by Dr. Sarah Tarr, 
LSHTM). From this experiment, four single cells and one of the 100 cell aliquots, along 
with two negative control wells (one open during sorting, the other sealed) were 
selected for whole transcriptome sequencing on an Illumina MiSeq. 
 
Alignment rates of short sequence reads to the P. falciparum 3D7 genome ranged 
between 37% - 89% for the samples containing schizonts (Table 5.1). For the single 
cells, all except one had an overall alignment rate of over 70%. The 100-cell sample had 
an alignment rate of 89%, the percentage of non-aligned reads is a reflection of the 
degree of contamination within a sample. Non-Plasmodium microbial contamination 
was assessed for each sample using Kraken (Wood and Salzberg 2014), a taxonomic 
assignment programme for assessing diversity of short sequence reads, using the 
MiniKraken database, representative of bacterial, archaeal, and viral species (Table 5.2). 
For each of the negative reactions (open and sealed during sorting), approximately 50% 
of short reads could be assigned to microbial species. The remaining 50% was likely 
either unclassifiable or belonged to non-microbial species, possibly resulting from 
human contamination. Approximately 40% of reads sequenced from the negative well 
which was sealed during FACS belonged to Enterobacteriaceae (Phylum: 
Proteobacteria), with 3% assigned to Escherichia coli. The negative well kept open  
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Table 5.1. Sequencing statistics of the P. falciparum 3D7 schizont samples containing 
limited cell numbers. 
Sample 
Number of 
cells 
Number of  
reads (millions) 
Alignment rate  
to 3D7 (%) 
1G 100 2.6 89.2 
2G 1 3.3 80.8 
2H 1 2.3 70.0 
3D 1 2.7 37.2 
3E 1 1.8 77.2 
Samples containing 100 cells or one cell were isolated by FACS and whole 
transcriptome amplified by Dr. Sarah Tarr (LSHTM). Alignment of short sequencing 
reads to the P. falciparum 3D7 reference genome ranged from 37% to 89%. 
 
 
 
 
 
during FACS contained 7% of reads mapping to E. coli and 4% of reads mapping to 
within the Burkholderiales (phylum: Proteobacteria). Reactions which contained 
Plasmodium parasites had considerably fewer reads mapping to contaminants with 
between 8% and 33% mapping to non-Plasmodium microbial species, and mostly these 
were assigned to bacterial species. A few phyla of bacteria were represented in multiple 
samples (Actinobacteria, Firmicutes, Spirochaetes, Proteobacteria). The species E. coli 
and Borrelia duttonii were present in all samples containing Plasmodium cells. 
 
To assess the Plasmodium transcriptome data qualitatively, the bam files which contain 
the mapped short sequence reads were viewed in the Artemis genome browsing 
software against the P. falciparum v3 3D7 reference genome. It was found that, 
although coverage across the transcriptome was high, sequencing reads were not 
restricted to exonic regions. Instead sequence data were observed extending into and 
throughout intronic and intergenic regions, showing no differentiation between exons  
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Table 5.2 Contamination present in sequence data from whole transcriptome 
amplified samples.   
Percentage of short reads mapping to the named taxa for each 
sample 
Taxonomic name and rank 1B  
(-ve 
closed) 
1C 
(-ve 
open) 
1G 
(100 
cells) 
2G  
(1 
cell) 
2H 
(1 
cell) 
3D 
(1 
cell) 
3E 
(1 
cell) 
Bacteria Domain 51.0 51.0 4.50 6.50 8.90 31.7 9.35 
Proteobacteria Phylum 43.5 45.0 1.10 3.29 6.39 24.6 6.76 
…Gammaproteobacteria Clade 43.1 40.3 0.66 2.83 3.36 24.0 6.32 
…Betaproteobacteria Clade 0.30 4.30 0.04 0.15 2.79 0.21 0.05 
…Alphaproteobacteria Clade 0.06 0.04 0.24 0.22 0.18 0.33 0.34 
Actinobacteria Phylum 1.25 1.37 0.21 0.57 0.23 0.37 0.25 
Firmicutes Phylum 0.09 0.22 0.64 0.58 0.48 0.35 0.73 
…Bacilli Clade 0.09 0.22 0.27 0.22 0.19 0.25 0.40 
…Clostridia Clade 0.00 0.00 0.25 0.27 0.24 0.06 0.20 
Tenericutes Phylum 0.00 0.00 0.26 0.18 0.16 0.09 0.12 
…Mollicutes Clade 0.00 0.00 0.26 0.18 0.16 0.09 0.12 
Spirochaetes Phylum 0.00 0.00 1.07 0.70 0.65 0.32 0.49 
Viruses Domain 0.61 0.14 0.92 0.77 0.68 0.38 0.57 
Archaea Domain 0.00 0.00 0.57 0.55 0.40 0.10 0.37 
Euryarchaeotra Phylum 0.00 0.00 0.57 0.55 0.40 0.10 0.37 
…Methanococci Clade 0.00 0.00 0.3 0.26 0.23 0.06 0.17 
…Methanomicrobia Clade 0.00 0.00 0.21 0.25 0.14 0.03 0.18 
The software Kraken was used to assign taxonomic labels to the short sequence reads 
that did not map to P. falciparum 3D7. A number of Phyla and clades were represented 
at above 0.1% of short sequence reads per sample, which are listed above. The vast 
majority of contamination originated from bacteria. Other taxa were represented at 
lower levels. The negative wells contained far greater amounts of contamination due 
to no competition for reagents with Plasmodium DNA. 
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and introns, and therefore showing no evidence of splicing (Figure 5.1). This lack of 
spliced material and the presence of substantial data in intergenic regions indicated that 
the material sequenced could not have been cDNA originating from RNA, but instead 
was likely to include genomic DNA contamination originating from the same cells, 
despite the DNase “gDNA WipeOut” step included in the REPLI-g® protocol. 
 
 
5.3.1 Design and testing of a cDNA and gDNA discriminatory PCR on single cell 
samples 
As the first single-cell experiment resulted in the amplification and sequencing of 
material originating from P. falciparum genomic DNA, a PCR assay was developed to 
rapidly and effectively discriminate between gDNA and cDNA before sequencing was 
undertaken. Three genes known to be expressed during schizogony were selected for 
primer design, cyrpa, msp-4, and clag9 (Bozdech et al. 2003b). Two discriminatory 
strategies were tested. The first was to design primer sets with one primer spanning an 
exon-exon boundary, aimed at preventing primer binding and therefore amplification 
from gDNA in which introns are present. The second was an intron-spanning strategy 
designed to have forward and reverse primers in separate exons to use amplicon size 
difference to distinguish between gDNA and cDNA products. After testing on bulk 
prepared P. falciparum 3D7 gDNA and cDNA, the msp-4 intron-spanning strategy was 
selected (PCR strategy shown in Figure 2.1) due to the amplicon size difference with 
cDNA and gDNA products being clearly identifiable. This PCR was used to assess all 
material prepared by whole transcriptome amplification and ensure samples showing 
only the msp-4 cDNA product were sequenced. 
 
The msp-4 intron-spanning PCR was tested on the WTA samples that were sequenced, 
along with other single cells which were amplified but not sequenced. A gDNA positive  
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Figure 5.1. Sequence data from bulk RNA-seq and single-cell RNA-seq mapping to 
multi-exon genes shown in the Artemis genome browser. Schizonts from P. 
falciparum 3D7 were isolated by FACS and dispensed into single or 100 cell aliquots. A 
selection of these samples were whole transcriptome amplified by the REPLI-g® MDA 
chemistry and sequenced. Artemis was used to view transcriptomes to assess quality. 
PF3D7_1438700 is a multi-exon gene on chromosome 14, and is shown here as a 
representation of multi-exon genes across the genome. A. The expected distribution of 
sequencing short reads from bulk RNA-seq of P. falciparum 3D7 parasites (Dr. Sarah 
Tarr, unpublished data), showing sharp boundaries between exonic sequence data 
(blue and green bars) and the absence of intronic sequence data (grey), indicative and 
expected of data originating from RNA due to the action of splicing. B. Sequence reads 
pooled from the single cells and the 100 cell sample that were amplified using the 
REPLI-g® method and sequenced. Reads extend throughout intronic regions, showing 
no evidence of splicing. This indicates that the sequence data originated at least in part 
from P. falciparum 3D7 genomic DNA contamination rather than from RNA. 
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control and a cDNA positive control, both originating from bulk 3D7 parasite culture 
were also included (Figure 5.2). The gDNA positive control showed a strong band 
approximately 600bp in size (expected product 589bp), while the cDNA control showed 
a strong band approximately 400bp in size (expected product 440bp), along with a weak 
band the same size as the gDNA product; thought to originate from unspliced msp-4 
product. A third much larger band seen in the PCR product after amplifying cDNA 
reaction is likely to be non-specific. The results from the PCR from samples of 100 and 
1000 parasite cells show the REPLI-g® kit had exclusively amplified gDNA and not 
cDNA, as only msp-4 gDNA product was visible (Figure 5.2). 
 
5.3.2 Optimisations of the REPLI-g® protocol to minimise gDNA contamination 
Several modifications to the standard REPLI-g® protocol were trialled in order to 
eliminate contamination from Plasmodium gDNA. Two steps of the REPLI-g® protocol 
were suspected to be performing with low efficiency to allow gDNA amplification and 
at the same time preclude effective generation of cDNA. One of these is the ‘gDNA 
WipeOut’ DNase treatment step, which must be ineffective for gDNA to be present 
during the amplification. In addition, as no cDNA was seen (rather than a mix of gDNA 
and cDNA) it was possible that the reverse transcription (RT) step was failing or 
performing inefficiently. Reverse transcription failure could be due to inefficiencies in 
the reaction itself or could be because of an underlying lack of high enough quality 
RNA for the reaction to proceed due to RNA degradation. 
 
To directly address the gDNA contamination, aliquots of 1000 and 100 schizont-
infected erythrocytes were prepared by serial dilution. Alongside each iteration of the 
protocol tested, a positive control of previously purified and DNase-treated bulk P. 
falciparum 3D7 RNA was included. A subset of reactions was set up to include an  
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Figure 5.2. msp-4 intron-spanning PCR confirms the absence of cDNA in single cells. 
Next-generation sequencing revealed that the REPLI-g® protocol had failed to 
sufficiently capture and amplify the RNA from single cell and 100 cell samples. A PCR 
assay was designed to test for gDNA contamination in amplified samples prior to 
whole transcriptome sequencing. The gene msp-4 is a multi-exon gene known to be 
reliably expressed in P. falciparum schizonts. Primers were designed within exon 1 and 
exon 2 of this gene to produce different sized products from cDNA and gDNA based on 
exclusion/inclusion of the intron. Expected product sizes are 589bp for gDNA and 
440bp for cDNA. The msp-4 assay was tested on the four single cells (lanes 4-7) and 
100 cell sample (lane 3) that underwent sequencing, along with three additional single 
cells that did not undergo sequencing (lanes 8-10). Genomic DNA and cDNA 
independently extracted from P. falciparum 3D7 bulk culture were run as positive 
controls (lanes 11 and 12, respectively) and show that the gDNA shows a larger 
product than cDNA, as expected. The REPLI-g® negative control (lane 2) and the 
reverse transcription negative control (lane 13) were both negative. As suspected from 
the sequencing data, all the cells prepared with the REPLI-g® protocol contained only 
gDNA msp-4 product. 
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additional treatment with DNase 1 (Qiagen) alongside the REPLI-g® gDNA WipeOut 
step. Another subset of reactions was set up to address possible inefficiencies in the RT 
reaction resulting from the unusual AT richness of the P. falciparum genome (~80% 
genome wide) and these samples were run with a lower RT incubation temperature of 
37°C rather than the recommended 42°C. A third subset of reactions was set up to 
combine these alterations, which underwent an additional DNase treatment step and 
were incubated at 37˚C during the RT reaction. The success of each alteration was 
assessed using the msp-4 intron-spanning PCR (Figure 5.3). In this experiment, all but 
one of the reactions failed outright, based on the msp-4 PCR, and the one sample that 
had successful amplification showed msp-4 gDNA product. This suggested that there 
was a more fundamental issue that was affecting reaction success, particularly as the 
purified RNA control showed a product whose size was consistent with cDNA, in 
addition to some residual gDNA (Figure 5.3, lane 2). This indicates not only that the 
protocol can be successful given ideal starting conditions, but also that something 
present specifically in the whole cell reactions was impacting the reaction success. One 
avenue that seemed likely was the introduction of RNases into the reactions, and this 
was explored further. 
 
5.3.3 RNA degradation is a probable cause of REPLI-g® failure 
One possible entry route for RNases was thought to be through the filtered 1X PBS 
used to isolate, wash, and dilute parasites. Therefore, sterile, molecular-grade 1X PBS, 
free from RNases and DNases, was tested alongside the originally used PBS for cell 
isolation and dilution. Reactions were set up using 1000 cells and the purified RNA 
positive control that was used previously. The first purified RNA reaction was set up 
using the same 1X PBS that was used for the whole cell dilutions and the second 
reaction was set up with molecular-grade 1X PBS, using 50pg of purified RNA. Both of  
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Figure 5.3. Alteration of reverse transcription incubation and addition of DNase I 
treatment does not improve REPLI-g® success. The REPLI-g® protocol was carried out 
on 100 and 1000 cell aliquots of P. falciparum schizonts to reduce genomic DNA 
contamination. The msp-4 intron-spanning PCR was used to determine the success of 
each alteration. Lane 2 contains preciously purified 3D7 RNA (1ng), which underwent 
the REPLI-g® protocol following the manufacturer’s instructions; the msp-4 PCR 
showed that cDNA had been produced, mixed with a small amount of gDNA, seen as a 
faint band (lane 2). The standard REPLI-g® protocol was also carried out on 100 cell 
(lane 3) and 1000 cell (lane 4) aliquots, and these did not produce gDNA or cDNA. The 
first alteration tested was the addition of 1µl DNase 1 alongside the standard gDNA 
WipeOut step, this was tested on 100 cell (lane 5) and 1000 cell (lane 6) aliquots and 
these reactions failed to produce cDNA or gDNA msp-4 amplicons. The second 
alteration was to lower the temperature of the reverse transcription reaction from 
42°C to 37°C, again tested on 100 cells (lane 7) and 1000 cells (lane 8), which 
generated msp-4 gDNA product. The final alteration was to combine the addition of 
DNase 1 with a 37°C RT temperature in a reaction of 1000 cells (lane 9). Lanes 10-12: 
cDNA positive control, gDNA positive control, and negative control, respectively. 
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these reactions showed msp-4 product consistent with cDNA. Two 1000 cell reactions 
were set up, one with the original 1X PBS and the second with molecular-grade PBS; 
these both only produced msp-4 gDNA. The final two reactions contained 1000 cells 
spiked with 0.5ng of purified RNA, one with the old PBS and one with the molecular-
grade PBS to test whether the REPLI-g® kit could generate cDNA from the purified 
RNA in the presence of cellular material., and these also only showed msp-4 gDNA 
(Figure 5.4). These results indicate that it is unlikely to be an external factor such as 
PBS resulting in the destruction of the RNA in a reaction. The failure of the whole cell 
reactions spiked with purified RNA to produce cDNA indicated that there were RNases 
being introduced into the reactions by association with the cells themselves resulting in 
RNA degradation as soon as the cells are lysed by the REPLI-g® lysis buffer. 
 
5.3.4 Testing a modified protocol with the addition of an RNase inhibitor 
Introduction of RNases into the reaction would have to occur during the initial steps of 
the REPLI-g® protocol, likely prior to cell lysis and resulting in degradation of the 
RNA before the reverse transcription reaction is carried out. This would explain why 
the whole cell reactions spiked with purified RNA only produced gDNA product. While 
the REPLI-g® kit contains an RNase inhibitor, details beyond this are proprietary 
information and as such the inhibitor is of unknown type and concentration. Other 
protocols and chemistries for single-cell transcriptomics use an RNase inhibitor at the 
cell lysis step, and again immediately afterwards (Poran et al. 2017). The REPLI-g® 
protocol was adjusted to include the RNase inhibitor, recombinant RNasin® 
(rRNasin®, Promega) in the initial lysis mix into which whole cells were directly 
diluted into. As rRNasin® is denatured at temperature higher than 50°C, additional 
rRNasin® was added immediately following the 95°C cell lysis step and these  
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Figure 5.4. msp-4 PCR testing the effect of using DNase/RNase free PBS on gDNA 
contamination. A possible cause for the failed reactions and gDNA contamination was 
through introduction of RNases through the PBS used to isolate whole cells. As such, 
molecular-grade, RNase/DNase free 1X PBS was tested against the sterile-filtered PBS 
used previously. The msp-4 intron-spanning PCR was carried out on the samples. 
Reactions containing 50pg of purified RNA were used as controls; one diluted into the 
original PBS (lane 2) and one diluted into the molecular-grade PBS (lane 3) all showed 
msp-4 cDNA product. When using 1000 whole cells in a reaction with the old (lane 4) 
and molecular grade (lane 5) PBS, only msp-4 gDNA product was seen. Two reactions 
containing 1000 cells were spiked with 0.5ng purified RNA, to test if this was able to be 
reverse transcribed in the presence of whole cells; one of these reactions was diluted 
with the old PBS (lane 6) and the second with molecular-grade PBS (lane 7); these both 
showed only msp-4 gDNA product. Lanes 8-10: gDNA and cDNA positive controls, and 
negative control, respectively. 
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alterations were tested on purified RNA and on reactions containing 1000 cells (Figure 
5.5). Two purified RNA (50pg) positive controls were run without the addition of 
rRNasin®, both of which produced cDNA in the msp-4 PCR. A third experimental 
reaction contained 50pg of purified RNA, set up with the addition of 1U/µl (the 
manufacturer recommended concentration) of rRNasin® in the lysis mix and an 
additional 1U/µl added immediately after cell lysis, to ensure that the rRNasin® was not 
having a detrimental effect on the WTA reaction, this reaction also produced msp-4 
cDNA product. A reaction containing 1000 whole cells diluted directly into lysis mix, 
without any rRNasin® also produced cDNA, however at an approximately 50:50 mix 
with gDNA. Another reaction (a repeat of one carried out in the previous experiment) 
contained 1000 whole cells, spiked with 0.5ng purified RNA, and unlike in the previous 
experiment this reaction produced a mix of cDNA and gDNA. Two reactions contained 
1000 cells each, with rRNasin® added at a final concentration of 1U/µl and 3U/µl and 
these reactions produced the greatest amount of cDNA. Finally, 1000 whole cells were 
spiked with 0.5ng purified RNA and had rRNasin® added at 1U/µl, resulting in a 
reaction that produced very faint bands of mixed msp-4 cDNA and gDNA (Figure 5.5). 
Over all of the REPLI-g® experiments, the success or failure of reactions has not been 
consistent, however a possible contributory factor is that in this experiment the whole 
cells were diluted directly into the REPLI-g® lysis buffer and used immediately, 
whereas previously these cells had been frozen in 1000 cell aliquots at -80C and stored 
overnight before whole transcriptome amplification possibly resulting in RNA 
degradation. The 1000 whole cell reactions with added rRNasin® contained 
approximately double the concentration of DNA compared to those without rRNasin®. 
The higher concentration of rRNasin® did not seem to improve cDNA production, and 
together these results suggest that the adapted protocol with additional RNase inhibitor 
to be a promising improvement.  
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Figure 5.5. msp-4 PCR showing the effect of adding an RNase inhibitor on the REPLI-
g® protocol. Reactions were set up to test whether the introduction of rRNasin® into 
the reactions before and after cell lysis would prevent high degradation of RNA. The 
msp-4 intron-spanning PCR was carried out on the reactions. Three purified RNA 
controls, two following the standard REPLI-g® protocol (lanes 2 and 3) and one with 
the rRNasin® addition (lane 4) all produced msp-4 cDNA. The remaining reactions were 
set up using “fresh” aliquots of 1000 parasites (not frozen between collection and WTA 
as had been done previously). The 1000 cell reaction following the REPLI-g® protocol 
produced a mix of cDNA and gDNA (lane 5). A repeat of a previous reaction contained 
1000 cells spiked with 0.5ng purified RNA also produced a cDNA and gDNA mix, with 
stronger cDNA product (lane 6). When 1000 cell reactions included rRNasin® at two 
concentrations, cDNA products were notably stronger than gDNA product (rRNasin® 
included at 1U/µl and 3U/µl in lanes 7 and 8, respectively). 1000 cells spiked with 
0.5ng purified RNA plus 1U/µl rRNasin® produced very weak mixed cDNA and gDNA 
product. Lanes 10-12 show the gDNA, cDNA and negative controls. 
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The sensitivity of the RNase inhibitor adapted protocol was tested to assess whether the 
success of the 1000 whole cell reactions could be recreated when using far fewer cells 
per reaction; with the target being a single cell per reaction. The REPLI-g® protocol 
was followed, utilising molecular-grade PBS, freshly isolated and diluted parasites, and 
with the addition of rRNasin® at a final concentration of 1U/µl with the lysis buffer 
into which cells were diluted and again immediately following the 95°C cell lysis step. 
Parasites were diluted to the appropriate concentration to obtain 1000, 100, 10, 3, or 1 
cell per reaction.  The msp-4 PCR was carried out to determine success (Figure 5.6). 
The reaction containing 1000 whole cells was unsuccessful. Two reactions were set up 
to contain 100 parasites; one of these produced predominantly gDNA, while the second 
produced a mix of gDNA and cDNA. Two reactions contained 10 whole cells, and these 
both showed strong, clean msp-4 cDNA product. Three reactions contained three cells 
each. One of these failed, the second produced a mix of cDNA and gDNA, and the final 
reaction showed cDNA product. Three reactions contained single cells. Two of these 
failed, while the third produced a PCR product consistent with cDNA (Figure 5.6).  
 
With the success of the low cell number experiment, particularly when using between 
one and ten cells, the next experiment was set up to include reactions set up by limiting 
dilution and reactions containing cells isolated by FACS (FACS was carried out by Dr. 
Sarah Tarr, LSHTM). Parasites were prepared and enriched for schizonts as a single 
culture, before being split into ‘FACS isolated’ and ‘serially diluted’ aliquots, in order 
to minimise technical bias. FACS cells were sorted directly into the lysis buffer with 
1U/µl rRNasin®. For both cell isolation methods, reactions were set up with 100, 10, 3, 
and single cells. Based on the msp-4 PCR, both of the 100 cell reactions (FACS and 
limiting dilution isolated) contained gDNA. Of the remaining reactions containing 
serially diluted cells, one 3 cell reaction produced a strong msp-4 cDNA band, and one  
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Figure 5.6. msp-4 PCR carried out on samples containing 1 – 100 schizonts amplified 
using the RNase inhibitor-supplemented REPLI-g® protocol. The REPLI-g® protocol 
was adapted to include the addition of rRNasin® in the cell lysis mix into which cells 
were deposited and again just after the cell lysis 95˚C incubation step. The protocol 
was tested on several reactions containing 1000 cells down to single cells, obtained by 
limiting dilution. The msp-4 PCR was used to assess gDNA and cDNA product. The 1000 
cell reaction did not produce any DNA (lane 2). The reactions containing 100 cells 
produced mixes of cDNA and gDNA PCR product; with one (lane 3) producing far 
greater gDNA than cDNA, and the other (lane 4) producing them in roughly equal 
amounts. Both of the reactions containing 10 cells produced strong bands consistent 
with cDNA (lanes 5 and 6). One out of three reactions containing three cells failed (lane 
7), another produced a mix of cDNA and gDNA (lane 8), and the final one had a weak 
but clean cDNA product. Of three single cell reactions, two failed (lanes 10 and 11), 
and the final one produced a clean cDNA msp-4 band (lane 12). Lanes 14-16 show to 
gDNA, cDNA and negative controls. 
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single cell produced a weak msp-4 cDNA band. The reactions containing cells isolated 
by FACS were more successful. Both 10 cell reactions, one 3 cell reaction, and two 
single cell reactions produced msp-4 cDNA, although the product from the single cells 
was very faint (Figure 5.7). The single cell reactions showing msp-4 cDNA product 
(one reaction contained a cell isolated by limiting dilution, two by FACS), the FACS-
isolated 3 cell reaction showing msp-4 cDNA product, and the FACS-isolated 10 cell 
reaction showing msp-4 cDNA product underwent whole transcriptome sequencing. 
 
5.3.5 Whole transcriptome sequencing of material from low input and single 
parasite samples 
Five of the reactions from the REPLI-g® protocol supplemented with rRNasin® were 
whole transcriptome sequenced. These consisted of one single cell reaction isolated by 
limiting dilution (1A, Figure 5.7A Lane 10), two single cells isolated by FACS (1D and 
1E, Figure 5.7B Lanes 8 and 10), one reaction containing three cells isolated by FACS 
(1C, Figure 5.B Lane 5) and one reaction containing 10 cells isolated by FACS (1B, 
Figure 5.B Lane 4). Sequencing reads were mapped to the P. falciparum 3D7 genome. 
Alignment rates were generally good (Table 5.3), except for one of the FACS-isolated 
single cells (1D) which had an alignment rate of 2.6%, indicating that nearly 100% of 
reads did not belong to P. falciparum 3D7. MiniKraken was used to assess 
contamination in the newly sequenced transcriptomes (Table 5.4). As with the 
previously sequenced gDNA contaminated samples, bacterial species accounted for the 
bulk of microbial contamination, with Enterobacteria being the most highly represented. 
The samples had varying degrees of contamination with species that were found in the 
originally sequenced single cells. Single cell 1A had 17% of reads mapping to the 
Firmicutes phylum, which is represented in all of the Plasmodium samples but at much 
lower amounts. The single cell sample (1D) which had a very low Plasmodium  
 171 
 
 
 
Figure 5.7. msp-4 PCR carried out on samples containing 1 – 100 schizonts isolated by 
FACS and limiting dilution using the amended REPLI-g® protocol. So far, the REPLI-g® 
protocol alterations had been tested on large pools of 1000 parasites and on purified 
RNA. The altered protocol was carried out on reactions containing 100, 10, 3, or single 
parasites, and material was used in the msp-4 PCR A. Parasite aliquots of 100, 10, 3, 
and single cells were obtained by serial dilution. Reactions underwent WTA with the 
addition of rRNasin®. One reaction was set up with 100 cells, and the msp-4 PCR 
showed gDNA product (lane 2). Two reactions containing 10 cells failed (lanes 3 and 4). 
One out of three reactions containing 3 cells showed msp-4 cDNA product (lane 5). Of 
three reactions containing a single cell, one produced a very weak msp-4 cDNA 
product (lane 10). B. Parallel reactions set up using FACS to isolate cells. The 100 cell 
reaction showed msp-4 gDNA (lane 2). The two 10 cell reactions and one 3 cell 
reaction showed cDNA products (lanes 3-5). Two single cells showed very weak msp-4 
cDNA product (lanes 8 and 10). Lanes 11-12 show the gDNA and cDNA controls. Lane 
13 shows the negative control. 
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Table 5.3. Sequencing statistic from the P. falciparum 3D7 schizonts samples 
amplified using the amended REPLI-g® protocol, supplemented with an RNase 
inhibitor. 
Sample  
No. of 
cells 
No. of 
reads 
(millions) 
Alignment 
rate to 3D7 
(%) 
No. of genes 
with >0 
reads 
No. of genes 
with >10 reads 
Isolation 
method 
1A (Fig.5.7A, L10*) 1 10.4 37 1736 652 Dilution 
1B (Fig.5.7B, L4*) 10 9.0 69.2 4422 2514 FACS 
1C (Fig.5.7B, L5*) 3 6.9 64.7 2045 867 FACS 
1D (Fig.5.7B, L8*) 1 5.3 2.6 807 117 FACS 
1E (Fig.5.7B, L10*) 1 14.85 45.6 2076 889 FACS 
One sample contained a schizont-infected erythrocyte isolated by limiting dilution, 
four samples (one with 10 infected erythrocytes, one with 3 and two with 1) were 
isolated by FACS. Alignment to the P. falciparum 3D7 reference genome ranged from 
2% to 69%. * L indicates the electrophoresis lane showing the MSP-4 amplicon for each 
sample in Figure 5.7. 
 
 
 
 
alignment rate (2.5%), had 5% of reads mapping to the microbial database, with human 
contamination being a possibility for the remainder of the reads.  
 
To ensure that cDNA has indeed been captured and sequenced, the sequence data were 
viewed in Artemis. Several multi-exon genes were viewed, where intron-exon 
boundaries were clearly visible, confirming that the transcriptomes had indeed been 
sequenced (Figure 5.8). Sequence data obtained from a limiting number of cells are 
likely to show “patchy” coverage across the transcriptome due to the effect of random 
sampling error, particularly for low transcript number genes (Brennecke et al. 2013). To 
investigate the extent to which this impacted the single cell data, the WTA samples 
were compared to five schizont-specific P. falciparum 3D7 transcriptomes generated 
from bulk culture (prepared and sequenced by Dr. Sarah Tarr). Most genes (>4500) 
sequenced from the bulk cultures are detectable (with one or more mapped reads)  
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Table 5.4 Contamination present in sequence data from samples whole 
transcriptome amplified using the amended REPLI-g® protocol. 
 Percentage of short reads mapping to the named taxa 
for each sample 
Taxonomic name and rank 1A  
(1 cell) 
1B  
(100 cells) 
1C  
(3 cells) 
1D  
(1 cell) 
1E  
(1 cell) 
Bacteria Domain 24.7 16.0 11.9 4.88 13.0 
Proteobacteria Phylum 4.79 14.8 9.22 4.05 9.10 
…Gammaproteobacteria Clade 4.62 13.6 8.73 3.81 9.03 
…Betaproteobacteria Clade 0.14 0.08 0.16 0.03 0.05 
…Alphaproteobacteria Clade 0.01 0.08 0.23 0.03 0.01 
Actinobacteria Phylum 0.40 0.01 0.26 0.00 0.50 
Firmicutes Phylum 18.1 0.66 0.52 0.03 0.19 
…Bacilli Clade 18.1 0.05 0.52 0.03 0.18 
Viruses Domain 0.15 0.22 0.35 0.20 0.14 
The software Kraken was used to assign taxonomic labels to the short sequence reads 
that did not map to P. falciparum 3D7. A number of Phyla and Clades were 
represented at above 0.1% of short sequence reads per sample, which are listed 
above. The vast majority of contamination originated from bacteria. Other taxa were 
represented at lower levels. 
 
 
 
 
(Figure 5.9A), and these whole transcriptomes are represented mostly by moderately 
expressed genes, with a small number having zero counts, and fewer being expressed at 
very high levels (Figure 5.9B). 
The single and three cell samples had a far greater number of genes with no detectable 
expression (Figure 5.9A) and these represented the bulk of genes (Figure 5.9D and E). 
The single cell (1D) with very low alignment rate had the greatest number of genes with 
no mapped reads, and only had 117 genes with more than 10 mapped reads (Table 5.3), 
indicating that the number of detected genes is more likely to be a function of poor data 
sampling and sparseness, rather than true biological variation in which genes are 
expressed in a single cell or small subset of cells. The three cell and the other single cell  
transcriptomes had roughly equal numbers of genes with zero mapped reads and had 
867 and 889 genes with more than 10 mapped reads, respectively (Table 5.3). The  
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Figure 5.8. Sequence data from the samples whole transcriptome amplified using the 
amended REPLI-g® protocol mapping to multi-exon genes shown in the Artemis 
genome browser. The distribution of short sequencing reads pooled from reactions 
containing 10, 3, and single cells across two multi-exon genes show sharp boundaries 
at intron-exon boundaries, represented by the grey bars that signify when a short 
sequence read (blue and green bars) has been split across an intron. This indicates that 
sequence data has originated from RNA, rather than from genomic DNA, in contrast to 
the read distribution seen in Figure 5.1B from the first single cell experiment. 
 
 
 
 
transcriptome from the ten pooled cells (1B) recapitulated more closely the number of 
detected genes seen in the five bulk transcriptomes and had 2514 genes with more than 
10 mapped reads (Table 5.3), and perhaps indicates that this number of cells provided 
sufficient RNA to reduce the transcriptome-wide sparseness. The read distributions for 
the single, 3 cell and 10 cell samples are heavily skewed towards zero and low count 
read mapping (Figure 5.9C-E). While the 10 cell sample is shown to have slightly more 
genes with moderate numbers of read counts (Figure 5.9C), few genes have moderate of 
high read counts in the single cell transcriptomic sequence data (Figure 5.9D). 
 
Further investigation into the distribution skew of read mapping revealed that while the 
library sizes for the single and low number samples were reasonably large 
(approximately 2x106 reads or more), the vast majority of the reads mapped to  
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Figure 5.9. Technical graphs showing the number of detectable genes and 
distribution of read counts per gene in each of the whole transcriptome sequenced 
samples. Using the REPLI-g® protocol, whole transcriptomes were sequenced from 
three single P. falciparum schizonts, along with a transcriptome from three pooled 
cells, and one from ten pooled cells. A. The number of detectable genes (those with 1+ 
mapped reads) is substantially lower at lower cell numbers (blue bars) when compared 
to transcriptomes generated from bulk culture material (grey bars). The reaction 
containing ten cells contained numbers of detectable genes comparable to that of the 
bulk transcriptomes from schizonts previously prepared. B-E. The frequency 
distributions of number of reads per gene. Bulk transcriptomes (B) show an even 
distribution of gene expression levels, with the majority of genes being moderately 
expressed. The sample containing ten cells (C) showed some moderately expressed 
genes, however the majority of genes were either not detectable, or contained less 
than 5 mapped reads. The reactions containing three cells (D) and single cells (E) 
showed an even greater proportion of genes with zero mapped reads, and few genes 
with moderate expression. 
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ribosomal RNA genes rather than to protein-coding genes (Figure 5.10). 83% of reads 
from the ten pooled cells mapped to rRNA genes, 88% of reads from the three pooled 
cells samples mapped to rRNA genes, and between 94% and 96% of the reads from the 
three single cells mapped to rRNA genes, resulting in the number of reads mapping to 
protein coding genes ranging between 6,056 (single cell 1D) to 710,326 (ten pooled 
cells). By contrast, transcriptomes sequenced from bulk P. falciparum 3D7 schizonts 
had an average of only 14% of reads mapping to rRNA genes, ranging from 0.2%-35%. 
 
 
5.3.6 The Fluidigm C1™ system for high-throughput acquisition of single cells 
The commercially available microfluidic system, the C1™ (Fluidigm) was tested as an 
alternative method to flow sorting and use of the REPLI-g® kit. The C1™ handles cell 
isolation, reverse transcription and amplification on a microfluidic chip (“Integrated 
fluidic circuit”) with minimal user input after the chip has been set up and utilises the 
SmartSeq® v4 template-switching PCR-based commercially available single cell kit 
(Clontech). Amplified material from the C1™ can then be prepared for whole 
transcriptome sequencing. The microfluidic chip used contained 96 “capture sites” 
through which the cell suspension flows and into which cells are isolated, ideally one 
per capture site. To test the C1™ system, P. falciparum 3D7 schizonts were purified 
and fixed with DSP. Schizonts were stained with Vybrant® DyeCycle™ Green to 
fluoresce DNA, and assessed microscopically after fixation to ensure that erythrocytes 
were intact and undamaged (Figure 5.11). The schizont suspension was subsequently 
loaded onto the C1™ microfluidic chip and after cell capture had taken place each of 
the capture sites was viewed microscopically to assess the state of each capture site. Of 
the 96 sites, 33 contained a single schizont, six contained a single cell plus 
unidentifiable “debris”, 19 contained more than one cell (one site contained five cells), 
and 37 sites were empty. 
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Figure 5.10. The proportion of reads mapping to P. falciparum genes encoding rRNA 
and protein-coding genes for the whole transcriptome sequence samples, compared 
to bulk RNA-seq data. RNA-seq data from five transcriptomes obtained from P. 
falciparum 3D7 bulk preparations (Bulk 1 – 5) showed that an average of 14% of reads 
mapped to genes encoding rRNAs. The three single cells (1A, 1D and 1E), the three 
pooled cells (1C) and the ten pooled cells (1B) that were prepared by whole 
transcriptome amplification (WTA) using the amended REPLI-g® protocol by 
comparison contained between 83% and 96% of reads mapping to rRNA genes. 
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Figure 5.11. DSP fixation of P. falciparum 3D7 schizonts. The Fluidigm C1™ platform 
was tested for single-cell RNA-seq. P. falciparum schizonts were isolated and fixed with 
DSP, following tested protocols (Attar et al. 2018), stained with Vybrant® DyeCyle™ 
Green DNA dye, before being loaded onto the C1 microfluidic chip. A. After DSP 
fixation, schizont-infected erythrocytes remained intact and retained their expected 
morphology. B. The Vybrant® DyeCyle™ Green DNA dye was used to stain the 
schizonts to allow viewing of cells after isolation on the microfluidic chip, showing 
individual merozoites within the fixed schizonts. 
 
 
 
 
The average concentration of DNA per single cell was 0.8 ng/ul. Quality of DNA from 
the C1™ samples was assessed on the Bioanalyzer, to evaluate suitability of samples 
for whole transcriptome sequencing. Two distinct features were apparent among the 
Bioanalyzer trace. The first is a small (~40bp) peak of low intensity which can be seen 
just adjacent to the lower marker (Figure 5.12A), either in isolation, or along with a 
large peak, between ~7kb and ~10kb in size, often overlapping with the upper marker 
(Figure 5.12B). The expected distribution of fragment sizes for material generate by the 
C1™ is ~ 600bp - ~2000bp (Figure 5.12C) and the SmartSeq® v4 chemistry is not 
expected to result in very long, ligated cDNA fragments (unlike the previously used 
MDA REPLI-g® method) and so the msp-4 intron-spanning PCR was used to 
determine whether the large DNA fragments represent gDNA. The PCR revealed that 
out of the 33 single cells, 15 were positive for msp-4 gDNA, the remaining 18 did not  
A B 
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Figure 5.12. Bioanalyzer traces showing DNA fragments obtained using the C1™ 
platform. Samples containing cells isolated using the Fluidigm C1™ had cDNA run on a 
Bioanalyzer to determine their suitability for whole transcriptome sequencing. Several 
samples did not show any peaks on the BioAnalyzer. Those that did have peaks 
showed one of two patterns. A. Some samples contained a single, low intensity peak of 
low molecular weight (~40bp), believed to be cDNA originating from heavily degraded 
RNA. B. Some samples showed the ~40bp peak, along with a high intensity, high 
molecular weight peak representing fragments approximately 7kb-10kb in size. It is 
thought that this peak originated from P. falciparum genomic DNA. C. The expected 
Bioanalyzer trace from cDNA successfully amplified from single cells (spiked with 
purified RNA) using the Fluidigm C1™, showing the expected peak size distribution of 
~600 - ~2000bp (Source: “Using C1 to generate Single-Cell cDNA libraries for mRNA 
sequencing” manual by Fluidigm). 
 
 
 
 
 
 
 180 
have any product. Without confirmation, it is likely that the small peak on the 
Bioanalyzer at ~40bp (Figure 5.12A) represents very short cDNA fragments originating 
from highly degraded RNA, and that the large peak represents amplified gDNA. 
 
 
5.4 Discussion 
In this chapter, methods for whole transcriptome amplification and sequencing from P. 
falciparum single schizonts were tested, resulting in the sequencing of three single cell 
transcriptomes after numerous method optimisations. Multiple displacement 
amplification was used to amplify cDNA obtained from RNA in single cell and low 
number cells isolated by FACS or by serial dilution. Initial experiments revealed that 
the amplification had failed to capture any cDNA, and instead the sequence data 
originated from P. falciparum genomic DNA. Following a series of optimisation steps, 
the addition of an RNase inhibitor allowed the amplification of cDNA from three single 
cells, one sample containing three cells, and one sample containing 10 cells. These 
samples underwent whole transcriptome sequencing. Comparison to transcriptomes 
obtained from bulk parasite culture exposed the level of sparseness seen in data 
belonging to very low cell number reactions. Among the genes with non-zero read 
counts, the vast majority had less than 10 mapped reads. These data illustrate the 
technical challenges that need to be overcome before single cell transcriptomes can 
reliably represent true biological differences. 
 
Contamination of reactions with non-target DNA was minimised by working within 
PCR-free environments, with  pre-amplification steps being carried out in a laminar 
flow hood, cleaned and UV-sterilised before use. However, of the short reads 
sequenced, alignment to the P. falciparum 3D7 genome varied from 2% to 70% of 
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reads; with the single cell reactions aligning on the lower end of this scale (2% to 45%), 
indicating that despite the precautions taken, contamination still occurred to a 
significant level. This level of contamination within single-cell work is not 
unprecedented (Reid et al. 2018). Bacterial species made up the vast majority of 
contamination in all samples. The exact composition of the contamination varied 
between samples, indicating that it occurred stochastically, rather than representing a 
systematic contamination problem. However there were some common contaminants, 
and these belonged to the Actinobacteria and Firmicutes phyla and the 
Enterobacteriacae family, species of which have previously been identified as common 
sequencing contaminants; the presence and volume of which was noted to be 
compounded by low concentration of the intended input material (Salter et al. 2014). 
 
Ribosomal RNA makes up around 90% of all total cellular RNA, which is problematic 
for transcriptomics. Commercial next-generation sequencing kits typically contain an 
rRNA depletion step prior to reverse transcription, designed to enrich for mRNA and 
ensure that it is these that make up the bulk of sequencing data. However, these 
protocols are not suited for such low concentrations of RNA found in single cells 
without significant depletion of mRNA molecules (Fang and Akinci-Tolun 2016). High 
levels of rRNA contamination in single cell sequencing has been reported previously 
both in Plasmodium and also in other single cell organisms, comprising up to 90% of 
sequencing reads (Kolisko et al. 2014; Reid et al. 2018). These studies utilised FACS 
followed by application of a single cell transcriptomic sequencing method known as 
Smart-seq2 (Picelli et al. 2014). A separate study used a different technique called 
Drop-seq; a droplet based method of single cell RNA-seq, which incorporated a tRNA 
and rRNA depletion step, resulting in less than 5% of reads on average mapping to 
these RNAs in the sequence data (Poran et al. 2017). This method resulted in the 
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detection of far fewer protein-coding genes (~650) compared to experiments using an 
optimised Smart-seq2 protocol (~1900), although another study utilising the Smart-seq2 
protocol detected only around 300-800 genes per parasite (Ngara et al. 2018; Reid et al. 
2018).  
 
Another issue needing to be addressed was the amplification of material from genomic 
DNA, rather than from RNA. It is thought that this resulted from a combination of RNA 
degradation prior to reverse transcription, and an insufficient DNase step, with the 
genomic composition of P. falciparum almost certainly being a compounding factor. 
Genomic G + C content is typically around 30% - 50% for prokaryotes and eukaryotes 
(Li and Du 2014). P. falciparum has an extremely rich AT genome, comprising around 
80% of DNA (up to 90% in intronic and intergenic regions), which is unusually high 
even for Plasmodium species generally (Figure 1.5) (Nikbakht et al. 2015). The reverse 
transcription step of the REPLI-g® protocol utilises an oligo(dT) primer, designed to 
bind to the poly(A) tails of mRNA molecules; precluding amplification from gDNA (or 
from tRNA and rRNA molecules). However, the extreme AT-richness of the P. 
falciparum genome is probably sufficient to allow for some (however inefficient) 
binding of the oligo(dT) primers in genomic DNA. The combination of all of these 
factors could add up to allow the massive amplification of gDNA to the exclusion of 
cDNA seen in the REPLI-g® optimisations, despite the relatively low level of gDNA in 
a schizont compared to mRNA molecules. 
 
The remaining sequencing reads that did map to protein-coding genes allowed detection 
of a variable number of genes per sample; within the expectations of previous studies 
(Poran et al. 2017; Ngara et al. 2018; Reid et al. 2018). Expectedly, as the number of 
cells per sample was increased to 10, a higher proportion of the genome’s complement 
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of genes were detectable. The samples containing single or three cells had far fewer 
detectable genes, which appears to be a result or poor representation due to the technical 
bias experienced, with the highly contaminated single cell having less than 1000 genes 
with one or more reads. However, detectable does not mean reliably expressed. In all 
the samples, almost all of the detected genes were represented by less than 10 mapped 
read, below the technical threshold for reliable “expression”. In previous studies, these 
low detectable gene numbers have none-the-less been used to accurately assign cells to 
specific life stages, indicating that biological information is retained, even when 
sequence data is incomplete (Poran et al. 2017; Ngara et al. 2018; Reid et al. 2018). 
 
The REPLI-g® protocol uses MDA chemistry and a high-fidelity F29 polymerase with 
an extremely low error rate, making it ideal for repeated amplification of cDNA from 
reverse transcribed RNA. An alternative, and arguably more popular, method for single 
cell transcriptomics is the aforementioned Smart-seq2 chemistry, which uses PCR 
amplification and a template-switching reverse transcriptase (Picelli et al. 2014). The 
high-throughput Fluidigm C1™ utilises microfluidics and the commercially available 
SmartSeq® v4 reagents (Clontech) to prepare cells for single-cell transcriptomics. This 
is the same reagent kit used in Chapter 4 to capture transcriptomes from low input 
clinical isolates. The C1™ is capable of capturing 96 single cells on one microfluidic 
chip, however only 1/3 of these “capture sites” contained a single parasitised 
erythrocyte, and none of these generated cDNA, indicating that the standard protocol 
would need adjustment akin to that of the Smart-seq2 protocol optimised by for use 
with P. falciparum cells (Reid et al. 2018) before being used successfully. Parasites 
used on the C1™ were preserved with DSP, use of which has been tested on single cell 
destined for transcriptomics on the C1 platform (Attar et al. 2018). As found with the 
Plasmodium schizonts, the DSP fixation was found not to impact cell morphology and 
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these were found to be captured by the C1™ microfluidics similarly to fresh cells. Most 
importantly, the cDNA profiles from fixed and fresh cells were found to be comparable, 
although the yield of cDNA was less for the fixed cells. This did not seem to impact the 
overall transcriptomic data obtained, with library complexity being maintained from 
fresh to fixed cells, indicating the DSP is most likely a safe fixation protocol to use to 
preserve the RNA in single cells. The Plasmodium parasites captured on the C1™ all 
failed to produce cDNA and roughly half produced gDNA and it seems unlikely that 
this is due to the DSP fixation process, and instead indicates that some modifications to 
the SmartSeq® v4 protocol are needed for this system. 
 
Despite efforts to optimise the REPLI-g® protocol, because the SmartSeq® v4 protocol 
was successful in Chapter 4, future work would be best directed using this approach, 
although utilising the non-commercial Smart-seq2 alternative would be preferable due 
to increased flexibility of integrating and optimising suggested protocols. Isolating cells 
by FACS would allow targeted separation of cells with a specific gene tagged, and 
presents an advantage over the use of the Fluidigm C1™ microfluidic system. It is 
likely that some optimisations would still be necessary when using the Smart-seq2 
protocol, and these can be guided by knowledge gathered through the REPLI-g® 
optimisation, along with those made in other Plasmodium single-cell transcriptomic 
studies (Poran et al. 2017; Ngara et al. 2018; Reid et al. 2018).  
 
In Chapter 4, the commercial Smart-Seq protocol was used to successfully obtain 
transcriptomes originating from limiting material in P. falciparum clinical isolates. 
Transcriptomic differences relating to the MSPDBL2 schizont expression phenotype 
were detectable in these samples. As MSPDBL2 is expressed in a small subset of 
schizonts, single cell sequencing would be a good avenue to pursue. If a P. falciparum 
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parasite line was developed in which mspdbl2 is tagged with GFP, single MSDBL2-
expressing parasites could be sorted by FACS and undergo single-cell transcriptomic 
analysis. This would provide a population of single parasites whose transcriptomes can 
be compared to non-MSPDBL2 expressing parasites of the same background to identify 
differentially expressed genes between the two populations of cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 186 
6 General discussion and concluding remarks 
 
Whole genome and transcriptome sequencing have been used throughout this thesis to 
address questions relating to Plasmodium populations and parasite biology. In addition, 
research undertaken has demonstrated both the power and limitations of working with 
clinical isolates of Plasmodium, for which there is often a very limited amount of 
available material. Chapters 4 and 5 in particular have addressed the very real technical 
limitations that are an integral part of working with very limited, low input material. In 
Chapter 3, sampling was carried out in peninsular Malaysia for clinical isolates of P. 
knowlesi, and 53% of samples collected contained sufficient genomic DNA to proceed 
with whole genome sequencing using the previously defined protocol. In Chapter 4, P. 
falciparum clinical isolates were thawed and cultured ex vivo, and only 17% of the 
samples yielded sufficient material for immunofluorescence assays and RNA-seq. 
Chapter 5 went further to directly test some of the techniques currently available for 
obtaining reliable sequence data from very low input samples containing just one or 
very few cells and to address the challenges faced when working with material of this 
nature, the methods tested produced single cell transcriptomes, however further 
optimisation or testing of alternative techniques is needed to produce high-quality data. 
The research presented in this thesis should go some way to contributing to our 
biological understanding of malaria parasites, while also highlighting the continuing 
need for development and innovation of the processing and sequencing of low input and 
clinical samples. 
 
Recognition of P. knowlesi as a major cause of human malaria in Malaysia has 
encouraged efforts towards understanding the genomics of this species with respect to 
the human host, and importantly how to develop strategies to limit its impact (Cox-
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Singh et al. 2008). Population genomics has played a role in this, firstly through the use 
of multi-locus microsatellite analysis, and more recently by whole genome sequencing 
(Divis et al. 2015; Divis et al. 2018). Whole genome sequencing provides a far greater 
amount of data than previous approaches and has been used to further investigate and 
deep diversity of the sympatric populations of P. knowlesi that co-exist in Malaysian 
Borneo (Divis et al. 2018). Thus far, the population genomics of P. knowlesi in 
peninsular Malaysia (and also throughout the rest of Southeast Asia) has remained 
limited, mainly based on the whole genome sequences of a few old laboratory lines 
from Southeast Asia which indicted the presence of a third divergence cluster, separate 
to those of Malaysian Borneo. Microsatellite analysis of P. knowlesi from humans and 
macaques from peninsular Malaysia has  previously confirmed the existence of this 
third cluster (Assefa et al. 2015; Divis et al. 2017) and single loci genomic analyses 
from P. knowlesi in other countries in Southeast Asia have provided evidence that 
Cluster 3 is found beyond peninsular Malaysia (Ahmed et al. 2018). 
 
The research carried out in Chapter 3 has been the first deep genomic sequencing of P. 
knowlesi parasites collected throughout peninsular Malaysia from hospital patients 
presenting with malaria and identified as P. knowlesi. As was expected from previous 
research, these samples showed clear divergence from the sympatric Clusters 1 and 2 in 
Malaysian Borneo, evidencing ancient population subdivision. This division possibly 
stems from the geographic isolation of Malaysian Borneo from mainland Southeast 
Asia when the last ice age ended around 13,000 years ago, although the divergence 
could predate this (Lee et al. 2011). What was of particular interest was evidence of 
some subdivision among the Cluster 3 samples, which indicates that there is possible 
selection driving divergence between the parasites, the nature of which remains 
unknown, and warrant further investigation. Reports of P. knowlesi malaria are now 
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commonplace throughout Southeast Asia, where its reservoir hosts are distributed and 
human P. knowlesi infections have now been reported in all countries in Southeast Asia. 
Sampling for clinical isolates should be undertaken not only in peninsular Malaysia, but 
in other countries as well, and obtaining sufficient material for whole genome 
sequencing should be matter of course. With divergence seen within Cluster 3 parasites 
from peninsular Malaysia, the genomic analyses of parasites from further into the 
Southeast Asian mainland and from other island countries such as Indonesia and the 
Philippines should prove extremely interesting. A wider repertoire of genomes would be 
very useful for determining the drivers of divergence for these zoonotic parasites, 
particularly with the ongoing risk of adaptation to human infection and the development 
of human-to-human transmission.  
 
An on-going ‘blind spot’ with P. knowlesi research is the relative lack of available 
material from the wild macaque reservoir hosts, and also from the wild vectors. 
Sampling from the blood of wild macaques in Malaysian Borneo followed by 
microsatellite analysis led to the discovery that the divergence between the sympatric 
Clusters 1 and 2 had been driven by the preferential infection of different macaque 
species by each cluster (Divis et al. 2015), although the biology underpinning this is still 
not understood. Sampling in peninsular Malaysia confirmed that Cluster 3 was found in 
both human and wild macaques, and that there were a subset of macaque infections 
which appeared to have intermediate assignments between Clusters 2 and 3 (Divis et al. 
2017). At this time, no whole genomes from wild macaque-sampled P. knowlesi have 
been sequenced. Obtaining usable samples from wild macaques that are suitable for 
whole genome sequencing is difficult as they often have low parasitaemia, multi-
genotype, multi-species infections which would make direct bulk sequencing of P. 
knowlesi parasites highly inefficient. A solution for tackling multi-species infections 
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would be to utilise single-cell techniques using FACS to isolate P. knowlesi-infected 
erythrocytes through the use of antibodies specific to a P. knowlesi protein and 
sequencing from single parasites. This would be technically challenging, though single-
cell genomics is generally more straight forward than the single-cell transcriptomics 
attempted in Chapter 5 as single-cell genomics precludes the need for preserving and 
accurately amplifying highly unstable RNA molecules. Nonetheless, it is hoped that the 
methods trialled in Chapter 5 will not just be useful for investigating P. falciparum, but 
will also be applicable for P. knowlesi, in order to streamline single cell investigations 
in this species. 
 
Study of clinical isolates of P. falciparum here focused on schizont transcriptomes 
correlated with expression of mspdbl2, which may be an early marker of commitment to 
gametocytogenesis. These samples contained very small amounts of infected red blood 
cells and parasites were developed ex vivo until most parasites had gained maturity and 
were harvested prior to reinvasion. The process of culture adaptation presents 
significant selection pressures on clinical isolates and there are detectable changes in 
transcriptomics and phenotypes of parasites adapted to culture (LeRoux et al. 2009; 
Lapp et al. 2015). In addition, long-term culture has been shown to result in the 
accumulation of genomic loss-of-function mutations, often affecting the 
gametocytogenesis pathway (Claessens et al. 2017). The genetics and transcriptomics 
underlying gametocytogenesis are complex. The genes gdv-1 and ap2-g have been 
identified as being required for gametocytogenesis, and mutations in these genes are 
responsible for loss of gametocytogenesis in laboratory lines and for the spontaneous 
loss in culture adapted clinical isolates (Eksi et al. 2012; Kafsack et al. 2014; Claessens 
et al. 2017). In addition, allelic divergence and structural dimorphism has been 
identified at the gdv-1 locus, and it is not yet known how this affects expression of gdv-
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1 and other genes (Duffy et al. 2018). Studies utilising over-expression and knockout of 
gdv-1 and ap2-g have begun to unravel the gene expression pathways necessary for 
gametocyte commitment to occur. However, further research – not just focused on 
laboratory lines, but also using clinical isolates – is needed to gain a clear picture of the 
gametocytogenesis pathway from a genomic and transcriptomic perspective (Filarsky et 
al. 2018; Josling et al. 2019; Usui et al. 2019).  Due to the accumulation of genetic 
mutations, specifically affecting gametocytogenesis, and the preceding changes in 
environmental selection pressure caused by long-term in vitro culture, short-term ex 
vivo culture of clinical isolates is preferable to obtain transcriptomic profiles from 
parasites which have been minimally affected by the in vitro culturing process, even if 
these approaches do present technical difficulties and limitations.  
 
Analysis of gene expression across the P. falciparum transcriptome based on 
MSPDBL2 protein expression in every case identified mspdbl2 to be the gene with the 
most different expression, indicating that the approaches used were reliably identifying 
transcriptional changes despite the limited amount of starting material. The technical 
limits beyond using ex vivo clinical isolates, in which there may be millions of parasites 
present in a sample, are still being explored. Single-cell transcriptomics have been 
applied to malaria parasites over the past few years, leading to biological inference for 
processes such as virulence and gametocytogenesis, however these approaches still rely 
on the sequencing of hundreds or thousands of individual cells to generate enough 
transcriptome information from these cells (Poran et al. 2017; Ngara et al. 2018; Reid et 
al. 2018).  
 
As seen in Chapter 5, sequencing of the mRNA molecules from single cells is still a 
factor of random sampling error and the stochastic nature of reverse transcription and 
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amplification, seen by the low number of genes with more than ten mapped reads. 
Previous evidence has shown how the recovery of mRNA molecules in single-cell 
transcriptomics is a factor of the amount of starting transcript levels. This makes it 
difficult to work with a small unicellular organism within which exists only a small 
number of mRNA molecules when compared to mammalian cells, such that only the 
genes with the highest numbers of transcripts can be very accurately quantified in 
individual cells (Brennecke et al. 2013). This in itself is a limitation, but not an absolute 
barrier and single-cell transcriptomics presents one of the best avenues of continued 
investigation into the work carried out in Chapter 4. For the clinical isolates investigated 
in Chapter 4, expression of the MSPDBL2 protein was usually only in a small 
proportion of parasites, and the transcriptomic profiles of these parasites therefore are 
mostly contributed to by mspdbl2 non-expressing parasites.  A targeted single-cell 
approach guided by developments tested in Chapter 5 could allow further investigation 
into mspdbl2, in particular to test its role in parasite differentiation.  
 
Concluding remarks 
Diverse approaches have been carried out utilising whole genome and transcriptome 
sequencing with an emphasis here on the study of clinical isolates, many of which 
contain limiting numbers of parasites and amounts of nucleic acid. Whole genomes of 
P. knowlesi in clinical isolates have been sequenced and used to investigate diversity 
and selection. Identifying drivers of selection within these parasites will be crucial to 
understanding the transmission dynamics affecting P. knowlesi, particularly as the risk 
of human infection may be increasing. 
In addition, low input techniques have been implemented to investigate how mspdbl2 
may be involved in gametocytogenesis in P. falciparum. With the current lack of safe 
and effective drugs that target gametocytes, increasing our understanding of the genetic 
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networks involved in this process should be central to driving development of new 
therapies that could also block transmission. Continued development and innovation in 
these low input approaches will prove crucial to future research into clinical material.  
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8 Appendices 
 
Appendix 1. Genes with suspected roles in gametocytogenesis based on relevant 
publications (separate Excel spreadsheet on CD-ROM) 
Appendix 2. Tajima’s D values for all P. knowlesi Cluster 3 genes (separate Excel 
spreadsheet on CD-ROM). 
 
Appendix 3. Genomic coordinates and genes within four regions of extended haplotype 
homozygosity in the P. knowlesi population in peninsular Malaysia (separate Excel 
spreadsheet on CD-ROM). 
 
Appendix 4. Genomic co-ordinates of SNPs with elevated Rsb values for Cluster 3 vs. 
Cluster 1 (A), Cluster 3 vs. Cluster 2 (B), and Cluster 3 sub-cluster A vs. sub-cluster B 
(C) (separate Excel spreadsheet on CD-ROM). 
 
Appendix 5. FWS values for all P. knowlesi clinical isolates (separate Excel spreadsheet 
on CD-ROM). 
 
Appendix 6A. Genes with increased expression in clinical isolates with >1% 
MSPDBL2-positive parasites compared with isolates with <1% MSPDBL2-positive 
parasites (separate Excel spreadsheet on CD-ROM). 
 
Appendix 6B. Genes with increased expression in clinical isolates with >3% 
MSPDBL2-positive parasites compared with isolates with <3% MSPDBL2-positive 
parasites (separate Excel spreadsheet on CD-ROM). 
 
Appendix 6C. Genes with increased expression in clinical isolates with >3% 
MSPDBL2-positive parasites compared with isolates with <1% MSPDBL2-positive 
parasites (separate Excel spreadsheet on CD-ROM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 214 
Appendix 7A. Genes with decreased transcription in clinical isolates with >1% 
MSPDBL2-positive parasites compared with isolates with <1% MSPDBL2-positive 
parasites. 
Gene ID log2FoldChange P-value Product Description 
PF3D7_0211600 -1.67 6.20E-03 UDP-N-acetylglucosamine transferase subunit  
PF3D7_0308000 -1.30 8.38E-03 DNA polymerase delta small subunit, putative 
PF3D7_0318700 -2.73 1.10E-03 conserved Plasmodium protein, unknown function 
PF3D7_0408000 -2.41 3.67E-03 conserved Plasmodium protein, unknown function 
PF3D7_0608200 -1.47 3.58E-03 conserved Plasmodium protein, unknown function 
PF3D7_0611700 -2.18 2.86E-03 60S ribosomal protein L39 
PF3D7_0623800 -1.71 6.82E-03 tyrosine kinase-like protein, putative 
PF3D7_0721900 -1.72 5.07E-03 V-type ATPase V0 subunit e, putative 
PF3D7_0819800 -2.02 3.82E-04 conserved Plasmodium protein, unknown function 
PF3D7_0825200 -1.57 7.88E-03 translation initiation factor IF-3 
PF3D7_1024100 -1.91 6.97E-03 conserved Plasmodium protein, unknown function 
PF3D7_1110000 -1.59 7.89E-03 conserved Plasmodium protein, unknown function 
PF3D7_1325500 -1.14 7.52E-03 conserved Plasmodium protein, unknown function 
PF3D7_1349700 -1.96 4.49E-03 peptidase, putative 
PF3D7_1426900 -1.53 7.09E-03 cytochrome b-c1 complex subunit 6, putative 
PF3D7_1428500 -1.30 6.82E-03 protein kinase, putative 
PF3D7_1463600 -1.93 1.43E-03 conserved Plasmodium protein, unknown function 
 
 
Appendix 7B. Genes with decreased transcription in clinical isolates with >3% 
MSPDBL2-positive parasites compared with isolates with <3% MSPDBL2-positive 
parasites. 
Gene ID log2FoldChange P-value Product Description 
PF3D7_0906600 -2.56 1.18E-03 Zinc finger protein, putative 
PF3D7_1111300 -2.63 6.62E-03 Protein transport protein BOS1, putative 
PF3D7_1409600 -1.86 1.07E-03 Conserved Plasmodium protein, unknown function 
PF3D7_1439500 -1.40 5.65E-03 oocyst rupture protein 2, putative 
 
 
Appendix 7C. Genes with decreased transcription in clinical isolates with >3% 
MSPDBL2-positive parasites compared with isolates with <1% MSPDBL2-positive 
parasites. 
Gene ID log2FoldChange P-value Product description 
PF3D7_0814500 -2.46 9.23E-03 conserved protein, unknown function 
PF3D7_0819800 -1.89 7.22E-03 conserved Plasmodium protein, unknown function 
PF3D7_0906600 -2.34 3.04E-03 zinc finger protein, putative 
PF3D7_1111300 -2.59 8.89E-03 protein transport protein BOS1, putative 
PF3D7_1349700 -2.35 6.86E-03 peptidase, putative 
PF3D7_1409600 -1.87 1.45E-03 conserved Plasmodium protein, unknown function 
PF3D7_1439500 -1.36 9.59E-03 oocyst rupture protein 2, putative 
PF3D7_1463600 -2.05 8.49E-03 conserved Plasmodium protein, unknown function 
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Appendix 8. Genes with higher expression correlated to ranked MSPDBL2 protein 
expression at P < 0.01 (separate Excel spreadsheet on CD-ROM). 
 
Appendix 9. Genes with lower expression correlated to ranked MSPDBL2 protein 
expression at P < 0.01 (separate Excel spreadsheet on CD-ROM). 
 
Appendix 10. Genes with decreased transcription correlated to increased mspdbl2 
transcript levels at a P-value of <0.001 (separate Excel spreadsheet on CD-ROM). 
 
 
